,Drug Name,Drug Class,LigandType,ModeOfAction,DrugAliases,TargetCategory,Gene,EntryName,Uniprot,Class,Target class,Subfamily,Target_novelty,INDEX,Trial name,Indication(s),Phase,PhaseDate,ClinicalStatus,Status,Approval,Note,PMID
0,abaloparatide,peptide,Peptide,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,ASH_Sep2016_345,"Abaloparatide, ITM-058, BA-058",Anti-osteoporotic,4,,-,approved,2017,,28389324|26562265
1,abarelix,peptide,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,19,"abarelix, plenaxis",Antineoplastic,4,,-,approved,2003,,16985933
2,acamprosate,small molecule,Amino acid ,antagonist,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,34,"acamprosate,campral",Antineoplastic,4,,-,approved,2004,,15963001
3,acebutolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD001,-,Antihypertensive,4,,-,approved,1984,,2453744|2568935|16268148|11752352
4,acepromazine,small molecule,Aminergic ,antagonist,aceprometazine,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_383,acepromazine,Antipsychotic,4,,-,approved,-,,7918347
5,acepromazine,small molecule,Aminergic ,antagonist,aceprometazine,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_379,acepromazine,Antipsychotic,4,,-,approved,-,,10821438|8593484
6,acepromazine,small molecule,Aminergic ,antagonist,aceprometazine,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_387,acepromazine,Antipsychotic,4,,-,approved,-,,11103886|11873706|15694263|16867246|11752352|20643630
7,acepromazine,small molecule,Aminergic ,antagonist,aceprometazine,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_391,acepromazine,Antipsychotic,4,,-,approved,-,,11755134|9760039
8,acepromazine,small molecule,Aminergic ,antagonist,aceprometazine,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD003,-,Hypnotics and Sedatives,4,,-,approved,-,Withdrawn in EU - not sure if ever in trials in US,17139284|17016423|4406367|11752352
9,acetophenazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD006,-,schizophrenia,4,,-,approved,1961,,17139284|17016423
10,acetophenazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD006,-,schizophrenia,4,,-,approved,1961,,17139284|17016423|11873706|6147851|11752352
11,acetylcholine,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_68,acetylcholine,Antiglaucomic,4,,-,approved,1973,,508313
12,acipimox,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,ASH_Oct2016_428,acipimox,lipid-lowering,4,,-,approved,2003,,22267479
13,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,,19710368|19478135
14,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,,19710368|19478135
15,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,,19710368|19478135
16,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,,19710368|19478135
17,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,,19710368|19478135
18,acrivastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_235,acrivastine,Anti-Allergic,4,,-,approved,1994,,1715267
19,adenosine,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2267,"adenogesic, adenosine (intravenous)",Analgesics,4,,-,approved,1989,endogenous ligand,11752352|20370662|20370661|17321471|16339914|20136829|17438146|17442976
20,adenosine,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2267,"adenogesic, adenosine (intravenous)",Analgesics,4,,-,approved,1989,endogenous ligand,20370662|20370661|17321471|16339914|19749080|20136829|17438146|17442976
21,adenosine,small molecule,Nucleotide ,agonist,,primary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2267,"adenogesic, adenosine (intravenous)",Analgesics,4,,-,approved,1989,endogenous ligand,20370662|20370661|17321471|16339914|20136829|17438146|17442976
22,adenosine,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2267,"adenogesic, adenosine (intravenous)",Analgesics,4,,-,approved,1989,endogenous ligand,20370662|20370661|17321471|20136829|17438146|17442976
23,agomelatine,small molecule,Melatonin ,agonist,,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,86,"agomelatine , ago178c, s-20098,valdoxan, thymanax",Anti-depressant,4,,-,approved,2009,,15289999
24,agomelatine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,87,"agomelatine, ago178c, s-20098,valdoxan, thymanax",Anti-depressant,4,,-,approved,2009,,15289999
25,agomelatine,small molecule,Melatonin ,agonist,,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,87,"agomelatine, ago178c, s-20098,valdoxan, thymanax",Anti-depressant,4,,-,approved,2009,,15289999
26,albiglutide,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,101,"albiglutide, gsk716155,syncria",Antidiabetic,4,,-,approved,2014,,25136065
27,albuterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_173,albuterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,1981,,17996583
28,alcaftadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD011,-,Anti-Allergic,4,,-,approved,2010,,22035879
29,alfentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0108,"ox51,  sublingual alfentanil",Analgesics,4,,-,approved,1986,,10955836|15694871|16906017|11240090|11752352
30,alfentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD015,-,Analgesics,4,,-,approved,1986,,10955836|15694871|16906017|11240090|11752352
31,alfuzosin,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,107,"alfuzosin,uroxatral",benign prostatic hyperplasia,4,,-,approved,2003,,11752352|8799556|12892027|9122046|15639685|9223558|8196478|9870119|16613526|16553574|11750253
32,alfuzosin,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,107,"alfuzosin,uroxatral",benign prostatic hyperplasia,4,,-,approved,2003,,11752352|8799556|9122046|15639685|8196478|16613526|16553574|11750253
33,alfuzosin,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,107,"alfuzosin,uroxatral",benign prostatic hyperplasia,4,,-,approved,2003,,11752352|8799556|9122046|15639685|8196478|9870119|16613526|16553574|11750253
34,almotriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,120,"almotriptan,axert, almogran, amignul",Anti-migraine,4,,-,approved,2001,,10193663|10824628|11050304|11069595|11134654|11752352
35,almotriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,120,"almotriptan,axert, almogran, amignul",Anti-migraine,4,,-,approved,2001,,10193663|11134654|11642004|11752352
36,alprenolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD019,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1966,"No longer marketed, but may still be available",2439825|2859531|2871880
37,alprenolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD019,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1966,"No longer marketed, but may still be available",7678677|7606348|10433496|12522078|2828119|11752352
38,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2039,"topical alprostadil cream,alprox-td, befar, vitaros",sexual dysfunction,4,,-,approved,1981,,10509658|15840408|11752352
39,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2039,"topical alprostadil cream,alprox-td, befar, vitaros",sexual dysfunction,4,,-,approved,1981,,15560119|14561849|10670413|16516814|11524243
40,alverine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_395,alverine,Antispasmodics,4,,-,approved,2014,,11697552
41,alvimopan,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2549,entereg,opioid-induced bowel dysfunction,4,,-,approved,2008,,17909271|19086236|16597533|11752352|15882122|11755894
42,alvimopan,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD021,-,Opiate Antagonists,4,,-,approved,2008,,17909271|19086236|16597533|11752352|15882122|11755894
43,amantadine hcl,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0242,"ads-5102, amantadine hcl extended release",dyskinesias,4,,-,approved,1968,,9195603|10443547
44,ambrisentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1111,letairis,Antihypertensive,4,,-,approved,2007,,20811346|19389876|19601701|19920913
45,amiodarone,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,160,"amiodarone hcl,amio-aqueous iv",Anti-Arrhythmia,4,,-,approved,1985,,12083991
46,amitriptyline,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1491,oms-103hp,Analgesics,4,,-,approved,1961,,7855217
47,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_200,amoxapine,unipolar depression,4,,-,approved,1980,,11180191
48,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_210,amoxapine,unipolar depression,4,,-,approved,1980,,16135699
49,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_221,amoxapine,unipolar depression,4,,-,approved,1980,,16135699
50,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_64,amoxapine,unipolar depression,4,,-,approved,1980,,1966571|11180191
51,amphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,1862,"sli 381, spd 465,adderall, adderall xr, adderall ir",cognitive dysfunction; ADHD,4,,-,approved,1996,,17218486|17234900|17212650|17234899|15764732
52,anileridine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD027,-,Analgesics; Narcotics,4,,-,approved,1982,,17139284|17016423|11752352
53,anisotropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD029,-,Antispasmodics; Anti-ulcer,4,,-,approved,1982,,17139284|17016423|4555460
54,anisotropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD029,-,Antispasmodics; Anti-ulcer,4,,-,approved,1982,,17139284|17016423|4555460
55,anisotropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD029,-,Antispasmodics; Anti-ulcer,4,,-,approved,1982,,17139284|17016423|4555460|6897316|20391952
56,antazoline,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_232,antazoline,atrial fibrillation,4,,-,approved,1994,,16129921
57,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,207,"apomorphine hydrochloride,apokyn, apo-go",anti-parkisonian,4,,-,approved,2004,,11752352
58,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,207,"apomorphine hydrochloride,apokyn, apo-go",anti-parkisonian,4,,-,approved,2004,,11343576|11752352|11212866|18691132|10641988|11692072|11215397|10494453
59,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,207,"apomorphine hydrochloride,apokyn, apo-go",anti-parkisonian,4,,-,approved,2004,,15007532|11752352|18691132|9497025|17067298|9871530|17164075
60,apraclonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_135,apraclonidine,Antiglaucomic,4,,-,approved,1987,,1676991
61,apraclonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_162,apraclonidine,Antiglaucomic,4,,-,approved,1987,,1676991
62,apraclonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD032,-,Antiglaucomic,4,,-,approved,1987,,17139284|17016423|11481271|17824139|16921219|12630335|14575724|15748550|20399934|17572343|16935593
63,aprepitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,209,"aprepitant, mk-869, fosaprepitant dimeglumine, mk-0517,emend",Antiemetics,4,,-,approved,2003,,11752352|12590540|17643344|12784346|12227806|15121485
64,arbutamine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD034,-,Cardiotonic,4,,-,approved,1997,,17139284|17016423|8723169
65,arformoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2276,brovana,Bronchodilator,4,,-,approved,2006,,14725487|17594727|17352511|20406080|16022567|18501650|17472819|11752352
66,arformoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD036,-,Bronchodilator,4,,-,approved,2006,,14725487|17594727|17352511|20406080|16022567|18501650|17472819|11752352
67,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,22,abilify,schizophrenia,4,,-,approved,2002,,12063084|14647959|14709325|15257633|15862515
68,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_1,"aripiprazole lauroxil, alks 9070",psychosis,4,,-,approved,2015,,12063084|14647959|14709325|15257633|15862515
69,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,22,abilify,schizophrenia,4,,-,approved,2002,,14642974|17242925|17265076
70,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_14,"aripiprazole lauroxil, alks 9070",psychosis,4,,-,approved,2015,,14642974|17242925|17265076
71,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,22,abilify,schizophrenia,4,,-,approved,2002,,16366516|9083792|16925992|16981227|17501690|11752352
72,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_58,"aripiprazole lauroxil, alks 9070",psychosis,4,,-,approved,2015,,16366516|9083792|16925992|16981227|17501690|11752352
73,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,10592235|18308814
74,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,10592235|21655346|18308814
75,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,10592235|21655346|18308814
76,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,10592235|21655346|18308814
77,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,21655346|18308814
78,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR5A,5ht5a_human,P47898,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,21655346|18308814
79,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,21655346|18308814
80,asenapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,21655346|21658377|18308814
81,asfotase alfa,enzyme,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,ASH_Sep2016_303,asfotase alfa,hypophosphatasia,4,,-,approved,2015,,20446681|21345969
82,astemizole,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD037,-,Anti-Allergic,4,,-,approved,1988,,8001268|6146346|3147222|10597865|10597866|6204835|2892659|11752352
83,atenolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD038,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1981,,10913016|12065078|17628611|9300315|11752352
84,atosiban,small molecule,Protein,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,ASH_Oct2016_425,atosiban,labor repressant,4,,-,approved,2013,,22069312
85,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,,16248990|17087737|15333678|17588565|16188951|7855217
86,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,,7855217|17139284|17016423
87,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,,7855217|17139284|17016423
88,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,,7855217|17139284|17016423
89,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,,7855217|17139284|17016423|11752352
90,azatadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD041,-,Anti-Allergic,4,,-,approved,1977,,9638277|2568212|2523301|7528133|11752352
91,azelastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,313,azelastine,Anti-Allergic,4,,-,approved,1996,,2540229|8829888|9585822|11752352|19209282|17723160|10478514
92,azelastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,314,"azelastine hydrochloride nasal spray,astepro",Anti-Allergic,4,,-,approved,1996,,2540229|8829888|9585822|11752352|19209282|17723160|10478514
93,azelastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,679,"dymista, azelastine hydrochloride + fluticasone propionate, mp29-02",Anti-Allergic,4,,-,approved,2012,,2540229|8829888|9585822|11752352|19209282|17723160|10478514
94,azilsartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,315,"azilsartan medoxomil, tak-491",Antihypertensive,4,,-,approved,2011,,11752352|23563275
95,azilsartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMAmay2016_0371,"edarbyclor, azilsartan medoxomil + chlorthalidone",Antihypertensive,4,,-,approved,2011,,11752352|23563275
96,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2017_001,baclofen,anti-spastic,4,,-,approved,1977,,10658574|15235087|8388192|10751439|11008066|19303900|10328880|10545129
97,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2017_001,baclofen,anti-spastic,4,,-,approved,1977,,8388192|11752352|10386831|19303900|10444662|10482760|10494996|10545129|10094428
98,benperidol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_384,benperidol,Antipsychotic,4,,-,approved,2006,"not FDA approved, European approval",27241797
99,benzphetamine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD046,-,Central Nervous System Stimulants,4,,-,approved,1960,,17139284|17016423
100,benzphetamine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD046,-,Central Nervous System Stimulants,4,,-,approved,1960,,17139284|17016423
101,benztropine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD049,-,Antiparkinson,4,,-,approved,1954,,16460947
102,bepotastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,336,"bepotastine besilate,bepreve, talion",Anti-Allergic,4,,-,approved,2009,,16914135|11752352
103,betahistine,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0919,betahistine,vertigo,4,,-,approved,1970,,18447604|11700150
104,betahistine,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0920,betahistine,vertigo,4,,-,approved,1970,,18447604|11700150|20530654
105,betanechol,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,648,dm-71,Antidiabetic,4,,-,approved,1970,,11798291|17413603
106,betaxolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD052,-,Antihypertensive,4,,-,approved,1985,,12181453|17513029|2077180|2891463|11752352
107,betazole,small molecule,Aminergic ,agonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD053,-,Diagnostic,4,,-,approved,1982,,2892392|3661710|2886642|2874214|7213132|11752352
108,bethanechol,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_57,bethanechol,eosinophilic esophagitis,4,,-,approved,1948,,17139284|17016423|17413603|11798291|16953191
109,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,,11752352
110,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,,11752352
111,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,,11752352
112,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,,11752352|2545383
113,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,,11752352|2545383
114,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,,11752352|2545383
115,bilastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_359,bilastine,Anti-Allergic,4,,-,approved,2010,,27110120
116,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,359,"bimatoprost,  agn 192024,lumigan",Antiglaucomic,4,,-,approved,2001,,11740958|12222762|14733708|18452763|689791|19697832|17724194|11752352
117,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,359,"bimatoprost,  agn 192024,lumigan",Antiglaucomic,4,,-,approved,2001,,14733708|16877408
118,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,359,"bimatoprost,  agn 192024,lumigan",Antiglaucomic,4,,-,approved,2001,,14733708|19232013|16877408
119,biperiden,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD057,-,Antidyskinetics,4,,-,approved,1959,,17139284|17016423|10907719|9798802|10370904|8081071|11752352
120,bisoprolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD058,-,Antihypertensive,4,,-,approved,1992,,1280737|14757145|16325050|1676675|1691366|11752352
121,bitolterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_183,bitolterol,obstructive lung disease,4,,-,approved,1984,,17139284|17016423|10796631|3278878
122,bopindolol,small molecule,Aminergic ,partial agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_371,bopindolol,Antihypertensive,4,,-,approved,-,,11752352|14608456|1687398|2148726|8884690|2907348
123,bosentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2053,tracleer,Antihypertensive,4,,-,approved,2001,,11728166|11752352|11447307|11704565|10961375|11849873
124,bosentan,small molecule,Peptide,antagonist,,primary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2053,tracleer,Antihypertensive,4,,-,approved,2001,,11752352|7921608|16335785|9806221|7858879|15629255
125,brexpiprazole,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1502,brexpiprazole,Anti-depressant,4,,-,approved,2015,,24947465
126,brexpiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1502,brexpiprazole,Anti-depressant,4,,-,approved,2015,,24947465
127,brexpiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1502,brexpiprazole,Anti-depressant,4,,-,approved,2015,,24947465
128,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,385,"brimonidine tartrate,alphagan",Antiglaucomic,4,,-,approved,1996,,10799649|11481271|1373179|11752352
129,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1996,,10799649|11481271|1373179|11752352
130,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,385,"brimonidine tartrate,alphagan",Antiglaucomic,4,,-,approved,1996,,14610637|11606316|12670699|16757535
131,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1996,,14610637|11606316|12670699|16757535
132,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,385,"brimonidine tartrate,alphagan",Antiglaucomic,4,,-,approved,1996,,14610637|8097565
133,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1996,,14610637|8097565
134,bromocriptine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,389,"bromocriptine mesylate,cycloset, ergoset",Antidiabetic,4,,-,approved,1978,,12010185|11752352|18691132|10641988|10626749|12753422|10721819|11444429
135,bromocriptine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,389,"bromocriptine mesylate,cycloset, ergoset",Antidiabetic,4,,-,approved,1978,,18691132|10641988
136,bromodiphenhydramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD062,-,Anti-Allergic,4,,-,approved,1954,,17139284|17016423|11752352
137,bromopride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_366,bromopride,Antiemetics,4,,-,approved,-,,14871277
138,brompheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD063,-,Anti-Allergic,4,,-,approved,1957,,1680053|1970615|7714410|7855217|10212017|11752352
139,buclizine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD064,-,Antiemetics,4,,-,approved,1982,,17139284|17016423
140,buclizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD064,-,Antiemetics,4,,-,approved,1982,,17139284|17016423|11752352
141,bupranolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_369,bupranolol,Antihypertensive,4,,-,approved,-,,19439807
142,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,333,"bema buprenorphine, buccal mucosa adhesive",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,,10729371|10942856|11275413|12435410|15100703|11752352
143,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,,10729371|10942856|11275413|12435410|15100703|11752352
144,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,407,"buprenorphine subcutaneous implant,probuphine",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,2016,,10729371|10942856|11275413|12435410|15100703|11752352
145,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,408,"buprenorphine sublingual tablet,subutex",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,,10729371|10942856|11275413|12435410|15100703|11752352
146,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,409,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,,10729371|10942856|11275413|12435410|15100703|11752352
147,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0045,"butab, rel-1028, oral, enteric-coated buprenorphine",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,,10729371|10942856|11275413|12435410|15100703|11752352
148,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0514,"ox219, buprenorphine + naloxone sublingual tablet",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,,10729371|10942856|11275413|12435410|15100703|11752352
149,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,333,"bema buprenorphine, buccal mucosa adhesive",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,,17244875|16953647
150,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,,17244875|16953647
151,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,407,"buprenorphine subcutaneous implant,probuphine",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,2016,,17244875|16953647
152,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,408,"buprenorphine sublingual tablet,subutex",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,,17244875|16953647
153,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,409,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,,17244875|16953647
154,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0047,"butab, rel-1028, oral, enteric-coated buprenorphine",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,,17244875|16953647
155,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0516,"ox219, buprenorphine + naloxone sublingual tablet",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,,17244875|16953647
156,buserelin,peptide,Peptide,not available,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,ASH_Oct2016_426,buserelin,LHRH analogue,4,,-,approved,-,,20053189
157,buspirone,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD066,-,Anti-anxiety,4,,-,approved,1986,,10027850|10064829|10215901|10221756|10428422|11752352|14769835
158,buspirone,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD066,-,Anti-anxiety,4,,-,approved,1986,,12781354|11421254|11224194|14522358|16214127
159,butorphanol,small molecule,Peptide,partial agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD070,-,Analgesics,4,,-,approved,1978,,10381785|10779697|12127012|12470863|15942128|8968334|8746803|7705457|2555580|17909753
160,butorphanol,small molecule,Peptide,partial agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD070,-,Analgesics,4,,-,approved,1978,,10381785|12127012|12470863|15942128|8968334|8746803|9399970|7705457|17909753
161,butorphanol,small molecule,Peptide,partial agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD070,-,Analgesics,4,,-,approved,1978,,12127012|12470863|15942128|8968334|8746803|7705457|17909753|11752352
162,butriptyline,small molecule,Peptide,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Oct2016_363,butriptyline,Anti-depressant,4,,-,approved,1974,,6086881|3816971|9537821
163,butriptyline,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_365,butriptyline,Anti-depressant,4,,-,approved,1974,,6086881|3816971|9537821
164,cabergoline,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD071,-,Antiparkinson,4,,-,approved,1996,,11752352|12464354|12008749|12721865|15341508|8951172|11436517|18303487
165,caffeine,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,NRDD072,-,Central Nervous System Stimulants,4,,-,approved,1999,,16702031|17372967|17126319|17162470|17085856|11752352
166,caffeine,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,NRDD072,-,Central Nervous System Stimulants,4,,-,approved,1999,,17558310|17577101|17616786|11752352
167,calcitonin human,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,ASH_Sep2016_324,calcitonin human,parathyroid disease,4,,-,approved,1986,endogenous ligand,22461211
168,calcitonin salmon recombinant,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class A (Rhodopsin),GPCR;Secretin,Adrenoceptors,established,ASH_Oct2016_418,calcitonin (salmon),Paget's disease,4,,-,approved,2005,,7610922
169,calcitonin salmon recombinant,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,ASH_Sep2016_321,calcitonin salmon recombinant,osteitis deformans,4,,-,approved,2005,,7610922
170,calcitonin salmon recombinant,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,ASH_Sep2016_323,calcitonin salmon,postmenopausal osteoporosis,4,,-,approved,1978,,7610922
171,candesartan cilexetil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,427,"candesartan cilexetil,atacand",Antihypertensive,4,,-,approved,1998,,19436650|17588300
172,cangrelor,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,428,"cangrelor, ar69931",antithrombotic,4,,-,approved,2015,,26402735
173,captodiame,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_399,captodiame,anxiolytic,4,,-,approved,-,,23863923
174,captodiame,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_400,captodiame,anxiolytic,4,,-,approved,-,,23863923
175,carbachol,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD077,-,Antiglaucomic,4,,-,approved,1972,,15059034
176,carbachol,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD077,-,Antiglaucomic,4,,-,approved,1972,,15485827|15333678|12948933|12505062|16181410
177,carbinoxamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD080,-,Anti-Allergic,4,,-,approved,2003,,7513381|16574052|1143714|19761204|11752352
178,carboprost tromethamine,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD081,-,Abortifacient,4,,-,approved,1965,,17016423|20519365|11338376|9462300
179,cariprazine,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,433,"cariprazine, rgh-188",schizophrenia,4,,-,approved,2015,,23320989
180,cariprazine,small molecule,Aminergic ,partial agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,433,"cariprazine, rgh-188",schizophrenia,4,,-,approved,2015,,23320989
181,carphenazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD082,-,schizophrenia,4,,-,approved,1982,,4889058|4887393|4861216
182,carphenazine,small molecule,Aminergic ,antagonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD082,-,schizophrenia,4,,-,approved,1982,,4889058|4887393|4861216
183,carphenazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD082,-,schizophrenia,4,,-,approved,1982,,4889058|4887393|4861216|11752352
184,carteolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD084,-,Antiglaucomic,4,,-,approved,1988,,11752352|15526107|10864881|16160085
185,carteolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_176,carteolol,cardiovascular disease,4,,-,approved,1988,,1349493|15526107|11752352
186,carvedilol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,435,"carvedilol,coreg",cardiovascular disease,4,,-,approved,1995,,1712335|2575762|2577144|7908256
187,carvedilol,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,434,"carvedilol, coreg",congestive heart failure,4,,-,approved,1995,,17139284|17016423
188,celiprolol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_372,celiprolol,Antihypertensive,4,,-,approved,-,,17141277
189,celiprolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_370,celiprolol,Antihypertensive,4,,-,approved,-,,17384462|17141277|18636069
190,ceruletide,small molecule,Peptide,agonist,,primary,CCKAR,cckar_human,P32238,Class A (Rhodopsin),GPCR;Rhodopsin,Cholecystokinin receptors,established,NRDD085,-,Diagnostic,4,,-,approved,1982,,2087492|1620654|8182534|1356589|2587420|3440035
191,cetirizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,471,"cetirizine hcl,zyrtec",Anti-Allergic,4,,-,approved,2007,,11752352|12787835|15286093|14505791|10597865|15942272
192,cetrorelix,peptide,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,472,"cetrorelix,cetrotide",Antineoplastic,4,,-,approved,2000,,11854630|12606421|14561652|14605254|16809153|11752352
193,cevimeline,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD086,-,Parasympathomimetics,4,,-,approved,2000,,17139284|17016423|18450949|11752352
194,cevimeline,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD086,-,Parasympathomimetics,4,,-,approved,2000,,17139284|17016423|8624083
195,chenodeoxycholic acid,small molecule,Aminergic ,agonist,,primary,NR1H4,nr1h4_human,Q96RI1,Class A (Rhodopsin),Nuclear receptor,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_413,chenodeoxycholic acid,gall stones,4,,-,approved,1983,,10334993
196,chlophedianol,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD087,-,Antitussive,4,,-,approved,1987,Not available in US- discontinued,2905706
197,chlorcyclizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_358,chlorcyclizine,Anti-Allergic,4,,-,approved,-,,21058326
198,chloropyramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_356,chloropyramine,Anti-Allergic,4,,-,approved,-,,19610651
199,chlorpheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD094,-,Anti-Allergic,4,,-,approved,1950,,11736858
200,chlorpromazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_16,chlorpromazine,psychosis,4,,-,approved,1957,,10821438|8593484
201,chlorpromazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_59,chlorpromazine,psychosis,4,,-,approved,1957,,11103886|11873706|15694263|16867246|11752352|20643630|7908055|8524985
202,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,,17139284|17016423
203,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,,17139284|17016423
204,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,,17139284|17016423|1830565
205,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,,17139284|17016423|1830565
206,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,,3774629|2891550
207,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,,8101879|1830565|19091563|11752352
208,chorionic gonadotropin,protein,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,1756,"r-hcg,ovidrel",Antineoplastic,4,,-,approved,1973,,20836886
209,chorionic gonadotropin,protein,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,1904,"stem,ntx-265",stroke,4,,-,approved,1973,,20836886
210,chorionic gonadotropin,protein,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD099,-,Fertility,4,,-,approved,1973,,20836886
211,cimetidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0601,"tl-118, hamsa-1, cyclophosphamide + diclofenac + sulfasalazine + cimetidine",Antihistamines,4,,-,approved,1977,,11752352|10950107|8863950|16723495
212,cimetidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD104,-,GI Anti-Ulcer ; antihistamines,4,,-,approved,1977,,11752352|10950107|8863950|16723495
213,cinacalcet,small molecule,Ion ,PAM,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,2327,"cinacalcet hcl, amg 073,sensipar",hyperparathyroidism,4,,-,approved,2004,,15794735|15864123|15884662|16030053|16109140|19461861|19261825|19181759|19056615|11752352
214,cinacalcet,small molecule,Ion ,PAM,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,NRDD105,-,Calcimimetics,4,,-,approved,2004,,15794735|15864123|15884662|16030053|16109140|19461861|19261825|19181759|19056615|11752352
215,cinitapride,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Oct2016_414,cinitapride,gastrointestinal disorders,4,,-,approved,-,,9211565|9562338
216,cinitapride,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Oct2016_415,cinitapride,gastrointestinal disorders,4,,-,approved,-,,9211565|9562338
217,cinnarizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD107,-,Anti-Allergic,4,,-,approved,1989,,11752352|2866055
218,cisapride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD109,-,Parasympathomimetics,4,,-,approved,1993,,10027842|10328995|10556228|11034583|11218067|11752352
219,clemastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD112,-,Anti-Allergic,4,,-,approved,1977,,11752352|2890562|6701456|6387510|1678430|7513381|4074605|6449094|1266718|8930778
220,clenbuterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD113,-,Bronchodilator,4,,-,approved,-,Not approved in US,11720783|12388476|1322047|1685013|17449161|11752352
221,clidinium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD114,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,2013,,17139284|17016423|11752352
222,clofedanol,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_397,clofedanol,antitussive,4,,-,approved,1987,,17139284|17016423|11752352|2905706
223,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,501,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",diabetic neuropathy; ADHD; antimucositic,4,,-,approved,1974,,28715875
224,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,501,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",diabetic neuropathy; ADHD; antimucositic,4,,-,approved,1974,,28715875
225,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,501,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",diabetic neuropathy; ADHD; antimucositic,4,,-,approved,1974,,11752127|12357167|15306201|14757140|12098614
226,clopidogrel,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,478,cgt-2168,antiplatelet,4,,-,approved,1997,,14668029|15199474|15269827|15291969|15308557|11752352|19463375|16835302|12615691
227,clopidogrel,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,1619,plavix,antithrombotic,4,,-,approved,1997,,14668029|15199474|15269827|15291969|15308557|11752352|19463375|16835302|12615691
228,clozapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,,12769622|14575800|15286066|15781964|16040180|11752352
229,clozapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,,12973385|14530903|14687870|14751426|15037867|7520908
230,cocaine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD123,-,local anesthetic,4,,-,approved,1982,,15351386
231,cocaine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD123,-,local anesthetic,4,,-,approved,1982,,15351386|2840298
232,codeine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD124,-,Analgesics,4,,-,approved,2009,,15509185|17620111|8306082|11752352
233,codeine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD124,-,Analgesics,4,,-,approved,2009,,16386786|7885194|12067475|8119316|2156065|11752352
234,codeine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD124,-,Analgesics,4,,-,approved,2009,,17139284|17016423|17620111|7885194
235,conivaptan,small molecule,Peptide,antagonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,519,"conivaptan, ym-087,vaprisol",hyponatremia,4,,-,approved,2005,,11752352|15659304|16843091|17919259|17202666|17592003|19695403|16522696|19057376|20054444|17428103|19663609
236,conivaptan,small molecule,Peptide,antagonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,519,"conivaptan, ym-087,vaprisol",hyponatremia,4,,-,approved,2005,,11752352|17919259|17202666|17592003|19695403|16522696|19057376|20054444|17428103|19663609
237,corticorelin ovine triflutate,small molecule,Aminergic ,agonist,,primary,CRHR1,crfr1_human,P34998,Class A (Rhodopsin),GPCR;Secretin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_409,corticorelin ovine triflutate,Diagnostic,4,,-,approved,1996,endogenous ligand,20809121
238,cosyntropin,peptide,Peptide,agonist,,primary,MC2R,acthr_human,Q01718,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,established,NRDD128,-,Diagnostic,4,,-,approved,1970,,15710205|2156274|20562554|11752352
239,cromolyn sodium,small molecule,Orphan ,agonist,chromoglycate ,primary,GPR35,gpr35_human,Q9HC97,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,established,MMA_jun2017_010,cromolyn sodium,anti-allergenic,4,-,-,approved,2000,,20559017
240,cyclizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD130,-,Antiemetics,4,,-,approved,1982,,11752352|1983158
241,cyclobenzaprine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2489,"cyclobenzaprine hydrochloride extended-release capsules,amrix",Muscle Relaxants,4,,-,approved,1977,,12498911|8884233
242,cyclobenzaprine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD131,-,Anti-depressant,4,,-,approved,1977,,12498911|8884233
243,cyclopentolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD132,-,Mydriatics,4,,-,approved,1974,,17139284|17016423
244,cycrimine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD134,-,Antiparkinson,4,,-,approved,1982,,17139284|17016423|1267542|11752352
245,cyproheptadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD135,-,Anti-Allergic ; Appetite Stimulant,4,,-,approved,1961,,11752352
246,cyproheptadine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD135,-,Anti-Allergic ; Appetite Stimulant,4,,-,approved,1961,,12233819|12498911|1358088|1403790|16418149
247,danazol,small molecule,Peptide,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2297,optina,diabetic macular edema,4,,-,approved,1976,,2404115
248,danazol,small molecule,Peptide,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD139,-,Antiendometriosis ; Antineoplastic,4,,-,approved,1976,,2404115
249,danazol,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2297,optina,diabetic macular edema,4,,-,approved,1976,,14571621|3004220|14605254|2404115
250,danazol,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD139,-,Antiendometriosis ; Antineoplastic,4,,-,approved,1976,,14571621|3004220|14605254|2404115
251,dapiprazole,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD141,-,opthalmological,4,,-,approved,1990,,17139284|17016423
252,dapiprazole,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD141,-,opthalmological,4,,-,approved,1990,,17139284|17016423
253,dapiprazole,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD141,-,opthalmological,4,,-,approved,1990,,17139284|17016423|9401944
254,darifenacin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,598,"darifenacin,enablex, emselex",overactive bladder,4,,-,approved,2004,,20395537|19416629|18046909|11752352
255,degarelix,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,610,degarelix,Antineoplastic,4,,-,approved,2008,,20110043|20053189|19450172|15705170
256,desipramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD148,-,Anti-depressant,4,,-,approved,1964,,10467920|7855217
257,desloratadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,620,"desloratadine , clarinex",Anti-Allergic,4,,-,approved,2001,,15564772|7581058|8174605|11752352|18336052|17902729|12642846|18797058
258,desmopressin,peptide,Peptide,not available,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1537,"nocdurna,  desmopressin",Antidiuretic,4,,-,approved,1978,,10731046|10594321|8957254|15613460
259,desmopressin,peptide,Peptide,not available,,primary,AVPR1B,v1br_human,P47901,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1537,"nocdurna,  desmopressin",Antidiuretic,4,,-,approved,1978,,15613460|14971638|18655906
260,desmopressin,peptide,Peptide,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1537,"nocdurna,  desmopressin",Antidiuretic,4,,-,approved,1978,,18761325|16333859|11752352
261,dexbrompheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD153,-,Anti-Allergic,4,,-,approved,1963,,9691225|1680053|1970615|7714410|19085565|11752352
262,dexchlorpheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_238,dexchlorpheniramine,sunburn,4,,-,approved,1981,,374215
263,dexmedetomidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_130,dexmedetomidine,Analgesics,4,,-,approved,1999,,15306201
264,dexmedetomidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_149,dexmedetomidine,Antineoplastic,4,,-,approved,1999,,15306201
265,dexmedetomidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD155,-,Analgesics; Hypnotics and Sedatives,4,,-,approved,1999,,11752127|11834617|14583739|15087625|15306201|17692748
266,dezocine,small molecule,Peptide,partial agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD157,-,Analgesics,4,,-,approved,1989,,17139284|17016423|16433932|11752352
267,dezocine,small molecule,Peptide,partial agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD157,-,Analgesics,4,,-,approved,1989,,9399970|11702089|10958085|12513698|9972766|1361946
268,dicyclomine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD162,-,Antispasmodics,4,,-,approved,1950,,17139284|17016423|19533734|11752352
269,difenoxin,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_271,difenoxin,recurrent infection of the gastrointestinal tract,4,,-,approved,1978,,8386327
270,dihydrocodeine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_269,dihydrocodeine,Analgesics,4,,-,approved,1958,,12665158
271,dihydroergotamine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1214,"map-0004, tempo migraine,levadex",Anti-migraine,4,,-,approved,1997,,10455274|14744615|1660351|8622623|9650800
272,dihydroergotamine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1356,mt 300,Anti-migraine,4,,-,approved,1997,,10455274|14744615|1660351|8622623|9650800
273,dihydroergotamine,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1214,"map-0004, tempo migraine,levadex",Anti-migraine,4,,-,approved,1997,,11752352|9605573|1379707|1324091|12558771|1407010|14744615
274,dihydroergotamine,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1356,mt 300,Anti-migraine,4,,-,approved,1997,,11752352|9605573|1379707|1324091|12558771|1407010|14744615
275,dimenhydrinate,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD170,-,Antiemetics,4,,-,approved,1972,,11752352|11835984
276,dimetindene,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_360,dimetindene,Anti-Allergic,4,,-,approved,-,,8608784
277,dimetindene,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_357,dimetindene,Anti-Allergic,4,,-,approved,-,,20800486|8608784
278,dinoprost tromethamine,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD171,-,Abortifacient,4,,-,approved,1981,,17139284|17016423|11752352
279,dinoprostone,small molecule,Lipid ,agonist,,primary,PTGER4,pe2r4_human,P35408,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD172,-,Abortifacient,4,,-,approved,1977,,16545798|18715952|20599704|19788928|17329241
280,dinoprostone,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD172,-,Abortifacient,4,,-,approved,1977,,18715952|20599704|19788928|17329241
281,dinoprostone,small molecule,Lipid ,agonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD172,-,Abortifacient,4,,-,approved,1977,,18715952|20599704|19788928|17329241
282,dinoprostone,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD172,-,Abortifacient,4,,-,approved,1977,,18715952|20599704|19788928|17329241|11752352
283,diphemanil,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD173,-,Bronchodilator,4,,-,approved,1976,,6450282
284,diphenhydramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD174,-,Anti-Allergic ; Hypnotics and sedatives; Antiemetics; Antipruritics; Antitussives,4,,-,approved,1946,,11752352|17169617|16702624|17390763|17196194|17329841|2878016
285,diphenidol,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD175,-,Antiemetics,4,,-,approved,1967,,10497897|9851542|9454790|9059856|8050463|12185001|10530931|1863523
286,diphenidol,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD175,-,Antiemetics,4,,-,approved,1967,,17139284|17016423|12185001|10530931|1863523
287,diphenidol,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD175,-,Antiemetics,4,,-,approved,1967,,17139284|17016423|1863523
288,diphenoxylate,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD176,-,Antidiuretic,4,,-,approved,1960,,11752352|18192961|10202212|8583364|8386327
289,diphenylpyraline,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD177,-,Anti-Allergic,4,,-,approved,1982,,17139284|17016423|1912125|1678430|18977145|15627433|11752352
290,dipivefrin,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_185,dipivefrin,Antiglaucomic,4,,-,approved,1980,,11752352|17622774|17417877|17597612
291,dipivefrin,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD178,-,opthalmological,4,,-,approved,1980,,17139284|17016423
292,dipivefrin,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_88,dipivefrin,Antiglaucomic,4,,-,approved,1980,,17603545|17658513
293,dobutamine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD182,-,Cardiotonic,4,,-,approved,1978,,12098582|15564877|16325050|16627864|11752352
294,dopamine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_169,dopamine,hypotension,4,,-,approved,1974,endogenous ligand,23241039
295,doxacurium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD185,-,Muscle Relaxants,4,,-,approved,1991,,9523819
296,doxacurium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD186,-,Muscle Relaxants,4,,-,approved,1991,,9523819
297,doxazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD187,-,Anticholesteremic ; Antihypertensive ; Vasodilator,4,,-,approved,1990,,15573147|8736427|14767264|9205965|16225542|19002123|17070143|10393471|11752352
298,doxazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD187,-,Anticholesteremic ; Antihypertensive ; Vasodilator,4,,-,approved,1990,,18231614|19002123|17070143|10393471
299,doxazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD187,-,Anticholesteremic ; Antihypertensive ; Vasodilator,4,,-,approved,1990,,18231614|19002123|17070143|10393471
300,doxepin,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,,15286093|7238574|15255990|3011460|6086881|7855217|19179941|17685877|2141000|11752352
301,doxepin,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,,2897127|2141000
302,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,,7855217|19179941|2329499|2141000
303,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,,7855217|2329499|2141000
304,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,,7855217|2329499|2141000
305,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,,7855217|2329499|2141000
306,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,,7855217|2329499|2141000
307,doxepin,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,,7855217|309138
308,doxepin,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,,7855217|309138
309,doxepin,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,,7855217|309138|19179941
310,doxylamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0669,diclectin + diclegis; doxylamine succinate + pyridoxine hydrochloride dr tablets,Antihistamine; for nausea and vomiting of pregnancy,4,,-,approved,1948,,17139284|17016423|11752352
311,doxylamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD188,-,Anti-Allergic ; Antiemetics; Antitussive ; Hypnotics and Sedatives,4,,-,approved,1948,,17139284|17016423|11752352
312,dronabinol,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,437,"cat-310 , relivar",Analgesics,4,,-,approved,1985,,17139284|17016423|12686391|11204352|11752352
313,dronabinol,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,667,"dronabinol ,marinol",Appetite stimulant,4,,-,approved,1985,,17139284|17016423|12686391|11204352|11752352
314,dronedarone,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2270,dronedarone,Anti-Arrhythmia,4,,-,approved,2009,,17389667
315,dronedarone,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2270,dronedarone,Anti-Arrhythmia,4,,-,approved,2009,,17389667
316,dronedarone,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD190,-,Anti-Arrhythmia,4,,-,approved,2009,,17389667
317,dronedarone,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD190,-,Anti-Arrhythmia,4,,-,approved,2009,,17389667
318,droperidol,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_17,droperidol,psychosis,4,,-,approved,1970,,2527092
319,droperidol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD191,-,Adjuvants; Anesthesia,4,,-,approved,1970,,1549935|2527092|14633536|20358234
320,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,,11482743|17266602|20412040|9138687|8825367
321,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,,17266602|20412040|7582530|7674815
322,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,,17266602|20412040|7773533|8166240
323,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,,19434307|9464897|19110970|18064417
324,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,,21173850|18680204|11306720
325,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,,21173850|18680204|18064417
326,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,,21173850|18680204|8590979
327,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,,9464897|19110970|18064417
328,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,,9464897|9666280|7969507|19110970|18064417
329,dulaglutide,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,ASH_Sep2016_332,dulaglutide,Antidiabetic,4,,-,approved,2014,,25367716
330,eletriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_6,eletriptan,Anti-migraine,4,,-,approved,2002,,10193663|11050304|11069595|11513839|12384251|11752352
331,eletriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_10,eletriptan,Anti-migraine,4,,-,approved,2002,,10193663|11834243|15185063
332,eletriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1731,relpax,Anti-migraine,4,,-,approved,2002,,11752352|10193663|15821444|11513839|12498013|11152011
333,eluxadoline,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1363,"mu delta, eluxadoline",irritable bowel syndrome,4,,-,approved,2015,,25261794
334,eluxadoline,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1363,"mu delta, eluxadoline",irritable bowel syndrome,4,,-,approved,2015,,25261794|23583433
335,emedastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD199,-,Anti-Allergic,4,,-,approved,1997,,7714409|7714410|9747899|19558341|15553105|18714531|11752352
336,ephedrine,small molecule,Aminergic ,not available,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD204,-,Central Nervous System Stimulants,4,,-,approved,1963,,17405867|12557268|10592235
337,epinastine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,719,epinastine,Anti-Allergic,4,,-,approved,2003,,16131920
338,epinastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,719,epinastine,Anti-Allergic,4,,-,approved,2003,,17534605|1972625|11752352
339,epinephrine,small molecule,Aminergic ,agonist,adrenaline,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,,11306720|10742288|9836297|1980236|18680204|18064417
340,epinephrine,small molecule,Aminergic ,agonist,adrenaline,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,,11752352|17622774|17417877|17597612
341,epinephrine,small molecule,Aminergic ,agonist,adrenaline,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,,11752352|17622774|17541557
342,epinephrine,small molecule,Aminergic ,agonist,adrenaline,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,,17603545|17658513|20412040|20857090
343,epinephrine,small molecule,Aminergic ,agonist,adrenaline,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,,1979424|11728431|11053214|1980236|18064417
344,epinephrine,small molecule,Aminergic ,agonist,adrenaline,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,,20954794|19730427|20412040|20857090
345,epoprostenol,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD206,-,Antihypertensive ; Platelet Aggregation Inhibitors,4,,-,approved,1995,,19302827|12297509|20522800|11752352
346,eprosartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD207,-,Antihypertensive,4,,-,approved,1997,,11752352|12927226|10856732|12540520|9602957|12782193|12184062|12766389|12517247|18093407|11320369
347,ergoloid,small molecule,Aminergic ,agonist,co-dergocrine mesilate,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_100,ergoloid,cardiovascular disease,4,,-,approved,1953,,8786706|2869188
348,ergoloid,small molecule,Aminergic ,agonist,co-dergocrine mesilate,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_109,ergoloid,cardiovascular disease,4,,-,approved,1953,,8786706|2869188
349,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_141,ergoloid,cardiovascular disease,4,,-,approved,1953,,8786706|2869188
350,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_155,ergoloid,cardiovascular disease,4,,-,approved,1953,,8786706|2869188
351,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD209,-,Nootropic ; Vasodilator,4,,-,approved,1953,,8786706|2869188
352,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD209,-,Nootropic ; Vasodilator,4,,-,approved,1953,,8786706|2869188
353,ergonovine,small molecule,Aminergic ,agonist,ergometrine,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_367,ergonovine,antihaemorrhagic,4,,-,approved,1946,,2897449|19933260
354,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_112,ergotamine,Anti-migraine,4,,-,approved,1960,,18066532
355,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_158,ergotamine,Anti-migraine,4,,-,approved,1960,,18066532
356,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_99,ergotamine,Anti-migraine,4,,-,approved,1960,,18066532
357,ergotamine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD210,-,Anti-migraine,4,,-,approved,1960,,10188968|10455274|11015308|15224175
358,ergotamine,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD210,-,Anti-migraine,4,,-,approved,1960,,12558771|8384716|1407010|14504136|1646776
359,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_140,ergotamine,Anti-migraine,4,,-,approved,1960,,17139284|17016423
360,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_124,ergotamine,Anti-migraine,4,,-,approved,1960,,17139284|17016423|18066532
361,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_87,ergotamine,Anti-migraine,4,,-,approved,1960,,17139284|17016423|18066532
362,esmolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD212,-,Anti-Arrhythmia,4,,-,approved,1986,,11752352|7612051|7957532|2568748|2894187|1975995
363,etelcalcetide,peptide,Ion ,agonist,"amg 416,  velcalcetide,  kai-4169,  ono-5163",primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,MMAapril2016_0047,"etelcalcetide, amg 416, velcalcetide, kai-4169, ono-5163",parathyroid disorders,4,,-,approved,2017,new fda approval in Feb 2017,24235081
364,ethopropazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD217,-,Antidyskinetics,4,,-,approved,1982,,17016423|2904117|2236897|11752352
365,ethylmorphine,small molecule,Aminergic ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_353,ethylmorphine,Analgesics,4,,-,approved,-,,16530171|16580639|16580848|16682505|11752352
366,etomidate,small molecule,Aminergic ,PAM,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD222,-,Anesthetics; Intravenous,4,,-,approved,1982,,20496522|14508322
367,exenatide,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,769,exenatide,Antidiabetic,4,,-,approved,2005,,16722815|17292977|17353295|16534527|17379930|20649595|15331551|15495988|15700891|16341288|16627399|11752352
368,exendin-4,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1572,pc-dac:exendin-4,Antidiabetic,4,,-,approved,2005,,16374859
369,famotidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,929,"hzt-501,  ibuprofen + famotidine,duexa",acid reducer,4,,-,approved,1986,,11752352|17273750|16723495|16702624|16513821|12832840|12509588|2067140|1646056|19578661|18310651
370,famotidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,929,"hzt-501,  ibuprofen + famotidine,duexa",gastric ulcer and gastroesophageal reflux,4,,-,approved,1986,,11752352|17273750|16723495|16702624|16513821|12832840|12509588|2067140|1646056|19578661|18310651
371,famotidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1539,ox17,acid reducer,4,,-,approved,1986,,11752352|17273750|16723495|16702624|16513821|12832840|12509588|2067140|1646056|19578661|18310651
372,fenoldopam,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,778,"fenoldopam mesylate, skf-82526,corlopam",Antihypertensive,4,,-,approved,1997,,11752352|19293728|8103596
373,fenoldopam,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,778,"fenoldopam mesylate, skf-82526,corlopam",Antihypertensive,4,,-,approved,1997,,17139284|17016423|19293728|8103596
374,fenoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD229,-,Bronchodilator ; Tocolytic,4,,withdrawn,approved,-,,11730729|16324695|6203844|8777955|8911881|11752352
375,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,51,ad 923,Analgesics,4,,-,approved,1968,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
376,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,303,"az-003, staccato fentanyl",adjuvant to anesthesia,4,,-,approved,1968,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
377,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,334,"bema fentanyl,onsolis, breakyl",Analgesics,4,,-,approved,1968,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
378,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,394,buccal fentanyl,Analgesics,4,,-,approved,1968,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
379,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,775,"febt,fentora, effentora",Analgesics,4,,-,approved,1968,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
380,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,780,"fentanyl (sublingual), kw-2246,abstral, rapinyl",Analgesics,4,,-,approved,1968,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
381,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,781,"fentanyl citrate,pecfent, nasalfent",Analgesics,4,,-,approved,1968,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
382,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,784,"fentanyl spray, intranasal,instanyl",Analgesics,4,,-,approved,1968,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
383,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,785,fentanyl sublingual spray,Analgesics,4,,-,approved,1968,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
384,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,787,"fentanyl transdermal system,duragesic, ionsys",Analgesics,4,,-,approved,1968,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
385,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2069,"transmucosal fentanyl,actiq",Analgesics,4,,-,approved,1968,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
386,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,51,ad 923,Analgesics,4,,-,approved,1968,,15665994|15828941|15868528|16372825|16861092|19403616
387,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,303,"az-003, staccato fentanyl",adjuvant to anesthesia,4,,-,approved,1968,,15665994|15828941|15868528|16372825|16861092|19403616
388,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,334,"bema fentanyl,onsolis, breakyl",Analgesics,4,,-,approved,1968,,15665994|15828941|15868528|16372825|16861092|19403616
389,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,394,buccal fentanyl,Analgesics,4,,-,approved,1968,,15665994|15828941|15868528|16372825|16861092|19403616
390,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,775,"febt,fentora, effentora",Analgesics,4,,-,approved,1968,,15665994|15828941|15868528|16372825|16861092|19403616
391,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,780,"fentanyl (sublingual), kw-2246,abstral, rapinyl",Analgesics,4,,-,approved,1968,,15665994|15828941|15868528|16372825|16861092|19403616
392,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,781,"fentanyl citrate,pecfent, nasalfent",Analgesics,4,,-,approved,1968,,15665994|15828941|15868528|16372825|16861092|19403616
393,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,784,"fentanyl spray, intranasal,instanyl",Analgesics,4,,-,approved,1968,,15665994|15828941|15868528|16372825|16861092|19403616
394,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,785,fentanyl sublingual spray,Analgesics,4,,-,approved,1968,,15665994|15828941|15868528|16372825|16861092|19403616
395,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,787,"fentanyl transdermal system,duragesic, ionsys",Analgesics,4,,-,approved,1968,,15665994|15828941|15868528|16372825|16861092|19403616
396,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2069,"transmucosal fentanyl,actiq",Analgesics,4,,-,approved,1968,,15665994|15828941|15868528|16372825|16861092|19403616
397,fesoterodine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_53,fesoterodine,prostate adenocarcinoma,4,,-,approved,2007,,19029429
398,fesoterodine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,788,"fesoterodine fumarate, spm 907,toviaz",overactive bladder syndrome,4,,-,approved,2007,,11752352|12076307
399,fexofenadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,789,fexofenadine + ps/,Anti-Allergic,4,,-,approved,1996,,11752352|10864400|15352500|12712828|15286093|10597865|18336052|18797058|19545214|9506246
400,fingolimod,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,794,"fingolimod, fty 720,gilenia, gilenya",Multiple Sclerosis,4,,-,approved,2010,,16374859
401,fingolimod,small molecule,Lipid ,agonist,,primary,S1PR5,s1pr5_human,Q9H228,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,ASH_Aug2017_4,,Multiple Sclerosis,4,,-,approved,2010,,23579459|23579456
402,flavoxate,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD230,-,Antispasmodics,4,,-,approved,1970,,17139284|17016423|19002123|10858873|3247311
403,flavoxate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD230,-,Antispasmodics,4,,-,approved,1970,,17139284|17016423|3247311
404,flibanserin,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,801,flibanserin,sexual dysfunction,4,,-,approved,2015,,12890707|12177684|26412054
405,flunarizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD236,-,Anticonvulsants; Vasodilator,4,,-,approved,1968,,17139284|17016423|20493137
406,flupentixol,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_389,flupentixol,Antipsychotic,4,,-,approved,1965,,7052344
407,flupentixol,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_393,flupentixol,Antipsychotic,4,,-,approved,1965,,17111172
408,flupentixol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_385,flupentixol,Antipsychotic,4,,-,approved,1965,,11752352|11873706|6149133|7498321|1674528|8797192|17111172
409,flupentixol,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_381,flupentixol,Antipsychotic,4,,-,approved,1965,,17139284|17016423|10531405|17111172
410,fluphenazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD241,-,schizophrenia,4,,-,approved,1959,,11752352|11113312|10531405|11873706
411,fluphenazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD241,-,schizophrenia,4,,-,approved,1959,,11873706|7508675|7828655|11752352
412,fluphenazine decanoate,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_61,fluphenazine decanoate,psychosis,4,,-,approved,1972,,7828655
413,fluphenazine enanthate,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_66,fluphenazine enanthate,psychosis,4,,-,approved,1967,,7828655
414,fluspirilene,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD244,-,schizophrenia,4,,-,approved,1977,,17139284|17016423|11752352|11842444|8935801
415,follitropin,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,814,"follitropin alpha ,gonal-f",Fertility,4,,-,approved,1997,endogenous ligand,11299519|7755615|2108722|8319832|8070368|18020563|11752352
416,follitropin,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,MMAmay2016_0738,"bemfola, afolia recombinant follicle stimulating hormone",Fertility,4,,-,approved,1997,endogenous ligand,11299519|7755615|2108722|8319832|8070368|18020563|11752352
417,follitropin,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD246,-,Fertility,4,,-,approved,1997,endogenous ligand,11299519|7755615|2108722|8319832|8070368|18020563|11752352
418,forasartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD248,-,Antihypertensive,4,,-,approved,-,"Never approved by fda, used from long time ago",11569611|8981065|9156352|11752352
419,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,397,"budesonide + formoterol,symbicort",Bronchodilator,4,,-,approved,2001,,12090787|14662724|16432501|2544117|7675115|11752352|9506248|14720051|18686730|1718682|17594727
420,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,481,"chf-1535, beclomethasone dipropionate + formoterol fumarate",Anti-Asthmatic,4,,-,approved,2001,,12090787|14662724|16432501|2544117|7675115|11752352|9506248|14720051|18686730|1718682|17594727
421,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,815,"formoterol ,foradil",Bronchodilator,4,,-,approved,2001,,12090787|14662724|16432501|2544117|7675115|11752352|9506248|14720051|18686730|1718682|17594727
422,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,816,"formoterol fumarate,perforomist",chronic obstructive pulmonary disease (COPD),4,,-,approved,2001,,12090787|14662724|16432501|2544117|7675115|11752352|9506248|14720051|18686730|1718682|17594727
423,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1215,map-0005,Bronchodilator,4,,-,approved,2001,,12090787|14662724|16432501|2544117|7675115|11752352|9506248|14720051|18686730|1718682|17594727
424,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1325,"mometasone furoate + formoterol fumarate dihydrate,dulera",Anti-Asthmatic,4,,-,approved,2010,,12090787|14662724|16432501|2544117|7675115|11752352|9506248|14720051|18686730|1718682|17594727
425,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1681,"pt003, glycopyrrolate + formoterol inhalation aerosol",chronic obstructive pulmonary disease (COPD),4,,-,approved,2016,,12090787|14662724|16432501|2544117|7675115|11752352|9506248|14720051|18686730|1718682|17594727
426,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0044,aclidinium,Anti-Asthmatic ; COPD,4,,-,approved,2001,,12090787|14662724|16432501|2544117|7675115|11752352|9506248|14720051|18686730|1718682|17594727
427,frovatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,823,"frovatriptan,frovelan, frova",Anti-migraine,4,,-,approved,2001,,11752352|11735616|12028320|11152011|10883409|15185063|15311727|9700983|18360605|15342617|12028322
428,frovatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,823,"frovatriptan,frovelan, frova",Anti-migraine,4,,-,approved,2001,,11752352|15311727|12028320|9700983|11735616|17190530|11152011|10883409|18001261|18360605|15342617|12028322
429,gamma hydroxybutyric acid,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,1871,sodium oxybate,Hypnotics and Sedatives,4,,-,approved,2002,endogenous ligand,15745703
430,gamma hydroxybutyric acid,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,1871,sodium oxybate,Hypnotics and Sedatives,4,,-,approved,2002,endogenous ligand,15745703
431,ganirelix acetate,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_412,ganirelix,for prevention of premature ovulation in fertility treatment,4,,-,approved,1999,,15932933
432,ganirelix acetate,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Sep2016_256,ganirelix acetate,Fertility,4,,-,approved,1999,,15932933
433,glucagon,peptide,Peptide,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2458,dio-901,for prevention of hypoglycemia,4,,-,approved,1960,endogenous ligand,17623014| 17620721 
434,glucagon,peptide,Peptide,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,ASH_Sep2016_334,glucagon hydrochloride recombinant,hypoglycemia,4,,-,approved,1998,endogenous ligand,17623014| 17620721 
435,glucagon,peptide,Peptide,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmar2016_0239,zp-glucagon,Antidiabetic,4,,-,approved,1960,endogenous ligand,17623014| 17620721 
436,glucagon,peptide,Peptide,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,NRDD256,-,Antihypoglycemic,4,,-,approved,1960,endogenous ligand,17623014| 17620721 
437,glycopyrrolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,864,"glycopyrrolate, fhpc-02,cuvposa",Antineoplastic,4,,-,approved,1961,,8249551
438,glycopyrrolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1680,pt001,chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,,8249551
439,glycopyrrolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1681,"pt003, glycopyrrolate + formoterol inhalation aerosol",chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,,8249551
440,glycopyrrolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0378,ep-101,chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,,8249551
441,glycopyrronium,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1702,"qva149, glycopyrronium + i/",chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,,28767773
442,gonadorelin,small molecule,Peptide,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD259,-,Fertility,4,,-,approved,1982,endogenous ligand,16973761
443,gonadorelin,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD259,-,Fertility,4,,-,approved,1982,endogenous ligand,15967801|16962597|16973761|17002488|17068198|11752352
444,goserelin,peptide,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Sep2016_255,goserelin,Antineoplastic,4,,-,approved,1989,,20053189
445,goserelin,peptide,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD260,-,Antineoplastic s; Hormonal,4,,-,approved,1989,,17139284|17016423|20053189
446,guanabenz,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD261,-,Antihypertensive,4,,-,approved,1982,,8263811|7903385|8819507|15265636|9050980
447,guanfacine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,889,"guanfacine, spd 503,intuniv",ADHD,4,,-,approved,1986,,10942848|17173664|15928018|11164065|1356794|20331927
448,haloperidol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_65,haloperidol decanoate,psychosis,4,,-,approved,1986,,27578530
449,haloperidol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD266,-,schizophrenia,4,,-,approved,1967,,15894081|16132064|17134027|11752352|16730699|17316700|7520908|20643630
450,hexocyclium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_52,hexocyclium,digestive system disease,4,,-,approved,1982,,8075869
451,hexocyclium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_78,hexocyclium,digestive system disease,4,,-,approved,1982,,8075869
452,histamine,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_239,histamine,Anti-migraine,4,,-,approved,1939,endogenous ligand,16648669|17114052|17222324|17336292|17478759
453,histamine,small molecule,Aminergic ,agonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_410,histamine ,for diagnosis of gastric acid secretory function,4,,-,approved,1939,endogenous ligand,17334413|17359382|11752352
454,histrelin,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2177,"vp 002, histrelin implant,vantas, supprelin",Antineoplastic,4,,-,approved,1991,,10969915|9177416
455,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,,17139284|17016423|11752352
456,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,,17139284|17016423|20085574|11124384
457,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,,17139284|17016423|2612581|20085574|11124384
458,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,,17139284|17016423|6893558
459,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,,17139284|17016423|6893558|11124384
460,hydrocodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2254,"zx002, hydrocodone bitartrate",Analgesics,4,,-,approved,1943,,11752352|10640321|16291875|2849950|14600248|20665209|18606504
461,hydrocodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0192,hydrocodone,Analgesics,4,,-,approved,1943,,11752352|10640321|16291875|2849950|14600248|20665209|18606504
462,hydrocodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0009,"hysingla er, hydrocodone bitartrate extended release",Analgesics,4,,-,approved,1943,,11752352|10640321|16291875|2849950|14600248|20665209|18606504
463,hydrocodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0081,"s-718632, extended release hydrocodone",Analgesics,4,,-,approved,1943,,11752352|10640321|16291875|2849950|14600248|20665209|18606504
464,hydrocodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0753,hydrocodone bitartrate with acetaminophen,Analgesics,4,,-,approved,1943,,11752352|10640321|16291875|2849950|14600248|20665209|18606504
465,hydrocodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2254,"zx002, hydrocodone bitartrate",Analgesics,4,,-,approved,1943,,16291875|14600248|11752352
466,hydrocodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0193,hydrocodone,Analgesics,4,,-,approved,1943,,16291875|14600248|11752352
467,hydrocodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0010,"hysingla er, hydrocodone bitartrate extended release",Analgesics,4,,-,approved,1943,,16291875|14600248|11752352
468,hydrocodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0082,"s-718632, extended release hydrocodone",Analgesics,4,,-,approved,1943,,16291875|14600248|11752352
469,hydrocodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0754,hydrocodone bitartrate with acetaminophen,Analgesics,4,,-,approved,1943,,16291875|14600248|11752352
470,hydromorphone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1422,"nmed-1077,exalgo, jurnista, dilaudid",Analgesics,4,,-,approved,1984,,11869661|12479250|11305075|18789923
471,hydromorphone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1422,"nmed-1077,exalgo, jurnista, dilaudid",Analgesics,4,,-,approved,1984,,17139284|17016423|16433932
472,hydromorphone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1422,"nmed-1077,exalgo, jurnista, dilaudid",Analgesics,4,,-,approved,1984,,9301669|2849950|7511163|17658959|2478994|11752352
473,hydroxyzine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD275,-,Antipruritics; Anxiolytics sedatives and hypnotics,4,,-,approved,1956,,11752352|17222324|19057127|18781943|1979798
474,hyoscyamine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_396,hyoscyamine,Antispasmodics,4,,-,approved,-,,17139284|17016423|11495349
475,hyoscyamine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_394,hyoscyamine,Antispasmodics,4,,-,approved,-,,17139284|17016423|9732369
476,icatibant,small molecule,Peptide,antagonist,,primary,BDKRB2,bkrb2_human,P30411,Class A (Rhodopsin),GPCR;Rhodopsin,Bradykinin receptors,established,797,"firazyr, icatibant, je049",hereditary angioedema,4,,-,approved,2008,,14514033|11752352
477,icosapent,small molecule,Lipid,agonist,,primary,FFAR1,ffar1_human,O14842,Class A (Rhodopsin),GPCR;Rhodopsin,Free fatty acid receptors,established,ASH_Aug2017_310,,hypertriglyceridemia,4,2012,-,approved,-,,16214394
478,iloperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,,8997630|12861482
479,iloperidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,,8997630|12861482
480,iloprost,small molecule,Lipid ,agonist,,primary,PTGDR2,pd2r2_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,ASH_Oct2016_435,"iloprost,ventavis",Antihypertensive,4,,-,approved,2004,,9579725
481,iloprost,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,952,"iloprost,ventavis",Antihypertensive,4,,-,approved,2004,,11792366|1375507|17257398|17273558|2456096|15163595|20395700|19683911|19475782
482,iloprost,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,952,"iloprost,ventavis",Antihypertensive,4,,-,approved,2004,,11999132|11739243
483,indacaterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,969,indacaterol,Bronchodilator,4,,-,approved,2009,,16022567
484,indoramin,small molecule,Aminergic ,not available,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_431,indoramin,Antihypertensive,4,,-,approved,1993,,7536677
485,indoramin,small molecule,Aminergic ,not available,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_432,indoramin,Antihypertensive,4,,-,approved,1993,,7536677
486,indoramin,small molecule,Aminergic ,not available,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_433,indoramin,Antihypertensive,4,,-,approved,1993,,7536677
487,ipratropium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1021,"ipratropium bromide + albuterol sulfate,duoneb",chronic obstructive pulmonary disease (COPD),4,,-,approved,1986,,15987237
488,ipratropium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1021,"ipratropium bromide + albuterol sulfate,duoneb",chronic obstructive pulmonary disease (COPD),4,,-,approved,1986,,15987237
489,ipratropium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_72,ipratropium,chronic obstructive pulmonary disease (COPD),4,,-,approved,1986,,15987237
490,irbesartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1023,"irbesartan,avapro, irbetan",Antihypertensive,4,,-,approved,1997,,11752352|17408613|15030294|11486244|14716205|7843749|10069682|10075381|10082498|10373224|10822210|18627212|15101793
491,isoetharine,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_361,isoetharine,Anti-Asthmatic,4,,-,approved,1979,,6125600
492,isoetharine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD290,-,Bronchodilator,4,,-,approved,1979,,6125600
493,isometheptene,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_417,isometheptene,migraines,4,,-,approved,-,copy with conflicting subfamily,15094323|3129549
494,isometheptene,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmar2016_0022,"tnx-201, single isomer isometheptene, imh",Anti-migraine,4,,-,approved,1962,,15094323|3129549
495,isopropamide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_51,isopropamide,digestive system disease,4,,-,approved,1957,,3580704|29133
496,isopropamide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_74,isopropamide,digestive system disease,4,,-,approved,1957,,3580704|29133
497,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class B1 (Secretin),GPCR;Rhodopsin,Corticotropin-releasing factor receptors,established,ASH_Oct2016_403,isoprenaline,cardiovascular ; Anti-Asthmatic ,4,,-,approved,1956,,10988267
498,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD293,-,Bronchodilator ; Cardiotonic,4,,-,approved,1956,,10988267
499,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,p08588,Class A (Rhodopsin),GPCR;Rhodopsin,Thyrotropin-releasing hormone receptors,established,ASH_Oct2016_402,isoprenaline,cardiovascular ; Anti-Asthmatic ,4,,-,approved,1956,,11791000
500,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD293,-,Bronchodilator ; Cardiotonic,4,,-,approved,1956,,11791000
501,isothipendyl,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_373,isothipendyl,antipruritic,4,,-,approved,-,,8546983
502,itraconazole,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,MMAmar2016_0140,suba-itraconazole,Antineoplastic,4,,-,approved,1992,,20385363
503,ketobemidone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Oct2016_351,ketobemidone,Analgesics,4,,-,approved,-,,8153059
504,ketobemidone,small molecule,Aminergic ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_352,ketobemidone,Analgesics,4,,-,approved,-,,8153059
505,ketobemidone,small molecule,Aminergic ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_354,ketobemidone,Analgesics,4,,-,approved,-,,8878254|8153059
506,ketotifen,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1074,"ketotifen fumarate,zaditen, zaditor",Anti-Allergic,4,,-,approved,1999,,7893266|1434122|16404130|8836617|8101246|18490184|11752352
507,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_128,labetalol,cardiovascular disease,4,,-,approved,1984,,6355664
508,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_138,labetalol,cardiovascular disease,4,,-,approved,1984,,6355664
509,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_156,labetalol,cardiovascular disease,4,,-,approved,1984,,6355664
510,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD296,-,Antihypertensive,4,,-,approved,1984,,1361547|2907566|11752352|6355664|19879818|8104240|7684671
511,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD296,-,Antihypertensive,4,,-,approved,1984,,1687367|6151824|6355664|7286847|11752352|19879818|8104240|7684671
512,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_116,labetalol,cardiovascular disease,4,,-,approved,1984,,2696507|10529655
513,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_195,labetalol,cardiovascular disease,4,,-,approved,1984,,2696507|10529655
514,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD296,-,Antihypertensive,4,,-,approved,1984,,2696507|10529655
515,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD296,-,Antihypertensive,4,,-,approved,1984,,2696507|10529655
516,lanreotide,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1088,"lanreotide ,somatuline autogel, somatuline depot",acromegaly,4,,-,approved,2007,,15103227
517,lanreotide,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1089,"lanreotide,somatuline autogel, somatuline depot",acromegaly,4,,-,approved,2007,,26416534
518,lanreotide,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,ASH_Sep2016_283,lanreotide,Antineoplastic,4,,-,approved,2007,,26416534
519,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1095,"latanoprost + timolol,xalcom, xalacom",Antiglaucomic,4,,-,approved,1996,,16249494|14646172|15037111|9733584|12204699|11752352
520,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1096,"latanoprost, (sustained release, punctal plug delivery system)",Antiglaucomic,4,,-,approved,1996,,16249494|14646172|15037111|9733584|12204699|11752352
521,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1097,"latanoprost,xalatan fixed flow device",Antiglaucomic,4,,-,approved,1996,,16249494|14646172|15037111|9733584|12204699|11752352
522,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1918,sustained release latanoprost,Antiglaucomic,4,,-,approved,1996,,16249494|14646172|15037111|9733584|12204699|11752352
523,leuprolide,peptide,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,697,eligard,Antineoplastic,4,,-,approved,1985,,16809153|10687850|9625809|15758569|10394541
524,leuprolide,peptide,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1113,leuprolide,Antineoplastic ; endometriosis,4,,-,approved,1985,,16809153|10687850|9625809|15758569|10394541
525,leuprolide,peptide,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1114,"leuprolide acetate, tap-144 sr",Antineoplastic ; endometriosis,4,,-,approved,1985,,16809153|10687850|9625809|15758569|10394541
526,leuprolide,peptide,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1115,leupromaxx,Antineoplastic ; endometriosis,4,,-,approved,1985,,16809153|10687850|9625809|15758569|10394541
527,leuprolide,peptide,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1250,memryte,Alzheimer's disease,4,,-,approved,1985,,16809153|10687850|9625809|15758569|10394541
528,levallorphan,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD298,-,Opiate Antagonists,4,,-,approved,1982,,8968334|7723747|9016350|8819494|9862398
529,levobunolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD299,-,Antiglaucomic,4,,-,approved,1985,,11752352|6147147|11572462|7928182|1351412|2892662|2891463
530,levobunolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD299,-,Antiglaucomic,4,,-,approved,1985,,2891463|7928182|10864881|11572462|1351412|2892662
531,levocabastine,small molecule,Aminergic ,antagonist,,primary,NTSR2,ntr2_human,O95665,Class A (Rhodopsin),GPCR;Rhodopsin,Neurotensin receptors,established,,,Anti-Allergic,4,,-,approved,1993,,11723247|8647296|9080465
532,levocabastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD301,-,Anti-Allergic,4,,-,approved,1993,,11752352|10631382|8647296|9627096|9551716|11915520
533,levocetirizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1118,"levocetirizine dihydrochloride,xusal, xyzal",Anti-Allergic,4,,-,approved,2007,Actually approved in 2007 but not considered a NME because enantiomer of cetirizine  I think,21639816|18336052
534,levodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,,17553470|15710490|15824260|15728856|18549347|11978145|9633680
535,levodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,,17553470|15710490|15824260|15728856|18549347|11978145|9633680
536,levodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,,18549347|11978145|9633680
537,levodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,,18549347|11978145|9633680
538,levodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,,18549347|11978145|9633680
539,levodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,,18549347|11978145|9633680
540,levodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,,18549347|11978145|9633680
541,levodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,,18549347|11978145|9633680
542,levodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,,18549347|11978145|9633680
543,levodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,,18549347|11978145|9633680
544,levomepromazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_225,levomepromazine,psychosis,4,,-,approved,1982,Approved prior to 1982 and then discontinued,2870716
545,levomepromazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_63,levomepromazine,psychosis,4,,-,approved,1982,Approved prior to 1982 and then discontinued,2870716
546,levomepromazine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_213,levomepromazine,psychosis,4,,-,approved,1982,Approved prior to 1982 and then discontinued,10741754
547,levomepromazine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued,10741754
548,levomepromazine,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued,15701205
549,levomethadyl acetate,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD302,-,Analgesics,4,,-,approved,1993,,9360954|2471291|10911931|11561100|11752352
550,levonordefrin,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_405,levonordefrin,decongestant,4,,-,approved,1960,,19326476
551,levonordefrin,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_429,alpha-methylnoradrenaline,nasal decongestant,4,,-,approved,1960,,19326476
552,levorphanol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD303,-,Analgesics,4,,-,approved,1953,,12975489|17039381
553,levosalbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_174,levosalbutamol,Anti-Asthmatic,4,,-,approved,1999,,21453221
554,liraglutide,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1154,liraglutide,Antidiabetic,4,,-,approved,2009,,14678021|18333889
555,liraglutide,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0808,"ideglira,  insulin degludec + liraglutide,  nn-9068",Antidiabetic,4,,-,approved,2009,,14678021|18333889
556,liraglutide,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,NRDD305,-,Antidiabetic,4,,-,approved,2010,,14678021|18333889
557,lisdexamfetamine,small molecule,Aminergic ,antagonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,NRDD306,-,Central Nervous System Stimulants,4,,-,approved,2007,FDA approval 2007 for ADHD; pro-drug of dextroamphetamine so not NME,17016423|11752352
558,lisdexamfetamine,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD306,-,Central Nervous System Stimulants,4,,-,approved,2007,FDA approval 2007 for ADHD; pro-drug of dextroamphetamine so not NME,17016423|11752352
559,lisuride,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD307,-,Antiparkinson,4,,-,approved,2011,,11224054|18691132|12373423|1678728|1783326|2887435
560,lisuride,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD307,-,Antiparkinson,4,,-,approved,2011,,11752352|18691132
561,lisuride,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD307,-,Antiparkinson,4,,-,approved,2011,,17139284|17016423|18691132
562,lixisenatide,small molecule,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmar2016_0257,"lixilan, lantus (basal insulin) + lyxumia (lixisenatide)",Antidiabetic,4,,-,approved,2016,,25119443
563,lofexidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1159,"lofexidine,britlofex",opiate withdrawal,4,,-,approved,2006,,1357064|10598217
564,lofexidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1159,"lofexidine,britlofex",opiate withdrawal,4,,-,approved,2006,,1357064|10598217
565,lofexidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1159,"lofexidine,britlofex",opiate withdrawal,4,,-,approved,2006,,1357064|10598217|10882840
566,loperamide,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD308,-,Antidiuretic,4,,-,approved,1976,,10087042|14592702|8488368|11752352|6319884|18284554
567,loratadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1163,"loratadine + montelukast sodium,claritin + singulair",Anti-Asthmatic,4,,-,approved,1993,,11752352|1303772|7581058|8174605|10597865|15942272|1303773|9444440|1977506|11291777
568,lorcaserin,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1164,lorcaserin,Anti-obesity,4,,-,approved,2012,,16625817|16259227
569,losartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMAmay2016_0431,inv-144,Antihypertensive ; for Diabetic neuropathy,4,,-,approved,1995,,11752352|15026875|15991937|12710529|12719755|15573751
570,losartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD310,-,Antihypertensive,4,,-,approved,1995,,11752352|15026875|15991937|12710529|12719755|15573751
571,loxapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,304,az-004,schizophrenia,4,,-,approved,1975,,12664192
572,loxapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,304,az-004,schizophrenia,4,,-,approved,1975,,6239298|15694653|9570468|8101879|9342550|8665533|11752352
573,lurasidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,,23545936
574,lurasidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,,23545936
575,lurasidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAapril2016_0234,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,,23545936
576,lurasidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0236,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,,23545936
577,lutropin alfa,peptide,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD311,-,Fertility,4,,-,approved,2004,endogenous ligand,17139284|17016423|20161981|11752352
578,macitentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1209,"macitentan , act-064992",cardiovascular disease,4,,-,approved,2013,,22862294|22458347|24261583
579,macitentan,small molecule,Peptide,antagonist,,primary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1210,"macitentan, act-064992",cardiovascular disease,4,,-,approved,2013,,22862294|22458347|24261583
580,maraviroc,small molecule,Protein,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1834,selzentry,antiviral ; HIV,4,,-,approved,2007,,17139284|17016423|11752352|19098484|19692476|16298345
581,marinol,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,NRDD314,-,Antiemetics,4,,-,approved,1985,,17828291
582,meclizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD315,-,Antiemetics,4,,-,approved,1957,,7513381|1350745|1362160|1678430
583,melatonin,small molecule,Melatonin ,agonist,,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,NRDD320,-,Hypnotics and Sedatives,4,,-,approved,2005,,19463840|11752352|15992934|19449447|20827520|20674373|19966183
584,melatonin,small molecule,Melatonin ,agonist,,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,NRDD320,-,Hypnotics and Sedatives,4,,-,approved,2005,,19463840|15992934|19449447|20827520|20674373|19966183
585,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,,20302892
586,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,,20302892
587,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,,20302892
588,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,,20302892
589,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,,20302892
590,menotropins,protein,Protein,agonist,menotrophin,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD322,-,Fertility,4,,-,approved,1975,,17139284|17016423|14680547|7872378
591,menotropins,protein,Protein,agonist,menotrophin,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD322,-,Fertility,4,,-,approved,1975,,17139284|17016423|14680547|7872378|11752352
592,mepenzolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_47,mepenzolate,digestive system disease,4,,-,approved,1956,,7623487|2791613|7122991
593,mepenzolate,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_79,mepenzolate,digestive system disease,4,,-,approved,1956,,7623487|2791613|7122991
594,meperidine,small molecule,Peptide,agonist,pethidine,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD325,-,Analgesics,4,,-,approved,1942,,28625303|26732307
595,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_105,mephentermine,cardiovascular disease,4,,-,approved,1951,,21182601|5334234
596,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_123,mephentermine,cardiovascular disease,4,,-,approved,1951,,21182601|5334234
597,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_145,mephentermine,cardiovascular disease,4,,-,approved,1951,,21182601|5334234
598,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_161,mephentermine,cardiovascular disease,4,,-,approved,1951,,21182601|5334234
599,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_171,mephentermine,cardiovascular disease,4,,-,approved,1951,,21182601|5334234
600,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_186,mephentermine,cardiovascular disease,4,,-,approved,1951,,21182601|5334234
601,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_196,mephentermine,cardiovascular disease,4,,-,approved,1951,,21182601|5334234
602,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_90,mephentermine,cardiovascular disease,4,,-,approved,1951,,21182601|5334234
603,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD326,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1951,,21182601|5334234
604,mequitazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD329,-,Anti-Allergic,4,,-,approved,-,"Marketed but I don't think fda approved, if so then long ago",9454781|7650688|8808167|7511558|12244568|6418550|11752352
605,mesoridazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD331,-,schizophrenia,4,,-,approved,1970,,11752352|16135699|15357957
606,mesoridazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD331,-,schizophrenia,4,,-,approved,1970,,15357957|11561066|10991983
607,metaproterenol,small molecule,Aminergic ,agonist,orciprenaline,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_175,metaproterenol,Anti-Asthmatic,4,,-,approved,1973,,10490901|3168573|2870555|8760245|10973730|11752352
608,metaraminol,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD333,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1954,,17139284|17016423|9663612
609,methacholine,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_81,methacholine,Anti-Asthmatic,4,,-,approved,1986,,20888332|20347047|19951374|19460789
610,methadone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD334,-,Analgesics,4,,-,approved,1947,,17139284|17016423|11933204|17850768|14991152
611,methadyl acetate,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD335,-,Analgesics,4,,-,approved,1993,,20163389|6268422|19153939|11752352
612,methamphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,1167,low dose intravenous methamphetamine,neuroprotectant,4,,-,approved,1943,,17888514|11459929|17218486|17234900|17212650|17234899|15764732
613,methamphetamine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1167,low dose intravenous methamphetamine,neuroprotectant,4,,-,approved,1943,,9551769|15955613
614,methamphetamine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1167,low dose intravenous methamphetamine,neuroprotectant,4,,-,approved,1943,,9551769|15955613
615,methamphetamine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1167,low dose intravenous methamphetamine,neuroprotectant,4,,-,approved,1943,,9551769|15955613|12453616
616,methantheline,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_240,methantheline,digestive system disease,4,,-,approved,1951,,6116801
617,methantheline,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD336,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1951,,17139284|17016423
618,methdilazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD339,-,Anti-Allergic,4,,-,approved,1982,,17139284|17016423|11752352|9700532|20012879
619,methoxamine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_119,methoxamine,cardiovascular disease,4,,-,approved,1982,,19493707
620,methoxamine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD343,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1982,,2546049|2988814|8635240|11752352|11331292
621,methoxamine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD343,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1982,,7875228|1978244|1680715|7511752|8986981
622,methyldopa,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD346,-,Antihypertensive,4,,-,approved,1962,,17139284|17016423|17485976|9284427|10415926|8743022|1363322|14557373
623,methylergonovine,small molecule,Aminergic ,partial agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD347,-,Abortifacient,4,,-,approved,1946,,15930499
624,methylnaltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1262,methylnaltrexone,opioid-induced constipation,4,,-,approved,2008,,17504835
625,methylnaltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD348,-,OIC treatment,4,,-,approved,2008,,17504835
626,methylscopolamine,small molecule,Aminergic ,antagonist,methscopolamine,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_421,methylscopolamine bromide,Anti-ulcer,4,,-,approved,1953,conflicting subfamily ,17139284|17016423|20590642
627,methylscopolamine,small molecule,Aminergic ,antagonist,methscopolamine,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD351,-,Antispasmodics,4,,-,approved,1953,,17139284|17016423|20590642
628,methylscopolamine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_422,methylscopolamine bromide,Anti-ulcer,4,,-,approved,1953,conflicting subfamily ,19565307|11752352
629,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_25,methysergide,Anti-migraine,4,,-,approved,1962,,8743744
630,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD353,-,Anti-migraine s; Vasoconstrictor,4,,-,approved,1962,,14501155
631,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD353,-,Anti-migraine s; Vasoconstrictor,4,,-,approved,1962,,10080233|10455282|11061982|11704657|11720080
632,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD353,-,Anti-migraine s; Vasoconstrictor,4,,-,approved,1962,,11049861|14501155|14517765|14581123|1838579
633,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD353,-,Anti-migraine s; Vasoconstrictor,4,,-,approved,1962,,11752352|12555241
634,metiamide,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Oct2016_349,metiamide,acid reducer,4,,-,approved,-,,7725982
635,metipranolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD354,-,Anti-Arrhythmia ; Antihypertensive ; Anti-glaucoma,4,,-,approved,1989,,17139284|17016423|2895037|12967722|2885244
636,metipranolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD354,-,Anti-Arrhythmia ; Antihypertensive ; Anti-glaucoma,4,,-,approved,1989,,17139284|17016423|2895037|2876128|12967722|2885244
637,metixene,small molecule,Aminergic ,antagonist,methixene,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,,17139284|17016423
638,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,,17139284|17016423
639,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,,17139284|17016423
640,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,,17139284|17016423
641,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,,17139284|17016423|11752352
642,metoclopramide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1268,"metoclopramide hcl,metzoliv odt",motilitant; gastroesophageal reflux disease,4,,-,approved,1979,,11752352|8730709|8230103|7745844|8981558|9876882|15835479
643,metoclopramide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1269,"metoclopramide,emitasol, pramidin",Antiemetics,4,,-,approved,1979,,11752352|8730709|8230103|7745844|8981558|9876882|15835479
644,metoclopramide,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1268,"metoclopramide hcl,metzoliv odt",motilitant; gastroesophageal reflux disease,4,,-,approved,1979,,17139284|17016423|16466463|15835479
645,metoclopramide,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1269,"metoclopramide,emitasol, pramidin",Antiemetics,4,,-,approved,1979,,17139284|17016423|16466463|15835479
646,metoprolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1270,"metoprolol succinate,toprol-xl",Antihypertensive,4,,-,approved,1978,,10913016|11448474|12679135|12844134|14534524|11752352
647,metoprolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD359,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1978,,10913016|11448474|12679135|12844134|14534524|11752352
648,mianserin,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD363,-,Anti-depressant,4,,-,approved,1996,"Doesn't appear to be FDA approved, but analogue mirtazapine is ",11004734
649,mianserin,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD363,-,Anti-depressant,4,,-,approved,1996,"Doesn't appear to be FDA approved, but analogue mirtazapine is ",11004734
650,mianserin,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD363,-,Anti-depressant,4,,-,approved,1996,"Doesn't appear to be FDA approved, but analogue mirtazapine is ",16814817
651,mianserin,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD363,-,Anti-depressant,4,,-,approved,1996,"Doesn't appear to be FDA approved, but analogue mirtazapine is ",12967590|11004734|6302549
652,midodrine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_104,midodrine,cardiovascular disease,4,,-,approved,1996,,12238918
653,midodrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD365,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1996,,15163201
654,midodrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD365,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1996,,12163120|9007522|15163201
655,minaprine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used,1361012|2530096|2975224|3836113
656,minaprine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used,17139284|17016423|1361012|2975224
657,minaprine,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used,17139284|17016423|1361012|2975224|11752352
658,mirabegron,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0790,"ym178, mirabegron",incontinence,4,,-,approved,2012,,23550899
659,mirtazapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1295,"mirtazapine,remeron, remeron soltab, reflex",Anti-depressant,4,,-,approved,1996,,10446734|10446735|10446738|10451911|11063897|11607047
660,mirtazapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_29,mirtazapine,unipolar depression,4,,-,approved,1996,,14615872|10762339|9832994|16433010|11271412|11752352
661,mirtazapine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1295,"mirtazapine,remeron, remeron soltab, reflex",Anti-depressant,4,,-,approved,1996,,14628003|11607047|10793320|11931344|11939713|12523492
662,misoprostol,small molecule,Lipid ,agonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,ASH_Sep2016_312,misoprostol,hemorrhage,4,,-,approved,1988,,16039053|18472336|12097143|9313928|11602631
663,misoprostol,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMA_jun2017_001,misoprostol,hemorrhage,4,,-,approved,1988,,16039053|18472336|12097143|9313928|11602631
664,mivacurium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD370,-,Muscle Relaxants,4,,-,approved,1992,,17139284|17016423
665,molindone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD372,-,schizophrenia,4,,-,approved,1974,,17016423|9577836|9353417|9342550|11752352
666,montelukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,1327,"montelukast sodium,singulair",Anti-Asthmatic,4,,-,approved,1998,,15013935|15456537|16815057|16815146|17199874|11752352
667,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1984,,16530171|16534251|16539674|16650582|16678156|11752352|12015197
668,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1333,"morphine sulfate,avinza",Analgesics,4,,-,approved,2002,,16530171|16534251|16539674|16650582|16678156|11752352|12015197
669,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1334,"morphine sulfate,depodur, depomorphine",Analgesics,4,,-,approved,1984,,16530171|16534251|16539674|16650582|16678156|11752352|12015197
670,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2051,tpm-1/morphine,Analgesics,4,,-,approved,1984,,16530171|16534251|16539674|16650582|16678156|11752352|12015197
671,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0057,"egalet-001, reformulated morphine",Analgesics; opioid addiction,4,,-,approved,1984,,16530171|16534251|16539674|16650582|16678156|11752352|12015197
672,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1984,,16530171|16580639|16580848|16682505|11752352
673,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1333,"morphine sulfate,avinza",Analgesics,4,,-,approved,2002,,16530171|16580639|16580848|16682505|11752352
674,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1334,"morphine sulfate,depodur, depomorphine",Analgesics,4,,-,approved,1984,,16530171|16580639|16580848|16682505|11752352
675,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2051,tpm-1/morphine,Analgesics,4,,-,approved,1984,,16530171|16580639|16580848|16682505|11752352
676,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0056,"egalet-001, reformulated morphine",Analgesics; opioid addiction,4,,-,approved,1984,,16530171|16580639|16580848|16682505|11752352
677,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1984,,17139284|17016423|9808678|7959748|16753266
678,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1333,"morphine sulfate,avinza",Analgesics,4,,-,approved,2002,,17139284|17016423|9808678|7959748|16753266
679,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1334,"morphine sulfate,depodur, depomorphine",Analgesics,4,,-,approved,1984,,17139284|17016423|9808678|7959748|16753266
680,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1903,statex,Analgesics,4,,-,approved,1984,,17139284|17016423|9808678|7959748|16753266
681,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2051,tpm-1/morphine,Analgesics,4,,-,approved,1984,,17139284|17016423|9808678|7959748|16753266
682,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0055,"egalet-001, reformulated morphine",Analgesics; opioid addiction,4,,-,approved,1984,,17139284|17016423|9808678|7959748|16753266
683,nabilone,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1373,"nabilone,cesamet",Antiemetics,4,,-,approved,1985,,11786493|17450170|17139494|15221424|11698062
684,nabilone,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1373,"nabilone,cesamet",Antiemetics,4,,-,approved,1985,,17139494|11698062|8981483|10575283|8864542|11752352
685,nadolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD376,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1979,,11752352|7981009|1354084|10433496|10606440|7912539
686,nadolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD376,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1979,,11752352|7981009|17622774|8574280|1349493|10433496
687,nafarelin,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD377,-,Antiendometriosis,4,,-,approved,1990,,2137975|14687742|14644830|17097577|9622415|7996307|1830521|2140979|2151003|11752352
688,nafarelin,small molecule,Peptide,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD377,-,Antiendometriosis,4,,-,approved,1990,,2137975|14687742|17097577 
689,nalbuphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1374,"nalbuphine hydrochloride,  pw-4142",Analgesics,4,,-,approved,1979,,10844102|8388112|9084061|9399970|18425947|16517095|19403853|15602503|18810678|17407276
690,nalbuphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1374,"nalbuphine hydrochloride,  pw-4142",Analgesics,4,,-,approved,1979,,17139284|17016423|8388112|15655510|16517095|19403853|15602503|10534607|17407276
691,nalbuphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1374,"nalbuphine hydrochloride,  pw-4142",Analgesics,4,,-,approved,1979,,8093631|2826773|11752352
692,naldemedine,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Mar2017_1,naldemedine,opioid-induced constipation,4,,-,approved,2017,,25442002
693,nalmefene,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1375,"nalmefene, cph-101",smoking-cessation ; addiction,4,,-,approved,2013,,25442002
694,nalmefene,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2766,srd174,pruritus,4,,-,approved,1995,,25442002
695,nalmefene,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1375,"nalmefene, cph-101",smoking-cessation ; addiction,4,,-,approved,2013,,28844812|28721822
696,nalmefene,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1375,"nalmefene, cph-101",smoking-cessation ; addiction,4,,-,approved,2013,,28844812|28721823
697,nalmefene,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2766,srd174,pruritus,4,,-,approved,1995,,28844812|28721824
698,nalmefene,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2766,srd174,pruritus,4,,-,approved,1995,,28844812|28721825
699,naloxegol,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1419,nktr-118,opioid-induced constipation,4,,-,approved,2014,,25471070
700,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Analgesics,4,,-,approved,1971,,12566163|12799988|12842269|12887410|12909198|11752352|18354714|17918759|17367258
701,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Analgesics; opioid addiction,4,,-,approved,1971,,12566163|12799988|12842269|12887410|12909198|11752352|18354714|17918759|17367258
702,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,4,,-,approved,1971,,12566163|12799988|12842269|12887410|12909198|11752352|18354714|17918759|17367258
703,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0088,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",Analgesics,4,,-,approved,1971,,12566163|12799988|12842269|12887410|12909198|11752352|18354714|17918759|17367258
704,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0517,"ox219, buprenorphine + naloxone sublingual tablet",Analgesics; opioid addiction,4,,-,approved,1971,,12566163|12799988|12842269|12887410|12909198|11752352|18354714|17918759|17367258
705,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0645,"naloxone nasal spray, indivior",Analgesics; overdose/drug toxicity,4,,-,approved,1971,,12566163|12799988|12842269|12887410|12909198|11752352|18354714|17918759|17367258
706,naloxone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0709,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,,12566163|12799988|12842269|12887410|12909198|11752352|18354714|17918759|17367258
707,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Analgesics,4,,-,approved,1971,,12650833|12657847|12749773|14646257|14708857|18354714|17367258
708,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Analgesics; opioid addiction,4,,-,approved,1971,,12650833|12657847|12749773|14646257|14708857|18354714|17367258
709,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,4,,-,approved,1971,,12650833|12657847|12749773|14646257|14708857|18354714|17367258
710,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0089,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",Analgesics,4,,-,approved,1971,,12650833|12657847|12749773|14646257|14708857|18354714|17367258
711,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0646,"naloxone nasal spray, indivior",Analgesics; overdose/drug toxicity,4,,-,approved,1971,,12650833|12657847|12749773|14646257|14708857|18354714|17367258
712,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0710,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,,12650833|12657847|12749773|14646257|14708857|18354714|17367258
713,naloxone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0921,"ox219, buprenorphine + naloxone sublingual tablet",Analgesics; opioid addiction,4,,-,approved,1971,,12650833|12657847|12749773|14646257|14708857|18354714|17367258
714,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Analgesics,4,,-,approved,1971,,17305578|17367258|18354714
715,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Analgesics; opioid addiction,4,,-,approved,1971,,17305578|17367258|18354714
716,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,4,,-,approved,1971,,17305578|17367258|18354714
717,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0090,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",Analgesics,4,,-,approved,1971,,17305578|17367258|18354714
718,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0518,"ox219, buprenorphine + naloxone sublingual tablet",Analgesics; opioid addiction,4,,-,approved,1971,,17305578|17367258|18354714
719,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0647,"naloxone nasal spray, indivior",Analgesics; overdose/drug toxicity,4,,-,approved,1971,,17305578|17367258|18354714
720,naloxone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0711,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,,17305578|17367258|18354714
721,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1998,,11752352|15788780|17661275|17487229|9673788|9040115
722,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,522,contrave,Appetite suppressant,4,,-,approved,1998,,11752352|15788780|17661275|17487229|9673788|9040115
723,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,4,,-,approved,1998,,11752352|15788780|17661275|17487229|9673788|9040115
724,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1688,pti-901,Analgesics,4,,-,approved,1998,,11752352|15788780|17661275|17487229|9673788|9040115
725,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2168,vivitrol,substance abuse,4,,-,approved,1998,,11752352|15788780|17661275|17487229|9673788|9040115
726,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0085,eli-200,addiction,4,,-,approved,2016,,11752352|15788780|17661275|17487229|9673788|9040115
727,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0074,"pxt3003, baclofen + naltrexone + sorbitol",Analgesics; for type 1A Charcot-Marie-Tooth disease,4,,-,approved,1998,,11752352|15788780|17661275|17487229|9673788|9040115
728,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1998,,11752352|18354714|9040115|17661275|19484223
729,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,522,contrave,Appetite suppressant,4,,-,approved,1998,,11752352|18354714|9040115|17661275|19484223
730,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,4,,-,approved,1998,,11752352|18354714|9040115|17661275|19484223
731,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1688,pti-901,Analgesics,4,,-,approved,1998,,11752352|18354714|9040115|17661275|19484223
732,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2168,vivitrol,substance abuse,4,,-,approved,1998,,11752352|18354714|9040115|17661275|19484223
733,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0086,eli-200,addiction,4,,-,approved,2016,,11752352|18354714|9040115|17661275|19484223
734,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0075,"pxt3003, baclofen + naltrexone + sorbitol",Analgesics; for type 1A Charcot-Marie-Tooth disease,4,,-,approved,1998,,11752352|18354714|9040115|17661275|19484223
735,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1998,,11752352|19068776|18354714|17918759|17661275|17487229|9673788
736,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,522,contrave,Appetite suppressant,4,,-,approved,1998,,11752352|19068776|18354714|17918759|17661275|17487229|9673788
737,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,4,,-,approved,1998,,11752352|19068776|18354714|17918759|17661275|17487229|9673788
738,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1688,pti-901,Analgesics,4,,-,approved,1998,,11752352|19068776|18354714|17918759|17661275|17487229|9673788
739,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2168,vivitrol,substance abuse,4,,-,approved,1998,,11752352|19068776|18354714|17918759|17661275|17487229|9673788
740,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0084,eli-200,addiction,4,,-,approved,2016,,11752352|19068776|18354714|17918759|17661275|17487229|9673788
741,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0073,"pxt3003, baclofen + naltrexone + sorbitol",Analgesics; for type 1A Charcot-Marie-Tooth disease,4,,-,approved,1998,,11752352|19068776|18354714|17918759|17661275|17487229|9673788
742,naphazoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_86,naphazoline,nasal obstruction,4,,-,approved,1971,,10481510|16083326|8930173|10381812|10459292|11180982
743,naphazoline,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_126,naphazoline,eye allergy,4,,-,approved,1971,,8930173|17852165|11180982
744,naratriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1381,"naratriptan,naramig, amerge",Anti-migraine,4,,-,approved,1998,,10563228|11897116|8741180|11752352|12010764|14725972|14728705|20687618|10410185|11152011|12463278|16389295
745,naratriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1381,"naratriptan,naramig, amerge",Anti-migraine,4,,-,approved,1998,,11752352|14725972|11152011|12463278|15320857|14614913|12434581
746,naratriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1381,"naratriptan,naramig, amerge",Anti-migraine,4,,-,approved,1998,,12010764|14725972|14728705|9650800|11752352|20687618|10410185|11152011|12463278|16389295
747,naratriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1381,"naratriptan,naramig, amerge",Anti-migraine,4,,-,approved,1998,,14728705|11152011
748,nebivolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_172,nebivolol,Antihypertensive,4,,-,approved,2007,,12795776
749,nebivolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1394,"nebivolol ,bystolic",Antihypertensive,4,,-,approved,2007,,16961165|11752352|17661735
750,nedocromil,small molecule,Lipid ,antagonist,,primary,CYSLTR2,cltr2_human,Q9NS75,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,ASH_Aug_2017_1,-,Anti-Allergic ; Anti-Asthmatic,4,,-,approved,1992,,17139284|17016423|16164449|20558817
751,nedocromil,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,NRDD379,-,Anti-Allergic ; Anti-Asthmatic,4,,-,approved,1992,,17139284|17016423|16164449|20558817|8386571
752,nefazodone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD380,-,Anti-depressant,4,,-,approved,1994,,10220119|10435395|10577608|12873632|14520130|7649970|7855217|9098663
753,nefazodone,small molecule,Aminergic ,unknown,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD380,-,Anti-depressant,4,,-,approved,1994,,11752352|17139284|17016423
754,nefazodone,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_33,nefazodone,unipolar depression,4,,-,approved,1994,,16433010|11752352
755,nefazodone,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD380,-,Anti-depressant,4,,-,approved,1994,,7649970|7855217
756,netupitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,MMAmay2016_0499,netupitant + palonosetron,Antiemetics,4,,-,approved,2014,,25687374
757,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,2468,"niacin extended-release tablets,niaspan",Antihyperlipidemic,4,,-,approved,1997,,12522134|12646212|15580557|16018973|16099840
758,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,2468,"niacin extended-release tablets,niaspan",Antihyperlipidemic,4,,-,approved,1997,,12563315|15929991|16018973|16099840|16322797|12522134
759,nicergoline,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD384,-,Nootropic ; Vasodilator,4,,-,approved,-,"Marketed but I don't think fda approved, if so then long ago",10027088
760,nizatidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD394,-,GI Anti-Ulcer ; antihistamines,4,,-,approved,1988,,11752352|1843561|2858133|2877081|2567267|2895808
761,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,,11752352|9464897|19110970|18064417
762,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,,11752352|9464897|19110970|18064417
763,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,,17139284|17016423|11306720|10742288|9836297|1980236|18680204|18064417
764,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,,17139284|17016423|11306720|10742288|9836297|1980236|18680204|18064417
765,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,,17139284|17016423|15451776|7582530|7674815|17266602|18064417
766,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,,17139284|17016423|15451776|7582530|7674815|17266602|18064417
767,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,,17139284|17016423|1654268|8590979|17410123|1980236|18064417
768,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,,17139284|17016423|1654268|8590979|17410123|1980236|18064417
769,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,,17139284|17016423|1979424|11728431|11053214|1980236|18064417
770,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,,17139284|17016423|1979424|11728431|11053214|1980236|18064417
771,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,,17139284|17016423|8097243|8106131|8105356|9464897
772,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,,17139284|17016423|8097243|8106131|8105356|9464897
773,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,,17139284|17016423|8294418|7773533|8166240|17266602|18064417
774,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,,17139284|17016423|8294418|7773533|8166240|17266602|18064417
775,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,,17139284|17016423|9138687|8825367|17266602
776,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,,17139284|17016423|9138687|8825367|17266602
777,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,,17139284|17016423|9666280|7969507|11504801|9464897|19110970|18064417
778,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,,17139284|17016423|9666280|7969507|11504801|9464897|19110970|18064417
779,octreotide,peptide,Peptide,agonist,,primary,SSTR3,ssr3_human,P32745,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,ASH_Sep2016_284,octreotide,growth hormone excess,4,,-,approved,1988,,11753241
780,octreotide,peptide,Peptide,agonist,,primary,SSTR4,ssr4_human,P31391,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,ASH_Sep2016_285,octreotide,growth hormone excess,4,,-,approved,1988,,11753241
781,octreotide,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,421,cam-2029,Antineoplastic,4,,-,approved,1988,,16438887|15103227|16625841|16625842|16223973
782,octreotide,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,981,"injectable octreotide acetate,sandostatin lar",Antineoplastic,4,,-,approved,1988,,16438887|15103227|16625841|16625842|16223973
783,octreotide,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1470,"octrotide,atrigel",Antineoplastic,4,,-,approved,1988,,16438887|15103227|16625841|16625842|16223973
784,octreotide,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1508,"oral octreotide actetate ,octreolin",Antihypertensive,4,,-,approved,1988,,16438887|15103227|16625841|16625842|16223973
785,octreotide,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,421,cam-2029,Antineoplastic,4,,-,approved,1988,,16809928|16086874|16438887|16625841|16625842
786,octreotide,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,981,"injectable octreotide acetate,sandostatin lar",Antineoplastic,4,,-,approved,1988,,16809928|16086874|16438887|16625841|16625842
787,octreotide,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1470,"octrotide,atrigel",Antineoplastic,4,,-,approved,1988,,16809928|16086874|16438887|16625841|16625842
788,octreotide,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1509,"oral octreotide actetate,octreolin",Antihypertensive,4,,-,approved,1988,,16809928|16086874|16438887|16625841|16625842
789,octreotide,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,421,cam-2029,Antineoplastic,4,,-,approved,1988,,19537708|11752352
790,octreotide,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,981,"injectable octreotide acetate,sandostatin lar",Antineoplastic,4,,-,approved,1988,,19537708|11752352
791,octreotide,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1470,"octrotide,atrigel",Antineoplastic,4,,-,approved,1988,,19537708|11752352
792,octreotide,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1509,"oral octreotide actetate,octreolin",Antihypertensive,4,,-,approved,1988,,19537708|11752352
793,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,11752352|15729086|16141369|15893120|17316700|10227113
794,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,11752352|15729086|16141369|15893120|17316700|10227113
795,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,11752352|15729086|16141369|15893120|17316700|10227113
796,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,11752352|15729086|16141369|15893120|17316700|10227113
797,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0205,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,11752352|15729086|16141369|15893120|17316700|10227113
798,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,11752352|16237394
799,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,11752352|16237394
800,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,11752352|16237394
801,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,11752352|16237394
802,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0196,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,11752352|16237394
803,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,11752352|16336943|17624999|16983399|16918396|16952163|10227113
804,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,11752352|16336943|17624999|16983399|16918396|16952163|10227113
805,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,11752352|16336943|17624999|16983399|16918396|16952163|10227113
806,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,11752352|16336943|17624999|16983399|16918396|16952163|10227113
807,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0201,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,11752352|16336943|17624999|16983399|16918396|16952163|10227113
808,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,11752352|16730699|14575800|17092971|17067304|16513877|17316700|17848919
809,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,11752352|16730699|14575800|17092971|17067304|16513877|17316700|17848919
810,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,11752352|16730699|14575800|17092971|17067304|16513877|17316700|17848919
811,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,11752352|16730699|14575800|17092971|17067304|16513877|17316700|17848919
812,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0191,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,11752352|16730699|14575800|17092971|17067304|16513877|17316700|17848919
813,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,11752352|17848919
814,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,11752352|17848919
815,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,11752352|17848919
816,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,11752352|17848919
817,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0207,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,11752352|17848919
818,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,11752352|17848919|10227113
819,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,11752352|17848919|10227113
820,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,11752352|17848919|10227113
821,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,11752352|17848919|10227113
822,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0195,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,11752352|17848919|10227113
823,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,14530903|15358979|15816787|16038601|16905159|11752352|17316700|17848919|10227113
824,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,14530903|15358979|15816787|16038601|16905159|11752352|17316700|17848919|10227113
825,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,14530903|15358979|15816787|16038601|16905159|11752352|17316700|17848919|10227113
826,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,14530903|15358979|15816787|16038601|16905159|11752352|17316700|17848919|10227113
827,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0200,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,14530903|15358979|15816787|16038601|16905159|11752352|17316700|17848919|10227113
828,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17316700|17848919|10227113
829,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17316700|17848919|10227113
830,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17316700|17848919|10227113
831,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17316700|17848919|10227113
832,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0190,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17316700|17848919|10227113
833,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919|10227113
834,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919|10227113
835,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919|10227113
836,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919|10227113
837,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0204,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919|10227113
838,olmesartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,557,"cs-8663, amlodipine + olmesartan,azor, sevikar",Antihypertensive,4,,-,approved,2002,,11451212|12076183
839,olmesartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1478,"olmesartan medoxomil (cs-866),benicar",Antihypertensive,4,,-,approved,2002,,11451212|12076183
840,olmesartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1479,"olmesartan, de-092",Antiglaucomic,4,,-,approved,2002,,11451212|12076183
841,olmesartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,2080,tribenzor,Antihypertensive,4,,-,approved,2002,,11451212|12076183
842,olmesartan medoxomil,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,ASH_Sep2016_250,olmesartan medoxomil,cardiovascular disease,4,,-,approved,2002,,11451212|12076183
843,olodaterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0592,tiotropium + olodaterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2014,,20371707
844,olopatadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1480,"olopatadine hydrochloride,patanase",Anti-Allergic,4,,-,approved,1996,,15942272|12046981|8951675|15646365|11496828|20482305|20406593|20402382|11752352
845,orphenadrine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD400,-,Antiparkinson s; Muscle Relaxants; Central,4,,-,approved,1957,,17139284|17016423|2578597
846,oxprenolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD405,-,Antihypertensive ; Anti-Arrhythmia,4,,-,approved,1983,,17139284|17016423|6202960|6124492|2871880|11752352
847,oxprenolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD405,-,Antihypertensive ; Anti-Arrhythmia,4,,-,approved,1983,,17139284|17016423|7882570|9509999|11311890
848,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,14,aa-2010,incontinence,4,,-,approved,1975,,15963006|16188951|19446545|20590605|17222678
849,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,190,"ap-1034,anturol",overactive bladder,4,,-,approved,1975,,15963006|16188951|19446545|20590605|17222678
850,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2067,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",incontinence,4,,-,approved,1975,,15963006|16188951|19446545|20590605|17222678
851,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0198,jnp-010,overactive bladder,4,,-,approved,1975,,15963006|16188951|19446545|20590605|17222678
852,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,14,aa-2010,incontinence,4,,-,approved,1975,,17139284|17016423|19275276|19446545|20590605|17222678|16406943|11752352
853,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,190,"ap-1034,anturol",overactive bladder,4,,-,approved,1975,,17139284|17016423|19275276|19446545|20590605|17222678|16406943|11752352
854,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2067,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",incontinence,4,,-,approved,1975,,17139284|17016423|19275276|19446545|20590605|17222678|16406943|11752352
855,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0199,jnp-010,overactive bladder,4,,-,approved,1975,,17139284|17016423|19275276|19446545|20590605|17222678|16406943|11752352
856,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,14,aa-2010,incontinence,4,,-,approved,1975,,17139284|17016423|20590605|17222678|16406943
857,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,190,"ap-1034,anturol",overactive bladder,4,,-,approved,1975,,17139284|17016423|20590605|17222678|16406943
858,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2067,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",incontinence,4,,-,approved,1975,,17139284|17016423|20590605|17222678|16406943
859,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0197,jnp-010,overactive bladder,4,,-,approved,1975,,17139284|17016423|20590605|17222678|16406943
860,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,514,"col-003, sustained release oxycodone",Analgesics,4,,-,approved,2016,,17525040|11752352
861,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,515,"col-172, extended-release oxycodone",Analgesics,4,,-,approved,2011,,17525040|11752352
862,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1545,"oxycodone art, eli216,oxynal",Analgesics,4,,-,approved,1998,,17525040|11752352
863,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2068,transdermal oxycodone,Analgesics,4,,-,approved,1998,,17525040|11752352
864,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0088,eli-200,Analgesics,4,,-,approved,2016,,17525040|11752352
865,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0707,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,,17525040|11752352
866,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,514,"col-003, sustained release oxycodone",Analgesics,4,,-,approved,2016,,17525040|18039433|17467904
867,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,515,"col-172, extended-release oxycodone",Analgesics,4,,-,approved,2011,,17525040|18039433|17467904
868,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1545,"oxycodone art, eli216,oxynal",Analgesics,4,,-,approved,1998,,17525040|18039433|17467904
869,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2068,transdermal oxycodone,Analgesics,4,,-,approved,1998,,17525040|18039433|17467904
870,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0089,eli-200,Analgesics,4,,-,approved,2016,,17525040|18039433|17467904
871,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0708,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,,17525040|18039433|17467904
872,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,514,"col-003, sustained release oxycodone",Analgesics,4,,-,approved,2016,,17525040|18039433|19474215
873,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,515,"col-172, extended-release oxycodone",Analgesics,4,,-,approved,2011,,17525040|18039433|19474215
874,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1545,"oxycodone art, eli216,oxynal",Analgesics,4,,-,approved,1998,,17525040|18039433|19474215
875,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2068,transdermal oxycodone,Analgesics,4,,-,approved,1998,,17525040|18039433|19474215
876,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0087,eli-200,Analgesics,4,,-,approved,2016,,17525040|18039433|19474215
877,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0706,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,,17525040|18039433|19474215
878,oxymetazoline,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1491,oms-103hp,Analgesics,4,,-,approved,1986,,1327384|17164433|7892112
879,oxymetazoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1491,oms-103hp,Analgesics,4,,-,approved,1986,,8894610|8768700|11774707|8564226|11527538
880,oxymorphone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1548,"oxymorphone hydrochloride, en3202,opana, opana er",Analgesics,4,,-,approved,1959,,9712193|17006080|17595308|10854833|16343768|11752352
881,oxyphencyclimine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD407,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1982,,17139284|17016423|1426023|3247303
882,oxyphencyclimine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD407,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1982,,17139284|17016423|1426023|3247303
883,oxyphencyclimine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD407,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1982,,17139284|17016423|1426023|3247303
884,oxyphenonium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD408,-,Mydriatics,4,,-,approved,1982,,17139284|17016423|3580704|11752352
885,oxytocin,peptide,Peptide,agonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2014,"ti-001, intranasal oxytocin",Analgesics,4,,-,approved,1980,endogenous ligand,20108008|20104850|18655883|15646817|21208749
886,oxytocin,peptide,Peptide,agonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,MMA2016_0022,"opn-300, intranasal oxytocin",autism,4,,-,approved,1980,endogenous ligand,20108008|20104850|18655883|15646817|21208749
887,paliperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1558,"paliperidone er, paliperidone palmitate",schizophrenia,4,,-,approved,2006,,7524043|7531353|16119512|16513859|11132243|12211096|11752352
888,paliperidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1558,"paliperidone er, paliperidone palmitate",schizophrenia,4,,-,approved,2006,,7524043|7542676|7520908|7531353|11132243|12211096
889,parathyroid hormone,protein,Peptide,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2012,"bn-003,capthymone,thpth",Anti-osteoporotic,4,,-,approved,2015,endogenous ligand,10837469
890,parathyroid hormone,protein,Peptide,agonist,,primary,PTH2R,pth2r_human,P49190,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2012,thpth,Anti-osteoporotic,4,,-,approved,2015,endogenous ligand,10837469
891,parathyroid hormone,protein,Peptide,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2799,"air parathyroid hormone, air pth",hypoparathyroidism,4,,-,approved,2015,endogenous ligand,10837469
892,parathyroid hormone,protein,Peptide,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,MMAmay2016_0745,"natpara, npsp558, parathyroid horomone",Control hypocalcemia,4,,-,approved,2015,endogenous ligand,10837469
893,pasireotide,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1567,"pasireotide, som230",Antineoplastic ; acromegaly,4,,-,approved,2012,,17395978|11980628
894,pasireotide,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1567,"pasireotide, som230",Antineoplastic ; acromegaly,4,,-,approved,2012,,17395978|11980628
895,pasireotide,peptide,Peptide,agonist,,primary,SSTR3,ssr3_human,P32745,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1567,"pasireotide, som230",Antineoplastic ; acromegaly,4,,-,approved,2012,,17395978|11980628
896,pasireotide,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1567,"pasireotide, som230",Antineoplastic ; acromegaly,4,,-,approved,2012,,17395978|11980628
897,pemirolast,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD416,-,Anti-Allergic,4,,-,approved,1999,,26028608|18463425
898,penbutolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD417,-,Antihypertensive,4,,-,approved,1987,,16716|8098761|8982649|11224195|2446632|2189902
899,penbutolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD417,-,Antihypertensive,4,,-,approved,1987,,6755764|11224195|11738481|2189902
900,pentagastrin,small molecule,Peptide,agonist,,primary,CCKBR,gasr_human,P32239,Class A (Rhodopsin),GPCR;Rhodopsin,Cholecystokinin receptors,established,NRDD418,-,Diagnostic,4,,-,approved,1974,,12073167|15157745|1732532|3004700|7491961|11752352
901,pentazocine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD419,-,Analgesics,4,,-,approved,1967,,8788445
902,pentazocine,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD419,-,Analgesics,4,,-,approved,1967,,3419842|6094791|8042002|8968334|2286420
903,pergolide,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD422,-,Antiparkinson,4,,-,approved,1988,,11752352|2860228|1674528|18691132|10641988|10516878|16842172|3828803
904,perphenazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD425,-,schizophrenia,4,,-,approved,1957,,11873706|7508675|7828655|11752352|15007534|2573104
905,perphenazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD425,-,schizophrenia,4,,-,approved,1957,,17455212|2573104
906,phendimetrazine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD427,-,Appetite suppressant,4,,-,approved,1976,,17139284|17016423|16265126|11054601|11752352|17017961
907,phendimetrazine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD427,-,Appetite suppressant,4,,-,approved,1976,,17139284|17016423|16265126|11054601|17017961
908,phenindamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_355,phenindamine,Anti-Allergic,4,,-,approved,1949,,17016423|7650688|1360991|1686618|11752352
909,pheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD431,-,Anti-Allergic,4,,-,approved,1994,,17016423|2567596|7714410|11526976|8835636|20027159|14506317|11752352
910,phenoxybenzamine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_127,phenoxybenzamine,cardiovascular disease,4,,-,approved,1953,,11395517
911,phenoxybenzamine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD434,-,Anticonvulsants; Hypnotics and Sedatives,4,,-,approved,1953,,10401556|7911719|12818701|8935707|1978244
912,phentolamine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,288,"aviptadil,invicorp",sexual dysfunction,4,,-,approved,1952,,16273345|10988273|17115069|12721093|12770936|7562640|1346768|6176798
913,phentolamine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD437,-,Antihypertensive,4,,-,approved,1952,,16273345|10988273|17115069|12721093|12770936|7562640|1346768|6176798
914,phentolamine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,288,"aviptadil,invicorp",sexual dysfunction,4,,-,approved,1952,,7562640|1346768|6176798
915,phenylephrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1675,"psd-503, phenylephrine",incontinence,4,,-,approved,1952,,11752352
916,phenylephrine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1675,"psd-503, phenylephrine",incontinence,4,,-,approved,1952,,28369791
917,phenylephrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1675,"psd-503, phenylephrine",incontinence,4,,-,approved,1952,,17584443|17658513
918,phenylpropanolamine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD439,-,Appetite Depressants; Nasal Decongestants,4,,-,approved,1958,,17016423|9164583|12163120|15163201|2881994
919,phenylpropanolamine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD439,-,Appetite Depressants; Nasal Decongestants,4,,-,approved,1958,,17139284|17016423|15608085
920,pilocarpine,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,4,,-,approved,1974,,11752352|19465517|18824613
921,pilocarpine,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,4,,-,approved,1974,,17139284|17016423|18824613
922,pilocarpine,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,4,,-,approved,1974,,19498041|18824613
923,pimavanserin,small molecule,Aminergic ,inverse agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1610,pimavanserin,Antiparkinson,4,,-,approved,2016,,24016069
924,pimozide,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_211,pimozide,psychosis,4,,-,approved,1984,,8301582
925,pimozide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD443,-,Antidyskinetics; Antipsychotic,4,,-,approved,1984,,11752352|11873706|12828573|2378927|8082693|8301582|7855217|10503726
926,pindolol,small molecule,Aminergic ,partial agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD444,-,Antihypertensive,4,,-,approved,1982,,11752352|14608456|1687398|2148726|8884690|2907348
927,pindolol,small molecule,Aminergic ,partial agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD444,-,Antihypertensive,4,,-,approved,1982,,16574446|1666931|1678274|1687398|1979630|11752352
928,pipotiazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_382,pipotiazine,Antipsychotic,4,,-,approved,1980,,7918347
929,pipotiazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_378,pipotiazine,Antipsychotic,4,,-,approved,1980,,10821438|8593484
930,pipotiazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_386,pipotiazine,Antipsychotic,4,,-,approved,1980,,11103886|11873706|15694263|16867246|11752352|20643630|2875894
931,pipotiazine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_390,pipotiazine,Antipsychotic,4,,-,approved,1980,,11755134|9760039
932,pirbuterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_181,pirbuterol,obstructive lung disease,4,,-,approved,1986,,17260025|7053311|8945911|11752352
933,pirenzepine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD446,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,-,,11752352|12717096
934,plerixafor,small molecule,Protein,partial agonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1342,mozobil,Antineoplastic,4,,-,approved,2008,,18847313|23204107
935,practolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD449,-,Anti-Arrhythmia,4,,-,approved,-,,2871880|30388|6524278|11752352|2857116
936,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1293,mirapex,Antiparkinson,4,,-,approved,1997,,11752352|18691132
937,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1293,mirapex,Antiparkinson,4,,-,approved,1997,,11752352|18691132|10641988
938,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1293,mirapex,Antiparkinson,4,,-,approved,1997,,11752352|18691132|10641988
939,pramlintide acetate,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,1924,"pramlintide acetate, symlin",Antidiabetic,4,,-,approved,2005,,11772274
940,pranlukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,NRDD451,-,Anti-Asthmatic,4,,-,approved,-,,11264758|11854273|15475658|16864492|17112405|11752352
941,prasugrel,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,1640,"prasugrel, cs-747,efient",antithrombotic,4,,-,approved,2009,,18485086
942,prazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD453,-,Antihypertensive ; antispasmodics,4,,-,approved,1976,,11156594|11752352|8925876|12270758|12824165|7691623|7855217
943,prazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD453,-,Antihypertensive ; antispasmodics,4,,-,approved,1976,,12841945|8925876|15258254|7691623|10771044|17658513|14980979|7855217
944,prazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD453,-,Antihypertensive ; antispasmodics,4,,-,approved,1976,,18187928|11682453|7855217
945,prochlorperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,395,"buccal prochlorperazine maleate,emezine",Antiemetics,4,,-,approved,1956,,11752352|16677982|2527092|17044574|18534808|18955042|17169748
946,procyclidine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD460,-,Antidyskinetics; Antiparkinson s,4,,-,approved,1955,,17139284|17016423|2027917|2253700|20624420|1426023
947,procyclidine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD460,-,Antidyskinetics; Antiparkinson s,4,,-,approved,1955,,17139284|17016423|2027917|2253700|20624420|1426023
948,procyclidine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD460,-,Antidyskinetics; Antiparkinson s,4,,-,approved,1955,,17139284|17016423|2253700|7616431|20624420|1426023
949,progabide,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,NRDD461,-,Anticonvulsants,4,,-,approved,-,Not FDA approved but used in other countries,11752352|9443561|2985405
950,promazine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_208,promazine,psychosis,4,,-,approved,1956,,16135699
951,promazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423
952,promazine,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423
953,promazine,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423
954,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423
955,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423
956,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423
957,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423
958,promazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423
959,promazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423
960,promazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423
961,promazine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423
962,promazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423|10980325|12106771
963,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423|11752352
964,promazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,,17139284|17016423|2899826
965,promethazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,,11752352|12657913|8098142|2576052|3011460|9442829|2866055
966,propantheline,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD464,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1953,,17016423|2656175|3572714|15337834|16080359|11752352
967,propericiazine,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD466,-,schizophrenia,4,,-,approved,-,Not FDA approved but used in other countries,17139284|17016423|11752352
968,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423
969,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423
970,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423
971,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423
972,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423
973,propiomazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423
974,propiomazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423
975,propiomazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423
976,propiomazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423
977,propiomazine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423
978,propiomazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423|14035428|11752352
979,propoxyphene,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD468,-,Analgesics,4,,-,approved,1957,,6151117|6249436
980,propoxyphene,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD468,-,Analgesics,4,,-,approved,1957,,6151117|6249436
981,propoxyphene,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD468,-,Analgesics,4,,-,approved,1957,,6151117|6249436
982,propranolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2183,vt-122,cancer cachexia,4,,-,approved,1967,,11752352|14757703|16177222|17628611|15236843|17572694
983,protirelin,small molecule,Aminergic ,agonist,,primary,TRHR,trfr_human,P34981,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_408,protirelin,Diagnostic,4,,-,approved,1976,endogenous ligand,12467901|9075462
984,prucalopride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1665,"prucalopride ,resolor",motilitant,4,,-,approved,2009,,11438309
985,pseudoephedrine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,789,fexofenadine + ps/,Anti-Allergic,4,,-,approved,1975,,17139284|17016423
986,pseudoephedrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,789,fexofenadine + ps/,Anti-Allergic,4,,-,approved,1975,,17139284|17016423|11772135
987,pyrilamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_236,pyrilamine,pruritus,4,,-,approved,1973,,19552055
988,quetiapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1840,seroquel,Antipsychotic ; Anti-depressant,4,,-,approved,1997,,10839333|11132243|11873706|17848919|11752352
989,quetiapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1840,seroquel,Antipsychotic ; Anti-depressant,4,,-,approved,1997,,12973385|17563257|11132243|16038601|17848919
990,ramelteon,small molecule,Melatonin ,agonist,,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1713,"ramelteon, tak-375,rozerem",insomnia,4,,-,approved,2005,,15695169|16432265|17389558|16173650|16730121|15869323|19228178|19768947|19568703|17157111|17015817|17803013|11752352
991,ramelteon,small molecule,Melatonin ,agonist,,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1713,"ramelteon, tak-375,rozerem",insomnia,4,,-,approved,2005,,15695169|16432265|17389558|16173650|16730121|15869323|19228178|19768947|19568703|17157111|17015817|17803013|11752352
992,ranitidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1716,"ranitidine bismuth citrate,tritec",antiulcer,4,,-,approved,1977,,11752352|7554999
993,ranitidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,2238,"zantac,ranitidine hydrochloride",antiulcer,4,,-,approved,1977,,11752352|7554999
994,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_108,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter,7562902|1095275
995,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_121,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter,7562902|1095275
996,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_144,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter,7562902|1095275
997,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_160,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter,7562902|1095275
998,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_84,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter,7562902|1095275
999,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_93,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter,7562902|1095275
1000,regadenoson,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1726,"regadenoson,lexiscan",Diagnostic,4,,-,approved,2008,,22130964
1001,remifentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1732,"remifentanil,ultiva",Analgesics,4,,-,approved,1996,,16114980|16332149|8694317|9066316|11752352|9103501|8875131
1002,remoxipride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD479,-,schizophrenia,4,,-,approved,1990,Withdrawn ,11873706|8665533|11752352
1003,ridogrelum,small molecule,Lipid ,antagonist,,primary,TBXA2R,ta2r_human,P21731,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAjun2016_0002,ridogrel,for the prevention of systemic thrombo-embolism; adjunctive  to thrombolytic therapy,4,,-,approved,-,,8289199
1004,rimonabant,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1766,rimonabant,Anti-obesity,4,,-,approved,2007,,8636122|11752352
1005,risperidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1770,risperdal,schizophrenia,4,,-,approved,1993,,15907153|15992090|11132243|17316700
1006,risperidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD484,-,schizophrenia,4,,-,approved,1993,,15907153|15992090|11132243|17316700
1007,risperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1770,risperdal,schizophrenia,4,,-,approved,1993,,17059881|15907153|15140279|16730699|16513859|11132243|11752352
1008,risperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD484,-,schizophrenia,4,,-,approved,1993,,17059881|15907153|15140279|16730699|16513859|11132243|11752352
1009,ritodrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD485,-,Tocolytic,4,,-,approved,1987,,11311067|12871140|1332478|1976401|8059831|11752352
1010,rizatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD486,-,Anti-migraine,4,,-,approved,1998,,11752352|9127118|8904614|9056052|11487512|15821444|12093318|12269863|15056946
1011,rizatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD486,-,Anti-migraine,4,,-,approved,1998,,12093318|12269863|15056946|9650800|11752352|11487512|15821444
1012,rocuronium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1776,"rocuronium bromide,esmeron, zemuron, eslax",Muscle Relaxants,4,,-,approved,2008,,17139284|17016423|20400785
1013,rolapitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,MMAmay2016_0753,"sch 619734, rolapitant",Antiemetics,4,,-,approved,2015,,22497992
1014,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1737,ropinirole,Antiparkinson,4,,-,approved,1997,,11752352|1683559|10446316|18691132|10641988|17573046
1015,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_218,ropinirole,Antiparkinson,4,,-,approved,1997,,11752352|18691132
1016,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1737,ropinirole,Antiparkinson,4,,-,approved,1997,,11752352|18691132|10641988
1017,rotigotine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1404,neupro,Antiparkinson,4,,-,approved,2006,,18691132
1018,rotigotine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1404,neupro,Antiparkinson,4,,-,approved,2006,,18691132
1019,rotigotine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1404,neupro,Antiparkinson,4,,-,approved,2006,,18691132
1020,rupatadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Aug2017_5,-,Anti-Allergic,4,,-,approved,2016,approved in canada,8996188
1021,rupatadine,small molecule,Lipid ,antagonist,,primary,PTAFR,ptafr_human,P25105,Class A (Rhodopsin),GPCR;Rhodopsin,Platelet-activating factor receptors,established,ASH_Aug2017_6,-,Anti-Allergic,4,,-,approved,2016,approved in canada,8996188
1022,salbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,102,"albuterol,ventolin",Bronchodilator,4,,-,approved,1981,,12388338|12569076|12808710|14757145|15557128|11752352
1023,salbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1021,"ipratropium bromide + albuterol sulfate,duoneb",chronic obstructive pulmonary disease (COPD),4,,-,approved,1981,,12388338|12569076|12808710|14757145|15557128|11752352
1024,salbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1116,levalbuterol,Bronchodilator,4,,-,approved,1981,,12388338|12569076|12808710|14757145|15557128|11752352
1025,salbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1146,"lipo-102, salmeterol xinafoate + fluticasone propionate",symptomatic exophthalmos associated with thyroid-related eye disease,4,,-,approved,1981,,12388338|12569076|12808710|14757145|15557128|11752352
1026,salmeterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,61,advair/seretide/adoair,Bronchodilator,4,,-,approved,1994,,10471277|11250877|11516429|12897749|1359777|11752352
1027,salmeterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1839,serevent,Bronchodilator,4,,-,approved,1994,,10471277|11250877|11516429|12897749|1359777|11752352
1028,scopolamine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD491,-,Adjuvants; Anesthesia; Antispasmodics; Mydriatics,4,,-,approved,1953,,14534362|20398692
1029,secretin,peptide,Peptide,agonist,,primary,SCTR,sctr_human,P47872,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,NRDD493,-,Diagnostic,4,,-,approved,2002,endogenous ligand,17139284|17016423|11752352
1030,selexipag,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1831,"selexipag, act-293987",Antihypertensive,4,,-,approved,2015,,25850750
1031,selexipag,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0747,selixipag,Antihypertensive,4,,-,approved,2015,,25850750
1032,sermorelin,peptide,Peptide,agonist,,primary,GHRHR,ghrhr_human,Q02643,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,NRDD494,-,Hormone Replacement,4,,-,approved,1990,,14499707|11752352
1033,silodosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1852,silodosin,BPH-related urinary symptoms,4,,-,approved,2008,,21114397
1034,sitaxentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2010,"thelin, sitaxentan",Antihypertensive,4,,-,approved,2006,,17472992|11728166|11752352|11447307|11704565|10961375|11849873
1035,sitaxentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Oct2016_368,sitaxentan,Antihypertensive,4,,-,approved,2006,copy and conflicting subfamily,17472992|11728166|11752352|11447307|11704565|10961375|11849873
1036,solifenacin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,,17139284|17016423|19446545|20590605|19029429|11752352
1037,sonidegib,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,1101,lde225,Antineoplastic,4,,-,approved,2015,,26323341
1038,sotalol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_180,sotalol,cardiovascular disease,4,,-,approved,1992,,11815381|15060759|19259968|8095397|2865685
1039,sotalol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_168,sotalol,atrial fibrillation,4,,-,approved,1992,,11815381|15060759|19259968|8095397|2865685|11752352
1040,succinylcholine,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD501,-,Muscle Relaxants; Skeletal,4,,-,approved,1952,,17139284|17016423|10437710
1041,sufentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,242,"arx-01, sufentanil nanotab",Analgesics; adjuvant to anesthesia,4,,-,approved,1984,,11299311|1688220|2847746|3014923|6131653|11752352
1042,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1357,"mt 400,treximet",Anti-migraine,4,,-,approved,2008,,11513839
1043,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1438,"np101,zelrix",Anti-migraine,4,,-,approved,1992,,11513839
1044,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1914,sumatriptan,Anti-migraine,4,,-,approved,1992,,11513839
1045,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1915,"sumatriptan, triptan",Anti-migraine,4,,-,approved,1992,,11513839
1046,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1916,"sumatriptan,imitrex",Anti-migraine,4,,-,approved,1992,,11513839
1047,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1357,"mt 400,treximet",Anti-migraine,4,,-,approved,2008,,10073743|10367177|11015308|15178373|11752352|10225363|18723285|12110114
1048,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1438,"np101,zelrix",Anti-migraine,4,,-,approved,1992,,10073743|10367177|11015308|15178373|11752352|10225363|18723285|12110114
1049,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1914,sumatriptan,Anti-migraine,4,,-,approved,1992,,10073743|10367177|11015308|15178373|11752352|10225363|18723285|12110114
1050,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1915,"sumatriptan, triptan",Anti-migraine,4,,-,approved,1992,,10073743|10367177|11015308|15178373|11752352|10225363|18723285|12110114
1051,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1916,"sumatriptan,imitrex",Anti-migraine,4,,-,approved,1992,,10073743|10367177|11015308|15178373|11752352|10225363|18723285|12110114
1052,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1357,"mt 400,treximet",Anti-migraine,4,,-,approved,2008,,10101238|10225363|10454495|10458598|10513577|11752352|11874390|12010765|10772044|18723285|12110114
1053,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1438,"np101,zelrix",Anti-migraine,4,,-,approved,1992,,10101238|10225363|10454495|10458598|10513577|11752352|11874390|12010765|10772044|18723285|12110114
1054,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1914,sumatriptan,Anti-migraine,4,,-,approved,1992,,10101238|10225363|10454495|10458598|10513577|11752352|11874390|12010765|10772044|18723285|12110114
1055,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1915,"sumatriptan, triptan",Anti-migraine,4,,-,approved,1992,,10101238|10225363|10454495|10458598|10513577|11752352|11874390|12010765|10772044|18723285|12110114
1056,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1916,"sumatriptan,imitrex",Anti-migraine,4,,-,approved,1992,,10101238|10225363|10454495|10458598|10513577|11752352|11874390|12010765|10772044|18723285|12110114
1057,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1357,"mt 400,treximet",Anti-migraine,4,,-,approved,2008,,11313163|11641558|11874390|12010765|15554784|11752352|10225363|10454495|10772044|18723285|12110114
1058,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1438,"np101,zelrix",Anti-migraine,4,,-,approved,1992,,11313163|11641558|11874390|12010765|15554784|11752352|10225363|10454495|10772044|18723285|12110114
1059,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1914,sumatriptan,Anti-migraine,4,,-,approved,1992,,11313163|11641558|11874390|12010765|15554784|11752352|10225363|10454495|10772044|18723285|12110114
1060,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1915,"sumatriptan, triptan",Anti-migraine,4,,-,approved,1992,,11313163|11641558|11874390|12010765|15554784|11752352|10225363|10454495|10772044|18723285|12110114
1061,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1916,"sumatriptan,imitrex",Anti-migraine,4,,-,approved,1992,,11313163|11641558|11874390|12010765|15554784|11752352|10225363|10454495|10772044|18723285|12110114
1062,suramin,small molecule,Nucleotide ,antagonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y,established,ASH_Oct2016_346,Suramin,African trypanosomiasis,4,,-,approved,1916,,8762097|9647463|16388598|9112981|11132624
1063,suvorexant,small molecule,Peptide,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,1304,mk-4305,Hypnotics and Sedatives,4,,-,approved,2014,,23702225
1064,suvorexant,small molecule,Peptide,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,1304,mk-4305,Hypnotics and Sedatives,4,,-,approved,2014,,23702225
1065,tafluprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0794,"taflotan, tapros, zioptan, tafluprost, saflutan, de-085, mk-2452",Reduce intraocular pressure,4,,-,approved,2012,,21858491
1066,tamsulosin,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1946,"tamsulosin, ym-617,harnal, flomax",urinary symptoms associated with BPH,4,,-,approved,1997,,11752352|9117115|16986050|16518087|12270758|8996174|14680444
1067,tamsulosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,675,"dutasteride + tamsulosin,jalyn",benign prostatic hyperplasia,4,,-,approved,1997,,11752352|9352698|10503165|9352700|8647141|8647140|19427736|14680444
1068,tamsulosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1946,"tamsulosin, ym-617,harnal, flomax",urinary symptoms associated with BPH,4,,-,approved,1997,,11752352|9352698|10503165|9352700|8647141|8647140|19427736|14680444
1069,tamsulosin,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1946,"tamsulosin, ym-617,harnal, flomax",urinary symptoms associated with BPH,4,,-,approved,1997,,12270758|7911719|8996174|9294627|11752352|14680444
1070,tapentadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1950,tapentadol,Analgesics,4,,-,approved,2008,,10592235
1071,tapentadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1951,"tapentadol hydrochloride, cg-5503, r331333",Analgesics,4,,-,approved,2008,,10592235
1072,tasimelteon,small molecule,Melatonin ,agonist,,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1956,"tasimelteon, vec-162",Hypnotics and Sedatives,4,,-,approved,2014,,25534555
1073,tasimelteon,small molecule,Melatonin ,agonist,,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1956,"tasimelteon, vec-162",Hypnotics and Sedatives,4,,-,approved,2014,,25534555
1074,teduglutide,peptide,Peptide,agonist,,primary,GLP2R,glp2r_human,O95838,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2463,teduglutide,short bowel syndrome,4,,-,approved,2012,,23729002
1075,tegaserod,small molecule,Aminergic ,partial agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1975,"tegaserod,zelnorm, zelmac",motilitant,4,,-,approved,2002,,11207504|11876686|12150698|15466450|15645012|11752352
1076,telmisartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1977,"telmisartan,micardis, micardis hct",Antihypertensive,4,,-,approved,1998,,11752352|10067800|11444497|11408526|9259062|15498586|11558835|9878991|20448797|19147680|16938288|18580862|15617852|17691961
1077,terazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD514,-,Antineoplastic s; Antihypertensive,4,,-,approved,1987,,11752352
1078,terazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD514,-,Antineoplastic s; Antihypertensive,4,,-,approved,1987,,11711348|11752352|2988814|1358918
1079,terazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD514,-,Antineoplastic s; Antihypertensive,4,,-,approved,1987,,9732824|11752352|9352700|8736427|10503165|14767264
1080,terbutaline,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD515,-,Bronchodilator ; Tocolytic,4,,-,approved,1974,,10226872|11120594|11256987|11675405|12569076|11752352|20674738|18782903|1358833|2062329
1081,terfenadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD516,-,Anti-Allergic,4,,-,approved,1985,,11752352|9485522|8001268|7654486|2569356|2879489
1082,teriparatide,peptide,Peptide,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1983,"teriparatide, inhaled air",Anti-osteoporotic,4,,-,approved,1987,,11752352
1083,teriparatide,peptide,Peptide,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1984,"teriparatide, pth1-34 nasal spray",Anti-osteoporotic,4,,-,approved,1987,,11752352
1084,teriparatide,peptide,Peptide,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1985,"teriparatide,forteo, forsteo",Anti-osteoporotic,4,,-,approved,1987,,11752352
1085,teriparatide,peptide,Peptide,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2252,"zt-034, teriparatide nasal spray",Anti-osteoporotic,4,,-,approved,1987,,11752352
1086,teriparatide,peptide,Peptide,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2252,"zt-034, teriparatide nasal spray",Anti-osteoporotic,4,,-,approved,1987,,11752352
1087,teriparatide,peptide,Peptide,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,MMAmay2016_0763,"cp046, intranasal teriparatide",Anti-osteoporotic,4,,-,approved,1987,,11752352
1088,terlipressin,small molecule,Peptide,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1986,"terlipressin,lucassin",hepatorenal syndrome,4,,-,approved,2003,,17020465|16333859|16563128|17287200
1089,terlipressin,small molecule,Peptide,agonist,,primary,AVPR1B,v1br_human,P47901,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1986,"terlipressin,lucassin",hepatorenal syndrome,4,,-,approved,2003,,17027167|16720725|17284170|16114100|15993108
1090,terlipressin,small molecule,Peptide,agonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1986,"terlipressin,lucassin",hepatorenal syndrome,4,,-,approved,2003,,17275806|16532916|16511036|16011575|17303660|11752352
1091,tesamorelin,peptide,Peptide,agonist,,primary,GHRHR,ghrhr_human,Q02643,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1987,tesamorelin,HIV-associated lipodystrophy,4,,-,approved,2010,,22298602
1092,tetrahydrocannabinol,plant extract,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1812,sativex,Analgesics; neuropathic pain; restlegs legs syndrome,4,,-,approved,1985,,17828291
1093,tetrahydrocannabinol,plant extract,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1812,sativex,Analgesics; neuropathic pain; restlegs legs syndrome,4,,-,approved,1985,,20943404
1094,tetrahydrozoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_85,tetrahydrozoline,eye allergy,4,,-,approved,1979,,18259967
1095,tetryzoline,small molecule,Peptide,agonist,,primary,ADRA1A,ada1a_human,P35348,Class B1 (Secretin),GPCR;Rhodopsin,Calcitonin receptors,established,ASH_Oct2016_411,tetryzoline,"for eye irritation, decongestant",4,,-,approved,1982,,18259967
1096,theophylline,small molecule,Nucleotide ,antagonist,,primary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,53,"adc4022, low-dose inhaled theophylline",Bronchodilator,4,,-,approved,1976,,11752352|16545350|16581066|12954362|15980878|3588607
1097,theophylline,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,53,"adc4022, low-dose inhaled theophylline",Bronchodilator,4,,-,approved,1976,,14992338|3588607
1098,theophylline,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,53,"adc4022, low-dose inhaled theophylline",Bronchodilator,4,,-,approved,1976,,16357952|3588607
1099,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,,2947734
1100,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,,2947734
1101,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,,2947734
1102,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,,2947734
1103,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,,2947734
1104,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,,2947734
1105,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,,2947734
1106,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,,2947734
1107,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,,17139284|17016423
1108,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,,17139284|17016423
1109,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,,17139284|17016423|15469457
1110,thioproperazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_376,thioproperazine,Antipsychotic,4,,-,approved,1962,,15695070
1111,thioproperazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_380,thioproperazine,Antipsychotic,4,,-,approved,1962,,10821438|8593484
1112,thioproperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_388,thioproperazine,Antipsychotic,4,,-,approved,1962,,11103886|11873706|15694263|16867246|11752352|20643630
1113,thioproperazine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_392,thioproperazine,Antipsychotic,4,,-,approved,1962,,11755134|9760039
1114,thioridazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD521,-,schizophrenia,4,,-,approved,1962,,8720030
1115,thioridazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD521,-,schizophrenia,4,,-,approved,1962,,1978482|7689973|1352051|16434058|9292626
1116,thioridazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD521,-,schizophrenia,4,,-,approved,1962,,2866233|7898773|2423886|8680734|9918563
1117,thioridazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD521,-,schizophrenia,4,,-,approved,1962,,7691623|15695070
1118,thiothixene,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_19,thiothixene,psychosis,4,,-,approved,1967,,10821438|8593484
1119,thiothixene,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_67,thiothixene,psychosis,4,,-,approved,1967,,3039860|11103886|11873706|15694263|16867246|11752352|20643630
1120,thyrotropin alfa,protein,Protein,agonist,,primary,TSHR,tshr_human,P16473,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD522,-,Diagnostic,4,,-,approved,1998,endogenous ligand,15571461|9039330|11752352
1121,ticagrelor,small molecule,Nucleotide ,NAM,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,2015,ticagrelor,antithrombotic,4,,-,approved,2010,,19604248
1122,ticlopidine,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,NRDD525,-,Platelet Aggregation Inhibitors,4,,-,approved,1991,,11454254|15816504|15955565|17110146|11752352
1123,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1981,,11752352|16205624|8103526|9730867|8719802|9088585|10592235
1124,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1095,"latanoprost + timolol,xalcom, xalacom",Antiglaucomic,4,,-,approved,1981,,11752352|16205624|8103526|9730867|8719802|9088585|10592235
1125,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2071,"travoprost + timolol,extravan, duotrav",Antiglaucomic,4,,-,approved,1981,,11752352|16205624|8103526|9730867|8719802|9088585|10592235
1126,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1981,,11752352|16315032|10433496|10870519|12221524|8864321
1127,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1095,"latanoprost + timolol,xalcom, xalacom",Antiglaucomic,4,,-,approved,1981,,11752352|16315032|10433496|10870519|12221524|8864321
1128,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2071,"travoprost + timolol,extravan, duotrav",Antiglaucomic,4,,-,approved,1981,,11752352|16315032|10433496|10870519|12221524|8864321
1129,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2019,"tiotropium bromide,spiriva",cystic fibrosis; chronic obstructive pulmonary disorder (COPD),4,,-,approved,2004,,11752352|12582447|11281822|10188785
1130,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0591,tiotropium + olodaterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2004,,11752352|12582447|11281822|10188785
1131,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2019,"tiotropium bromide,spiriva",cystic fibrosis; chronic obstructive pulmonary disorder (COPD),4,,-,approved,2004,,12582447|10188785
1132,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0589,tiotropium + olodaterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2004,,12582447|10188785
1133,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2019,"tiotropium bromide,spiriva",cystic fibrosis; chronic obstructive pulmonary disorder (COPD),4,,-,approved,2004,,12582447|11281822|10188785
1134,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0590,tiotropium + olodaterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2004,,12582447|11281822|10188785
1135,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1458,"nvd-422, tizanidine oral spray",skeletal muscular spasticity,4,,-,approved,1996,,8930173
1136,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1458,"nvd-422, tizanidine oral spray",skeletal muscular spasticity,4,,-,approved,1996,,8930173
1137,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1458,"nvd-422, tizanidine oral spray",skeletal muscular spasticity,4,,-,approved,1996,,8930173
1138,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2021,"tizanidine hydrochloride,zanaflex",Muscle Relaxants,4,,-,approved,1996,,8930173
1139,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2021,"tizanidine hydrochloride,zanaflex",Muscle Relaxants,4,,-,approved,1996,,8930173
1140,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2021,"tizanidine hydrochloride,zanaflex",Muscle Relaxants,4,,-,approved,1996,,8930173
1141,tolazoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD530,-,Antihypertensive,4,,-,approved,1948,,17139284|17016423|16368348|11938943
1142,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,,11752352|14769832|19168050|11193006
1143,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,,16188951|14769832|19168050|11193006
1144,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,,17139284|17016423|14769832
1145,tolvaptan,small molecule,Peptide,antagonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2037,"tolvaptan, opc-41061,samsca",Antihypertensive,4,,-,approved,2009,,20868352|19337422
1146,tramadol,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2055,"tramadol extended-release,raliva er",Analgesics,4,,-,approved,1995,,12570923
1147,tramadol,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2056,"tramadol hydrochloride,ultram",Analgesics,4,,-,approved,1995,,12570923
1148,tramadol,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2057,"tramadol,tridural, ryzolt",Analgesics,4,,-,approved,1995,,12570923
1149,tramadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2055,"tramadol extended-release,raliva er",Analgesics,4,,-,approved,1995,,10961373|10991912|1309873|15509185|16793069|11752352|17380034|8955860
1150,tramadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2056,"tramadol hydrochloride,ultram",Analgesics,4,,-,approved,1995,,10961373|10991912|1309873|15509185|16793069|11752352|17380034|8955860
1151,tramadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2057,"tramadol,tridural, ryzolt",Analgesics,4,,-,approved,1995,,10961373|10991912|1309873|15509185|16793069|11752352|17380034|8955860
1152,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2055,"tramadol extended-release,raliva er",Analgesics,4,,-,approved,1995,,15105221|16679816
1153,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2056,"tramadol hydrochloride,ultram",Analgesics,4,,-,approved,1995,,15105221|16679816
1154,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2057,"tramadol,tridural, ryzolt",Analgesics,4,,-,approved,1995,,15105221|16679816
1155,travoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2071,"travoprost + timolol,extravan, duotrav",Antiglaucomic,4,,-,approved,2001,,16249494|16505027|18452763|19697832|19929706|9038626|19038618|18983226|11752352
1156,trazodone,small molecule,Aminergic ,partial agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2072,"trazodone extended release, dds-04a,oleptro",Anti-depressant,4,,-,approved,1981,,10594316|11714900|1365657|15610924|3039120|7855217
1157,trazodone,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2072,"trazodone extended release, dds-04a,oleptro",Anti-depressant,4,,-,approved,1981,,15888508|7855217|12127910
1158,trazodone,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2072,"trazodone extended release, dds-04a,oleptro",Anti-depressant,4,,-,approved,1981,,7659770|3039120
1159,treprostinil,small molecule,Nucleotide ,agonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,2767,"treprostinil inhaled/oral,tyvaso, viveta",Antihypertensive,4,,-,approved,2002,,17139284|17016423
1160,treprostinil,small molecule,Nucleotide ,agonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,2768,"treprostinil subcutaneous/intravenous,remodulin",Antihypertensive,4,,-,approved,2002,,17139284|17016423
1161,treprostinil,small molecule,Nucleotide ,agonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,MMA2016_0040,"transcon treprostinil, subcutaneous injection",Antihypertensive,4,,-,approved,2002,,17139284|17016423
1162,treprostinil,small molecule,Nucleotide ,agonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,NRDD537,-,Antihypertensive ; Antithrombotic,4,,-,approved,2002,,17139284|17016423
1163,treprostinil,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2767,"treprostinil inhaled/oral,tyvaso, viveta",Antihypertensive,4,,-,approved,2002,,20622039|18574748|15163595|11752352
1164,treprostinil,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2768,"treprostinil subcutaneous/intravenous,remodulin",Antihypertensive,4,,-,approved,2002,,20622039|18574748|15163595|11752352
1165,treprostinil,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMA2016_0038,"transcon treprostinil, subcutaneous injection",Antihypertensive,4,,-,approved,2002,,20622039|18574748|15163595|11752352
1166,tridihexethyl,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD540,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1954,,17139284|17016423
1167,tridihexethyl,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD540,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1954,,17139284|17016423
1168,tridihexethyl,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD540,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1954,,17139284|17016423
1169,trifluoperazine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_203,trifluoperazine,psychosis,4,,-,approved,1959,,11873706
1170,trifluoperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD541,-,Antiemetics; Antipsychotic,4,,-,approved,1959,,11752352|11873706|8102973|1676523|15695070|945467
1171,trifluoperazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_217,trifluoperazine,psychosis,4,,-,approved,1959,,11873706|8102973
1172,trifluoperazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD541,-,Antiemetics; Antipsychotic,4,,-,approved,1959,,17139284|17016423|8150214|6135146
1173,triflupromazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,,17139284|17016423
1174,triflupromazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,,17139284|17016423
1175,triflupromazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,,17139284|17016423|4152054
1176,triflupromazine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,,17139284|17016423|4152054
1177,triflupromazine,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,,17139284|17016423|497523|11752352
1178,trihexyphenidyl,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD543,-,Antiparkinson,4,,-,approved,1949,,17139284|17016423|18685832|2432979|17631384|1994002|3208836|11752352
1179,trimeprazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD545,-,Antipruritics,4,,-,approved,1982,,7713167
1180,trimipramine,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_101,trimipramine,unipolar depression,4,,-,approved,1979,,8863001
1181,trimipramine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_15,trimipramine,unipolar depression,4,,-,approved,1979,,8863001
1182,trimipramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_234,trimipramine,unipolar depression,4,,-,approved,1979,,8863001
1183,trimipramine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_62,trimipramine,unipolar depression,4,,-,approved,1979,,8863001
1184,trimipramine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_89,trimipramine,unipolar depression,4,,-,approved,1979,,8863001
1185,trimipramine,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_118,trimipramine,unipolar depression,4,,-,approved,1979,,9660111
1186,trimipramine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_37,trimipramine,unipolar depression,4,,-,approved,1979,,8863001|11752352
1187,tripelennamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD550,-,Anti-Allergic,4,,-,approved,1948,,11752352|6759742|996853|3253717|10208755|9226736
1188,triprolidine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD551,-,Anti-Allergic,4,,-,approved,1982,,7214150|3011460|10493107|8907591|7853212|10582735|2568212|7913608|2866055|11752352
1189,triptorelin,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2084,"triptorelin pamoate,trelstar, decapeptyl, salvacyl, moapar, pamorelin",Antineoplastic,4,,-,approved,2001,endogenous ligand,10969915|9777251
1190,triptorelin,small molecule,Peptide,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Oct2016_430,triptorelin,palliiative treatment of advanced prostate cancer,4,,-,approved,2001,endogenous ligand,10969915|9777251
1191,tropicamide,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD552,-,Diagnostic,4,,-,approved,1960,,17139284|17016423|17594079|11752352
1192,trospium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,,17139284|17016423
1193,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0618,umeclidinium + vilanterol,Bronchodilator ; COPD,4,,-,approved,2013,,23435542
1194,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0618,umeclidinium + vilanterol,Bronchodilator ; COPD,4,,-,approved,2013,,23435542
1195,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0713,"incruse ellipta,  umeclidinium bromide",chronic obstructive pulmonary disease (COPD),4,,-,approved,2013,,23435542
1196,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0714,"incruse ellipta,  umeclidinium bromide",chronic obstructive pulmonary disease (COPD),4,,-,approved,2013,,23435542
1197,urofollitropin,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD554,-,Fertility,4,,-,approved,1986,,11299519|7755615|2108722|8319832|8070368|11752352
1198,valsartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,2122,"valsartan,diovan",Antihypertensive,4,,-,approved,2012,,11752352|15579516|8242249|12460705|8577935|12023686
1199,valsartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMAmay2016_0742,sacubitril + valsartan,Antihypertensive,4,,-,approved,2012,,11752352|15579516|8242249|12460705|8577935|12023686
1200,vapreotide,small molecule,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2124,"vapreotide, debio 8609,sanvar, docrised",liver cirrhosis-related variceal bleeding,4,,-,approved,-,,19708854
1201,vapreotide,small molecule,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2124,"vapreotide, debio 8609,sanvar, docrised",liver cirrhosis-related variceal bleeding,4,,-,approved,-,,19708854
1202,vasopressin,peptide,Peptide,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD560,-,Antidiuretic,4,,-,approved,1982,endogenous ligand,17020465|16333859|16563128|17287200|11752352
1203,vasopressin,peptide,Peptide,agonist,,primary,AVPR1B,v1br_human,P47901,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD560,-,Antidiuretic,4,,-,approved,1982,endogenous ligand,17027167|16720725|17284170|16114100|15993108
1204,vasopressin,peptide,Peptide,agonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD560,-,Antidiuretic,4,,-,approved,1982,endogenous ligand,17275806|16532916|16511036|16011575|17303660
1205,vigabatrin,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,2159,"vigabatrin is a selective, irreversible enzyme-activated gaba transaminase inhibitor. gaba (gamma-aminobutyric acid) is a n/",addiction,4,,-,approved,2009,,20655489
1206,vilanterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0619,umeclidinium bromide (gsk573719) + vilanterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2013,,23131596
1207,vilanterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0779,fluticasone furoate and vilanterol inhalation powder,chronic obstructive pulmonary disease (COPD),4,,-,approved,2013,,23131596
1208,vilazodone,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2160,"vilazodone hydrochloride, sb 659746a",Anti-depressant,4,,-,approved,2011,,12183683|15507223
1209,vismodegib,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,2822,"gdc-0449, hedgehog pathway inhibitor",Antineoplastic,4,,-,approved,2012,,23662017
1210,vorapaxar,small molecule,Peptide,antagonist,,primary,F2R,par1_human,P25116,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2175,"vorapaxar , sch-530348",cardiovascular disease,4,,-,approved,2014,,19715408
1211,vortioxetine,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1171,lu aa21004,Anti-depressant,4,,-,approved,2013,,21486038
1212,vortioxetine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1171,lu aa21004,Anti-depressant,4,,-,approved,2013,,21486038
1213,vortioxetine,small molecule,Aminergic ,agonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1171,lu aa21004,Anti-depressant,4,,-,approved,2013,,21486038
1214,xylometazoline,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Oct2016_406,xylometazoline,decongestant,4,,-,approved,1959,,20030735
1215,xylometazoline,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_407,xylometazoline,decongestant,4,,-,approved,1959,,20030735|2868542
1216,xylometazoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_404,xylometazoline,decongestant,4,,-,approved,1959,,8894610|20030735
1217,zafirlukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,2235,"zafirlukast,accolate",Anti-Asthmatic,4,,-,approved,1996,,11752352|11061985|11979731|11006272|9042024|10851239
1218,ziprasidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2243,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",schizophrenia,4,,-,approved,2001,,11509214|12445705|12530423|15121646|17450180|14728084|17848919
1219,ziprasidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2243,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",schizophrenia,4,,-,approved,2001,,11873706|15726024|7562537|11752352|14728084|17848919
1220,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2246,"zolmitriptan,zomig",Anti-migraine,4,,-,approved,1997,,11513839
1221,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2246,"zolmitriptan,zomig",Anti-migraine,4,,-,approved,1997,,10463324|10563228|11752352|10844127|11513839|11594437|15096229|20407761|9859690|9399012
1222,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2246,"zolmitriptan,zomig",Anti-migraine,4,,-,approved,1997,,10844127|11513839|11594437|15096229|11752352|10463324|10563228|20407761|9859690|9399012
1223,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2246,"zolmitriptan,zomig",Anti-migraine,4,,-,approved,1997,,11752352|15096229|15320857|12434581|11834243|9718276
1224,zuclopenthixol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD567,-,schizophrenia,4,,-,approved,1962,,17535043|1822319|8748043|11752352
1225,zuclopenthixol,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD567,-,schizophrenia,4,,-,approved,1962,,1822319|10222441
1226,zuclopenthixol,small molecule,Aminergic ,antagonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD567,-,schizophrenia,4,,-,approved,1962,,1822319|10222441
1227,agomelatine,small molecule,Aminergic ,antagonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,87,"agomelatine, ago178c, s-20098,valdoxan, thymanax",Anti-depressant,4,,-,approved,2009,,15289999
1228,ambrisentan,small molecule,Peptide,antagonist,,secondary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1111,letairis,Antihypertensive,4,,-,approved,2007,,19920913|19601701
1229,amiodarone,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,160,"amiodarone hcl,amio-aqueous iv",Anti-Arrhythmia,4,,-,approved,1985,,12083991
1230,asenapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,18308814
1231,asenapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,18308814
1232,asenapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,18308814
1233,asenapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,18308814
1234,asenapine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,10592235|21655346|18308814
1235,asenapine,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,21655346|18308814
1236,asenapine,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,21655346|18308814
1237,asenapine,small molecule,Aminergic ,antagonist,,secondary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,21655346|18308814
1238,asenapine,small molecule,Aminergic ,antagonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,21655346|18308814
1239,asenapine,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,,21655346|21658377|18308814
1240,bethanechol,small molecule,Aminergic ,agonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_83,bethanechol,eosinophilic esophagitis,4,,-,approved,1948,,17413603|11798291
1241,bethanechol,small molecule,Aminergic ,agonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD054,-,Parasympathomimetics,4,,-,approved,1948,,17413603|11798291
1242,brexpiprazole,small molecule,Aminergic ,partial agonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1502,brexpiprazole,Anti-depressant,4,,-,approved,2015,,24947465
1243,bromocriptine,small molecule,Aminergic ,agonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_216,bromocriptine,growth hormone excess,4,,-,approved,1978,,18691132
1244,buserelin,peptide,Protein,not available,,secondary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,ASH_Oct2016_427,buserelin,LHRH analogue,4,,-,approved,-,,20053189
1245,caffeine,small molecule,Nucleotide ,antagonist,,secondary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_317,caffeine,coronary artery disease,4,,-,approved,1999,,22701600
1246,carbachol,small molecule,Aminergic ,agonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_80,carbachol,Antiglaucomic,4,,-,approved,1972,,1906173|8401322
1247,carbinoxamine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD080,-,Anti-Allergic,4,,-,approved,2003,,24040940
1248,carteolol,small molecule,Aminergic ,antagonist,,secondary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_194,carteolol,Antiglaucomic,4,,-,approved,1988,,11752352
1249,carvedilol,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_91,carvedilol,Antihypertensive,4,,-,approved,1995,,15306222
1250,carvedilol,small molecule,Aminergic ,antagonist,,secondary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_192,carvedilol,Antihypertensive,4,,-,approved,1995,,17440824
1251,carvedilol,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,435,"carvedilol,coreg",cardiovascular disease,4,,-,approved,1995,,12360591|12398570|14764656|1712335
1252,carvedilol,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_107,carvedilol,Antihypertensive,4,,-,approved,1995,,15306222|18657662
1253,chlorpromazine,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_204,chlorpromazine,psychosis,4,,-,approved,1957,,8301582
1254,chlorpromazine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_220,chlorpromazine,psychosis,4,,-,approved,1957,,8524985
1255,chlorprothixene,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,,17139284|17016423
1256,chorionic gonadotropin,protein,Protein,agonist,,secondary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD099,-,Fertility,4,,-,approved,1973,,12488338
1257,clozapine,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,,11752352
1258,clozapine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,,11752352|16223700|15992586|15886414|13129658|12763097
1259,clozapine,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,,11752352|17382376|7520908
1260,clozapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,,12564641|12589516|12923612|15213359|15261283
1261,clozapine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,,15917433|16182256
1262,cyclobenzaprine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_32,cyclobenzaprine,spasticity,4,,-,approved,1977,,8884233
1263,cyclopentolate,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_73,cyclopentolate,cycloplegia,4,,-,approved,1974,,11752352
1264,darifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_54,darifenacin,overactive bladder,4,,-,approved,2004,,18046909|10374898
1265,desipramine,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD148,-,Anti-depressant,4,,-,approved,1964,,7816863|8741184|8988485|17417877|17558518
1266,desipramine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD148,-,Anti-depressant,4,,-,approved,1964,,7855217|17139284|17016423
1267,desipramine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD148,-,Anti-depressant,4,,-,approved,1964,,7855217|17139284|17016423
1268,desipramine,small molecule,Aminergic ,unknown,,secondary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD148,-,Anti-depressant,4,,-,approved,1964,,8741184|12393876|7816863|15093822|8730743
1269,dicyclomine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_77,dicyclomine,digestive system disease,4,,-,approved,1950,,189711
1270,diphemanil,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_48,diphemanil,digestive system disease,4,,-,approved,1982,,6450282
1271,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_103,dipivefrin,Antiglaucomic,4,,-,approved,1980,,1319277
1272,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_106,dipivefrin,Antiglaucomic,4,,-,approved,1980,,1319277
1273,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_143,dipivefrin,Antiglaucomic,4,,-,approved,1980,,1319277
1274,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_164,dipivefrin,Antiglaucomic,4,,-,approved,1980,,1319277
1275,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_167,dipivefrin,Antiglaucomic,4,,-,approved,1980,,6713266|1319277
1276,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_197,dipivefrin,Antiglaucomic,4,,-,approved,1980,,6713266|1319277
1277,dobutamine,small molecule,Aminergic ,agonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_179,dobutamine,heart failure,4,,-,approved,1978,,9279221
1278,dronabinol,small molecule,Lipid ,agonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,438,"cat-310,relivar",Analgesics,4,,-,approved,1985,,17139494|19226257
1279,dronabinol,small molecule,Lipid ,agonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,667,"dronabinol ,marinol",Appetite stimulant,4,,-,approved,1985,,17139494|19226257
1280,droperidol,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_201,droperidol,vomiting,4,,-,approved,1970,,20358234
1281,droperidol,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_224,droperidol,psychosis,4,,-,approved,1970,,20358234
1282,epinephrine,small molecule,Aminergic ,agonist,adrenaline,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,,20954794|19730427|20412040|20857090
1283,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_198,ergoloid,cardiovascular disease,4,,-,approved,1953,,6297930
1284,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_60,ergoloid,cardiovascular disease,4,,-,approved,1953,,6297930
1285,ergoloid,small molecule,Aminergic ,agonist,co-dergocrine mesilate,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_0,ergoloid,cardiovascular disease,4,,-,approved,1953,,8786706
1286,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_206,ergoloid,cardiovascular disease,4,,-,approved,1953,,8786706|2869188
1287,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_215,ergoloid,cardiovascular disease,4,,-,approved,1953,,8786706|2869188
1288,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_229,ergoloid,cardiovascular disease,4,,-,approved,1953,,8786706|2869188
1289,ergoloid,small molecule,Aminergic ,agonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_7,ergoloid,cardiovascular disease,4,,-,approved,1953,,8786706|2869188
1290,esmolol,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_184,esmolol,tinnitus,4,,-,approved,1986,pharmacological action through beta 1- adrenergic receptor,27451411
1291,flibanserin,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,801,flibanserin,sexual dysfunction,4,,-,approved,2015,,12177684|12890707|26412054
1292,fluoxetine,small molecule,Aminergic ,antagonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1440,"npl-2008, fluoxetine",autism,4,,-,approved,1987,May be a bit tricky mode of action explanation but seems antagonist suits best,23994595
1293,glycopyrrolate,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_71,glycopyrrolate,obstructive lung disease,4,,-,approved,1961,,8249551
1294,glycopyrronium,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1457,"nva237, inhaled glycopyrronium bromide",chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,,17139284|17016423|8249551|11752352
1295,guanabenz,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_166,guanabenz,Antineoplastic,4,,-,approved,1982,pharmacological action through alpha 2A and maybe 2B ,15265636
1296,guanfacine,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_133,guanfacine,attention deficit hyperactivity disorder,4,,-,approved,1986,,1666366
1297,guanfacine,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_152,guanfacine,obstructive sleep apnea,4,,-,approved,1986,,10481832|7479575
1298,haloperidol,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_13,haloperidol,conduct disorder,4,,-,approved,1967,,7520908
1299,haloperidol,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_212,haloperidol decanoate,psychosis,4,,-,approved,1986,,18831971
1300,haloperidol,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_202,haloperidol,gastroparesis,4,,-,approved,1967,,7520908|19496999|18831971|16123775|9536001
1301,haloperidol,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_214,haloperidol,schizophrenia,4,,-,approved,1967,,26287845
1302,haloperidol,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_21,haloperidol decanoate,psychosis,4,,-,approved,1986,,21162693
1303,hydrocodone,small molecule,Peptide,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_265,hydrocodone,Analgesics,4,,-,approved,2013,,7824069
1304,icatibant,small molecule,Peptide,antagonist,,secondary,BDKRB1,bkrb1_human,P46663,Class A (Rhodopsin),GPCR;Rhodopsin,Bradykinin receptors,established,ASH_Oct2016_434,"firazyr, icatibant, je049",hereditary angioedema,4,,-,approved,2008,,9313952|10422787|17026984
1305,iloperidone,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,,23272794
1306,iloperidone,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,,23272794
1307,iloperidone,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,,23272794
1308,iloperidone,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,,23272794
1309,iloperidone,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,,23272794
1310,iloperidone,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,,23545936
1311,iloperidone,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,,23545936
1312,iloperidone,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,,23545936
1313,isoetharine,small molecule,Aminergic ,agonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_182,isoetharine,obstructive lung disease,4,,-,approved,1979,,22267580
1314,isoproterenol,small molecule,Aminergic ,agonist,,secondary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_401,isoprenaline,cardiovascular ; Anti-Asthmatic ,4,,-,approved,1956,,10824635
1315,isoproterenol,small molecule,Aminergic ,agonist,,secondary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_193,isoproterenol,Anti-Asthmatic,4,,-,approved,1956,,10824635
1316,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued,2870716
1317,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued,2870716
1318,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued,2870716
1319,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued,15701205
1320,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued,15701205
1321,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued,15701205
1322,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued,15701205
1323,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued,15701205
1324,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued,15701205
1325,loxapine,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_207,loxapine,psychosis,4,,-,approved,1975,,1349752
1326,loxapine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_223,loxapine,psychosis,4,,-,approved,1975,,8580115
1327,loxapine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_31,loxapine,psychosis,4,,-,approved,1975,,10991983
1328,lurasidone,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,,23545936
1329,lurasidone,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,,23545936
1330,lurasidone,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,,23545936
1331,lurasidone,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0233,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,,23545936
1332,lurasidone,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAapril2016_0235,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,,23545936
1333,lurasidone,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0237,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,,23545936
1334,mepenzolate,small molecule,Alicarboxylic acid ,antagonist,,secondary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,NRDD324,-,Antispasmodics,4,,-,approved,1956,,23159056
1335,meperidine,small molecule,Peptide,agonist,pethidine,secondary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_270,meperidine,Analgesics,4,,-,approved,1942,,17139284|17016423
1336,metaraminol,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_110,metaraminol,cardiovascular disease,4,,-,approved,1954,,9663612
1337,metaraminol,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_92,metaraminol,cardiovascular disease,4,,-,approved,1954,,9663612
1338,methyldopa,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_142,methyldopa,Antihypertensive,4,,-,approved,1962,,6326166
1339,methyldopa,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_157,methyldopa,Antihypertensive,4,,-,approved,1962,,6326166
1340,methylergonovine,small molecule,Aminergic ,partial agonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_26,methylergonovine,hemorrhage,4,,-,approved,1946,,11104741
1341,metoclopramide,small molecule,Aminergic ,antagonist,,secondary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_40,metoclopramide,pregnancy,4,,-,approved,1979,is this a completely different indication?,18948374
1342,minaprine,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used,17139284|17016423
1343,minaprine,small molecule,Aminergic ,antagonist,,secondary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used,17139284|17016423
1344,mirtazapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_131,mirtazapine,unipolar depression,4,,-,approved,1996,,10762339
1345,mirtazapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_148,mirtazapine,unipolar depression,4,,-,approved,1996,,15771415|3419539
1346,molindone,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_12,molindone,schizophrenia,4,,-,approved,1974,,2586632
1347,naphazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_111,naphazoline,eye allergy,4,,-,approved,1971,,628
1348,naphazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_129,naphazoline,nasal obstruction,4,,-,approved,1971,,628
1349,naphazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_150,naphazoline,nasal obstruction,4,,-,approved,1971,,628
1350,naphazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_96,naphazoline,nasal obstruction,4,,-,approved,1971,,628
1351,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919
1352,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919
1353,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919
1354,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919
1355,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919
1356,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919
1357,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919
1358,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919
1359,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919
1360,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919
1361,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919
1362,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919
1363,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919
1364,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919
1365,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919
1366,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919
1367,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919
1368,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919
1369,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919
1370,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919
1371,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919
1372,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919
1373,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919
1374,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919
1375,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919
1376,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919
1377,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919
1378,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919
1379,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919
1380,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919
1381,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919
1382,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919
1383,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919
1384,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919
1385,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919
1386,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919
1387,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0187,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919
1388,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0189,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919
1389,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0192,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919
1390,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0193,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919
1391,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0198,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919
1392,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0199,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919
1393,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0202,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919
1394,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0203,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919
1395,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0209,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919
1396,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,11752352|17316700|17848919|10227113
1397,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,11752352|17316700|17848919|10227113
1398,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,11752352|17316700|17848919|10227113
1399,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,11752352|17316700|17848919|10227113
1400,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0206,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,11752352|17316700|17848919|10227113
1401,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919|10227113
1402,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919|10227113
1403,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919|10227113
1404,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919|10227113
1405,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,,17848919|10227113
1406,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919|10227113
1407,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919|10227113
1408,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919|10227113
1409,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919|10227113
1410,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,,17848919|10227113
1411,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919|10227113
1412,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919|10227113
1413,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919|10227113
1414,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919|10227113
1415,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,,17848919|10227113
1416,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919|10227113
1417,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919|10227113
1418,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919|10227113
1419,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919|10227113
1420,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,,17848919|10227113
1421,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0185,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919|10227113
1422,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0186,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919|10227113
1423,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0188,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919|10227113
1424,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0194,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919|10227113
1425,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0197,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,,17848919|10227113
1426,oxymetazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_151,oxymetazoline,dry eye,4,,-,approved,1986,,20030735
1427,oxymetazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_132,oxymetazoline,dry eye,4,,-,approved,1986,,1666366|21948594
1428,oxymetazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_115,oxymetazoline,allergic conjunctivitis,4,,-,approved,1986,,20030735|23364786|21948594
1429,oxymetazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_98,oxymetazoline,Antiglaucomic,4,,-,approved,1986,,20030735|23364786|21948594
1430,oxymorphone,small molecule,Peptide,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1548,"oxymorphone hydrochloride, en3202,opana, opana er",Analgesics,4,,-,approved,1959,,17595308|14998329
1431,oxyphenonium,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_76,oxyphenonium,digestive system disease,4,,-,approved,1982,,13413139
1432,pentoxifylline,small molecule,Nucleotide ,antagonist,,secondary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1586,"pentoxifylline, eht0201",amyotrophic lateral sclerosis (ALS),4,,-,approved,1984,,19997047
1433,pentoxifylline,small molecule,Nucleotide ,antagonist,,secondary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_316,pentoxifylline,irritable bowel syndrome,4,,-,approved,1984,,9251897
1434,pergolide,small molecule,Aminergic ,agonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_226,pergolide,Antiparkinson,4,,-,approved,1988,,18691132
1435,pergolide,small molecule,Aminergic ,agonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_231,pergolide,Antiparkinson,4,,-,approved,1988,,18691132
1436,pergolide,small molecule,Aminergic ,agonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD422,-,Antiparkinson,4,,-,approved,1988,,11752352|18691132|10641988
1437,pergolide,small molecule,Aminergic ,agonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_209,pergolide,Antiparkinson,4,,-,approved,1988,,18691132|10641988|1683537
1438,phenoxybenzamine,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_114,phenoxybenzamine,adrenal gland pheochromocytoma,4,,-,approved,1953,,7969082
1439,phenoxybenzamine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_95,phenoxybenzamine,adrenal gland pheochromocytoma,4,,-,approved,1953,,7969082
1440,phenoxybenzamine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_136,phenoxybenzamine,cardiovascular disease,4,,-,approved,1953,,11395517
1441,phenoxybenzamine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_153,phenoxybenzamine,adrenal gland pheochromocytoma,4,,-,approved,1953,,11395517
1442,phentolamine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_102,phentolamine,cardiovascular disease,4,,-,approved,1952,,15306222
1443,phentolamine,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_117,phentolamine,cardiovascular disease,4,,-,approved,1952,,15306222
1444,phentolamine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_137,phentolamine,cardiovascular disease,4,,-,approved,1952,,10845768
1445,phentolamine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_163,phentolamine,cardiovascular disease,4,,-,approved,1952,,10845768
1446,pimozide,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_199,pimozide,psychosis,4,,-,approved,1984,,6138775
1447,pimozide,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_230,pimozide,psychosis,4,,-,approved,1984,,824116
1448,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,,12476402
1449,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,,12476402
1450,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,,12476402
1451,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,,12476402
1452,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,,12476402
1453,propafenone,small molecule,Aminergic ,antagonist,,secondary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_170,propafenone,cardiac arrhythmia,4,,-,approved,1989,,2468063
1454,propafenone,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_177,propafenone,atrial fibrillation,4,,-,approved,1989,,2468063
1455,propantheline,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_55,propantheline,digestive system disease,4,,-,approved,1953,,12049493
1456,propantheline,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_69,propantheline,digestive system disease,4,,-,approved,1953,,12049493
1457,propiomazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423
1458,propiomazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423
1459,propiomazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,,17139284|17016423
1460,propranolol,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_178,propranolol,Antihypertensive,4,,-,approved,1967,,16082424|16177222|16706406|17628611|11752352
1461,quetiapine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1840,seroquel,Antipsychotic ; Anti-depressant,4,,-,approved,1997,,11132243|17848919
1462,risperidone,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_28,risperidone,schizophrenia,4,,-,approved,1993,,11132243|7898773
1463,solifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,,19029429
1464,solifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,,19029429
1465,solifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,,17139284|17016423|20590605|19029429
1466,solifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,,20590605|19029429
1467,sufentanil,small molecule,Peptide,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,242,"arx-01, sufentanil nanotab",Analgesics; adjuvant to anesthesia,4,,-,approved,1984,,1330549|8612823
1468,sufentanil,small molecule,Peptide,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,242,"arx-01, sufentanil nanotab",Analgesics; adjuvant to anesthesia,4,,-,approved,1984,,8612823|2467589
1469,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_120,tetrahydrozoline,nasal obstruction,4,,-,approved,1979,,18259967
1470,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_122,tetrahydrozoline,eye allergy,4,,-,approved,1979,,18259967
1471,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_139,tetrahydrozoline,nasal obstruction,4,,-,approved,1979,,18259967
1472,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_159,tetrahydrozoline,nasal obstruction,4,,-,approved,1979,,18259967
1473,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_94,tetrahydrozoline,nasal obstruction,4,,-,approved,1979,,18259967
1474,theophylline,small molecule,Nucleotide ,antagonist,,secondary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_318,theophylline,Anti-Asthmatic,4,,-,approved,1976,,9459566
1475,thioproperazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_374,thioproperazine,Antipsychotic,4,,-,approved,1962,,15695070
1476,thioridazine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_34,thioridazine,psychosis,4,,-,approved,1962,,10991983
1477,tolazoline,small molecule,Aminergic ,agonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_233,tolazoline,cardiovascular disease,4,,-,approved,1948,,8487790
1478,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_134,tolazoline,arthralgia,4,,-,approved,1948,,9089664
1479,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_154,tolazoline,arthralgia,4,,-,approved,1948,,9089664
1480,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_125,tolazoline,cardiovascular disease,4,,-,approved,1948,,11938943
1481,tolazoline,small molecule,Aminergic ,agonist,,secondary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_241,tolazoline,arthralgia,4,,-,approved,1948,,6386273|21948594|8487790
1482,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_113,tolazoline,cardiovascular disease,4,,-,approved,1948,,3600818
1483,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_97,tolazoline,cardiovascular disease,4,,-,approved,1948,,3600818
1484,tolterodine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,,16406943
1485,tolterodine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,,16406943
1486,trifluoperazine,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_18,trifluoperazine,psychosis,4,,-,approved,1959,,2943890
1487,trifluoperazine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_36,trifluoperazine,psychosis,4,,-,approved,1959,,2943890
1488,tropicamide,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_70,tropicamide,myopia,4,,-,approved,1960,,17594079
1489,trospium,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,,16465186 |15482001
1490,trospium,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,,16465186 |15482001
1491,trospium,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,,16465186
1492,trospium,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,,16465186
1493,ziprasidone,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_30,ziprasidone,schizophrenia,4,,-,approved,2001,,14728084|11103883|7562537|11132243|16918396
1494,abediterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_190,abediterol,Anti-Asthmatic,2,2016,completed,in trial,-,,
1495,ac-100,peptide,Lipid ,not available,dentonin,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,29,"ac-100,dentonin",dental ossificant,1,2010,discontinued,in trial,-,,
1496,ac-100,peptide,Lipid ,not available,dentonin,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,29,"ac-100,dentonin",periodontal ossificant,1,2010,discontinued,in trial,-,,
1497,ac-100,peptide,Lipid ,not available,dentonin,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,29,"ac-100,dentonin",periodontal ossificant,1,2010,discontinued,in trial,-,,
1498,ac-100,peptide,Lipid ,not available,dentonin,primary,PTGER4,pe2r4_human,P35408,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,29,"ac-100,dentonin",periodontal ossificant,1,2010,discontinued,in trial,-,,
1499,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0039,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,,
1500,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0040,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,,
1501,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0041,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,,
1502,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0042,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,,
1503,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0043,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,,
1504,acp-104,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,47,acp-104,schizophrenia,2,2007,discontinued,in trial,-,The D2 and D3 partial agonism creates less side effects - different from typical anti-psychotics,
1505,acp-104,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,47,acp-104,schizophrenia,2,2007,discontinued,in trial,-,The D2 and D3 partial agonism creates less side effects - different from typical anti-psychotics,
1506,acp-104,small molecule,Aminergic ,partial agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,47,acp-104,schizophrenia,2,2007,discontinued,in trial,-,The D2 and D3 partial agonism creates less side effects - different from typical anti-psychotics,
1507,acp-104,small molecule,Aminergic ,inverse agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,47,acp-104,schizophrenia,2,2007,discontinued,in trial,-,The D2 and D3 partial agonism creates less side effects - different from typical anti-psychotics,
1508,ACT-246475,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,MMAaug2017_026,ACT-246475,cardiovascular diseases; myocardial infarction,1,2017,completed,in trial,-,,
1509,ACT-539313,small molecule,Peptide,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,MMAaug2017_025,ACT-539313,Anti-anxiety,1,2017,ongoing,in trial,-,,
1510,ACT-541468,small molecule,Peptide,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,MMAaug2017_023,ACT-541468,insomnia,2,2017,ongoing,in trial,-,,
1511,ACT-541468,small molecule,Peptide,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,MMAaug2017_024,ACT-541468,insomnia,2,2017,ongoing,in trial,-,,
1512,ACT-774312,small molecule,Lipid ,antagonist,,primary,PTGDR2,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,MMAaug2017_022,ACT-774312,Anti-Allergic,1,2017,ongoing,in trial,-,,
1513,adl5747,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,55,adl5747,osteoarthritis,2,2010,discontinued,in trial,-,,
1514,adl5859,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,56,"adl5859, pf-04856880",osteoarthritis,2,2009,discontinued,in trial,-,,
1515,adl5945,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,57,adl5945,motilitant,3,2013,terminated,in trial,-,Terminated lack of enrollment,
1516,adl7445,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,58,adl7445,motilitant,1,2011,terminated,in trial,-,Terminated lack of enrollment,
1517,adx10059,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,62,adx10059,Anti-migraine ; gastroesophageal reflux disease,2,2008,discontinued,in trial,-,,
1518,adx415,small molecule,Aminergic ,NAM,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,63,adx415,Antihypertensive,2,2008,completed,in trial,-,,
1519,adx-48621,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,2472,adx-48621,Antiparkinson,2,2011,completed,in trial,-,,
1520,adx-71149,small molecule,Amino acid ,PAM,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,64,"adx-71149,  JNJ-40411813",Antipsychotic ; Anti-depressant; anxiolytic,2,2011,completed,in trial,-,,
1521,afamelanotide,small molecule,Peptide,agonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,73,afamelanotide,dermatological,3,2009,completed,in trial,-,Seeking FDA approval,16293341
1522,aiko-150,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,92,aiko-150,opioid antagonist,1,2009,completed,in trial,-,,
1523,ajulemic acid,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,2361,"ip 751, ct-3",Analgesics;neuropathic pain,2,2017,not open yet,in trial,-,May have improved CB2 selectivity but still had CB1 affinity,
1524,ajulemic acid,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,2361,"ip 751, ct-3",Analgesics;neuropathic pain,2,2017,not open yet,in trial,-,May have improved CB2 selectivity but still had CB1 affinity,
1525,akl-0707,small molecule,Peptide,agonist,,primary,GHRH,ghrhr_human,Q02643,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,96,"akl-0707, ghrh analog",hormone replacement,2,2013,discontinued,in trial,-,,
1526,akp-11,small molecule,Lipid ,PAM,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMA2016_0028,akp-11,psoriasis,1,2016,completed,in trial,-,Australia,
1527,alb-127158(a),small molecule,Peptide,antagonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,100,alb-127158(a),Anti-obesity,1,2011,discontinued,in trial,-,UK,
1528,alks 33,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,115,"alks 29, Baclofen+samidorphan",alcohol dependance; Anti-depressant,1,2008,discontinued,in trial,-,,
1529,alks 33,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,115,"alks 29, Baclofen+samidorphan",alcohol dependance; Anti-depressant,1,2008,discontinued,in trial,-,,
1530,alks 33,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,116,"alks 33, samidorphan",alcohol dependance; Anti-depressant,2,2009,completed,in trial,-,,
1531,alks 33,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,116,"alks 33, samidorphan",alcohol dependance; Anti-depressant,2,2009,completed,in trial,-,,
1532,alks 33,small molecule,Peptide,antagonist,alks5461,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 33, alks 5461, Buprenorphine+samidorphan",alcohol dependance; Anti-depressant,3,2014,completed,in trial,-,,
1533,alks 33,small molecule,Peptide,antagonist,alks5461,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 33, alks 5461, Buprenorphine+samidorphan",alcohol dependance; Anti-depressant,3,2014,completed,in trial,-,,
1534,alks 33,small molecule,Peptide,antagonist,samidorphan,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0184,"alks 3831,  olanzapine + alks 33,samidorphan",Anti-obesity,3,2016,recruiting,in trial,-,,
1535,alks 33,small molecule,Peptide,antagonist,samidorphan,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0184,"alks 3831,  olanzapine + alks 33,samidorphan",Anti-obesity,3,2016,recruiting,in trial,-,,
1536,alks 37,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,117,alks 37,motilitant,2,2011,discontinued,in trial,-,,
1537,alks 37,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,117,alks 37,motilitant,2,2011,discontinued,in trial,-,,
1538,almorexant,small molecule,Peptide,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,119,"almorexant, act-078573",sleep disorder treatment,3,2009,discontinued,in trial,-,Not marketed-dropped in 2011 because of side effects profile,
1539,almorexant,small molecule,Peptide,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,119,"almorexant, act-078573",sleep disorder treatment,3,2009,discontinued,in trial,-,Not marketed-dropped in 2011 because of side effects profile,
1540,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,128,"alprostadil,alista",sexual dysfunction,2,2006,discontinued,in trial,-,,10509658|15840408|11752352
1541,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,129,"alprostadil,femprox",sexual dysfunction,3,2008,suspended,in trial,-,,10509658|15840408|11752352
1542,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,130,"alprostadil,topiglan",sexual dysfunction,2,2004,discontinued,in trial,-,,10509658|15840408|11752352
1543,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAapril2016_0158,"rayva, alprostadil + ddaip.hcl",Raynaud's Disease,2,2014,completed,in trial,-,,10509658|15840408|11752352
1544,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,128,"alprostadil,alista",sexual dysfunction,2,2006,discontinued,in trial,-,,15560119|14561849|10670413|16516814|11524243
1545,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,129,"alprostadil,femprox",sexual dysfunction,3,2008,suspended,in trial,-,,15560119|14561849|10670413|16516814|11524243
1546,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,130,"alprostadil,topiglan",sexual dysfunction,2,2004,discontinued,in trial,-,,15560119|14561849|10670413|16516814|11524243
1547,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAapril2016_0157,"rayva, alprostadil + ddaip.hcl",Raynaud's Disease,2,2014,completed,in trial,-,,15560119|14561849|10670413|16516814|11524243
1548,alx- 0651,antibody,Protein,antagonist,biparatopic nanobody,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAmay2016_0267,"alx- 0651, biparatopic nanobody",Antineoplastic,1,2011,terminated,in trial,-,,
1549,alx1-11,protein,Peptide,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1646,preos,Anti-osteoporotic,3,2005,completed,in trial,-,,
1550,alx1-11,protein,Peptide,agonist,,primary,PTH2R,pth2r_human,P49190,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1646,preos,Anti-osteoporotic,3,2005,completed,in trial,-,,
1551,am1030,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0116,am1030,Anti-inflammatory ; atopic dermatitis,2,2015,completed,in trial,-,,
1552,am-152,small molecule,Lipid ,antagonist,,primary,LPAR1,lpar1_human,Q92633,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,144,"am-152, BMS 986020",Anti-inflammatory ; antifibrotic,2,2015,completed,in trial,-,,
1553,am-211,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,145,am-211,Anti-inflammatory ; antiallergy,1,2011,unknown,in trial,-,,
1554,am-461,small molecule,Lipid ,antagonist,,primary,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,146,am-461,Anti-inflammatory,1,2011,unknown,in trial,-,,
1555,am-831,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0047,am-831,Antipsychotic ; schizophrenia,1,2011,discontinued,in trial,-,,
1556,am-831,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0048,am-831,Antipsychotic ; schizophrenia,1,2011,discontinued,in trial,-,,
1557,am-831,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0049,am-831,Antipsychotic ; schizophrenia,1,2011,discontinued,in trial,-,,
1558,amap102,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,148,amap102,Anti-inflammatory ; DMARD,2,2014,completed,in trial,-,Phase 2 in Europe,
1559,amap102,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,148,amap102,Anti-inflammatory ; DMARD,2,2014,completed,in trial,-,,
1560,amd-070,small molecule,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,150,amd-070,antiviral ; HIV,2,2004,discontinued,in trial,-,,
1561,amelubant,small molecule,Lipid ,antagonist,,primary,LTB4R,lt4r1_human,Q15722,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,not established,ASH_Sep2016_302,amelubant,chronic obstructive pulmonary disease (COPD),2,2014,discontinued,in trial,-,Disontinued due to significant increase in pulmonary related serious adverse events ,
1562,amibegron,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,158,"amibegron, sr 58611",Anti-depressant,3,2008,discontinued,in trial,-,,
1563,amisulpride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,161,"amisulpride,solian",schizophrenia,1,1999,discontinued,in trial,-,Amulsipride is marketed in Europe for schizophrenia but not past Phase 1 trials in US,12404702|16696579|11873706
1564,amisulpride,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,161,"amisulpride,solian",schizophrenia,1,1999,discontinued,in trial,-,Amulsipride is marketed in Europe for schizophrenia but not past Phase 1 trials in US,12404702|16696579|11873706
1565,amisulpride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0704,"apd403, apd421",Antiemetics,3,2013,completed,in trial,-,,12404702|16696579|11873706
1566,amisulpride,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0705,"apd403, apd421",Antiemetics,3,2013,completed,in trial,-,,12404702|16696579|11873706
1567,amphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,413,"c105, levo-amphetamine sulfate",cognitive dysfunction; ADHD,2,2008,completed,in trial,-,,17218486|17234900|17212650|17234899|15764732
1568,amphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,MMAmay2016_0357,d-amphetamine transdermal system (d-ats),cognitive dysfunction; ADHD,2,2012,completed,in trial,-,,17218486|17234900|17212650|17234899|15764732
1569,amphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,MMAmay2016_0658,"hld-100, reformulated amphetamine",cognitive dysfunction; ADHD,2,2017,ongoing,in trial,-,,17218486|17234900|17212650|17234899|15764732
1570,anamorelin,small molecule,Peptide,agonist,,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,175,"anamorelin, rc-1291",Appetite stimulant,3,2011,completed,in trial,-,,
1571,anatibant,small molecule,Peptide,antagonist,,primary,BDKRB2,bkrb2_human,P30411,Class A (Rhodopsin),GPCR;Rhodopsin,Bradykinin receptors,established,177,anatibant,traumatic brain injury,2,2007,discontinued,in trial,-,,10596852
1572,Anti-CXCR2 biparatopic nanobody,antibody,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GpCR;Rhodopsin,Chemokine receptors,not established,ASH_Jul2017_07,AntiCXCR2 biparatopic nanobody,Anti-inflammatory,1,2017,ongoing,in trial,-,,
1573,ap1030,small molecule,Peptide,PAM,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,189,ap1030,Anti-obesity,1,2010,completed,in trial,-,,
1574,ap1030,small molecule,Peptide,PAM,,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,189,ap1030,Anti-obesity,1,2010,completed,in trial,-,No development reported,
1575,ap214,peptide,Peptide,agonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,2538,ap214,post-surgical kidney injury,2,2008,discontinued,in trial,-,,
1576,ap214,peptide,Peptide,agonist,,primary,MC3R,mc3r_human,P41968,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,2538,ap214,post-surgical kidney injury,2,2008,discontinued,in trial,-,,
1577,ap214,peptide,Peptide,agonist,,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,2538,ap214,post-surgical kidney injury,2,2008,discontinued,in trial,-,,
1578,ap214,peptide,Peptide,agonist,,primary,MC5R,mc5r_human,P33032,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,2538,ap214,post-surgical kidney injury,2,2008,discontinued,in trial,-,,
1579,apadenoson,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_315,apadenoson,atrial fibrillation,3,2011,discontinued,in trial,-,,16524538
1580,apd125,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,192,apd125,insomnia,2,2008,discontinued,in trial,-,,
1581,apd125,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,192,"apd125, Nelotanserin",Dementia with Lewy Bodies,2,2016,recruiting,in trial,-,Added entry because Indication so different,
1582,apd334,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMAmay2016_0282,apd334,for autoimmune disorders,2,2015,recruiting,in trial,-,,
1583,apd597,small molecule,Lipid ,agonist,,primary,GPR119,gp119_human,Q8TDV5,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,2469,"apd597, JNJ-38431055",Antidiabetic,1,2008,discontinued,in trial,-,,
1584,apd668,small molecule,Lipid ,agonist,,primary,GPR119,gp119_human,Q8TDV5,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,194,apd668,Antidiabetic,1,2006,discontinued,in trial,-,,
1585,apd791,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,195,apd791,antithrombotic,1,2008,completed,in trial,-,,
1586,apd811,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0283,apd811,Antihypertensive,2,2014,ongoing,in trial,-,,
1587,apd916,small molecule,Aminergic ,agonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,196,apd916,sleep disorders; narcolepsy,1,2010,completed,in trial,-,,
1588,apelin,peptide,Peptide,not available,,primary,APLNR,apj_human,P35414,Class A (Rhodopsin),GPCR;Rhodopsin,Apelin receptors,not established,MMAjun2016_0045,apelin,Cardiovascular disorders; Insulin sensitivity,1,2013,completed,in trial,-,ligand,
1589,api246,small molecule,Peptide,antagonist,srx246,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,MMAjun2016_0005,"api246,  srx246",Treatment of affective and anger disorders,2,2016,completed,in trial,-,,
1590,aplindore,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,203,"aplindore, dab-452",Antiparkinson ; restlegs legs syndrome,2,2008,discontinued,in trial,-,,
1591,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,206,"apomorphine hcl,uprima, ixense",erectile dysfunction,1,2005,discontinued,in trial,-,,11752352
1592,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,976,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2012,discontinued,in trial,-,,11752352
1593,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1009,intranasal apomorphine,sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2006,completed,in trial,-,,11752352
1594,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAaug2017_012,apomorphine liquid formulation,Antiparkinson,1,2017,completed,in trial,-,,11752352
1595,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,206,"apomorphine hcl,uprima, ixense",erectile dysfunction,1,2005,discontinued,in trial,-,,11343576|11752352|11212866|18691132|10641988|11692072|11215397|10494453
1596,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,976,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2012,discontinued,in trial,-,,11343576|11752352|11212866|18691132|10641988|11692072|11215397|10494453
1597,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1009,intranasal apomorphine,sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2006,completed,in trial,-,,11343576|11752352|11212866|18691132|10641988|11692072|11215397|10494453
1598,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAaug2017_011,apomorphine liquid formulation,Antiparkinson,1,2017,completed,in trial,-,,11343576|11752352|11212866|18691132|10641988|11692072|11215397|10494453
1599,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,206,"apomorphine hcl,uprima, ixense",erectile dysfunction,1,2005,discontinued,in trial,-,,15007532|11752352|18691132|9497025|17067298|9871530|17164075
1600,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,976,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2012,discontinued,in trial,-,,15007532|11752352|18691132|9497025|17067298|9871530|17164075
1601,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1009,intranasal apomorphine,sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2006,completed,in trial,-,,15007532|11752352|18691132|9497025|17067298|9871530|17164075
1602,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAaug2017_013,apomorphine liquid formulation,Antiparkinson,1,2017,completed,in trial,-,,15007532|11752352|18691132|9497025|17067298|9871530|17164075
1603,aprocitentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,MMAaug2017_027,aprocitentan,Hypertension,2,2017,completed,in trial,-,,
1604,aprocitentan,small molecule,Peptide,antagonist,,primary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,MMAaug2017_028,aprocitentan,Hypertension,2,2017,completed,in trial,-,,
1605,arbaclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,216,arbaclofen,Fragile X syndrome,3,2017,discontinued,in trial,-,,10658574|15235087|8388192|10751439|11008066|19303900|10328880|10545129
1606,arbaclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,2222,"xp19986, arbaclofen",gastrointestinal reflux disease,2,2009,discontinued,in trial,-,,10658574|15235087|8388192|10751439|11008066|19303900|10328880|10545129
1607,arbaclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,216,arbaclofen,Fragile X syndrome,3,2017,discontinued,in trial,-,,8388192|11752352|10386831|19303900|10444662|10482760|10494996|10545129|10094428
1608,arbaclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,2222,"xp19986, arbaclofen",gastrointestinal reflux disease,2,2009,discontinued,in trial,-,,8388192|11752352|10386831|19303900|10444662|10482760|10494996|10545129|10094428
1609,ari-3037mo,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,226,ari-3037mo,Vitamin B analog; for treatment for hyperlipidemia,2,2015,completed,in trial,-,,
1610,ari-3037mo,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,226,ari-3037mo,Vitamin B analog; for treatment for hyperlipidemia,2,2015,completed,in trial,-,,
1611,arry-502,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,MMAapril2016_0314,arry-502,Anti-Allergic,2,2012,completed,in trial,-,,
1612,asimadoline,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,253,asimadoline,Analgesics,3,2015,discontinued,in trial,-,,
1613,asm-024,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0687,asm-024,Anti-Asthmatic ; COPD,2,2015,completed,in trial,-,,
1614,athx-105,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,263,athx-105,Anti-obesity,2,2008,discontinued,in trial,-,,
1615,ati-7505,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,265,ati-7505,Parasympathomimetic,2,2009,completed,in trial,-,,
1616,ati-9242,small molecule,Aminergic ,not available,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2423,ati-9242,schizophrenia,1,2016,ongoing,in trial,-,,
1617,ati-9242,small molecule,Aminergic ,not available,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2423,ati-9242,schizophrenia,1,2016,ongoing,in trial,-,,
1618,atopaxar,small molecule,Peptide,antagonist,,primary,F2R,par1_human,P25116,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,ASH_Sep2016_282,atopaxar,acute coronary syndrome,2,2007,discontinued,in trial,-,,
1619,atrasentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,270,"atrasentan, abt-627,xinlay",Antineoplastic,3,2005,discontinued,in trial,-,discontinued for this indication,
1620,atrasentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,270,Atrasentan,Diabetic nephropathy,3,2013,recruiting,in trial,-,Added entry because Indication so different,
1621,ATX2417,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,MMAaug2017_031,OC2417,Anti-Asthmatic,1,2017,completed,in trial,-,,
1622,av608,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,278,av608,Anti-depressant; irritable bowel syndrome; antispasmodic,2,2006,discontinued,in trial,-,,
1623,ave-1625,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,284,ave-1625,Anti-obesity ; Alzheimer's disease,2,2007,discontinued,in trial,-,,
1624,avicine,vaccine,Protein,not available,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,563,"ctp-37,avicine",Antineoplastic,1,1997,discontinued,in trial,-,,
1625,avn-101,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,290,avn-101,Alzheimer's disease,1,2009,completed,in trial,-,,
1626,avn-211,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,291,avn-211,schizophrenia,2,2010,unknown,in trial,-,,
1627,avn-322,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,292,avn-322,Alzheimer's disease,1,2010,discontinued,in trial,-,,
1628,avn-397,small molecule,Aminergic ,unknown,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2490,avn-397,Alzheimer's disease,2,2010,discontinued,in trial,-,Undefined or unknown MoA,
1629,avosentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,295,"avosentan, spp 301",Diabetic nephropathy,3,2005,terminated,in trial,-,,
1630,azd1981,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_311,azd1981,Anti-Asthmatic,2,2014,discontinued,in trial,-,,
1631,azd2066,small molecule,Amino acid ,antagonist,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,308,azd2066,Analgesics; gastroesophageal reflux disease,2,2010,discontinued,in trial,-,,
1632,azd2423,small molecule,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,2331,azd2423,chronic obstructive pulmonary disorder;Analgesics; neuropathic pain,2,2010,discontinued,in trial,-,,
1633,azd2820,small molecule,Peptide,agonist,,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,MMAmay2016_0297,azd2820,Anti-obesity,1,2011,discontinued,in trial,-,,
1634,azd3199,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_191,azd3199,chronic obstructive pulmonary disease (COPD),2,2011,discontinued,in trial,-,Appears to be discontinued,
1635,AZD8871,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAaug2017_032,AZD8871,Anti-Asthmatic,1,2017,completed,in trial,-,,
1636,AZD8871,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_033,AZD8871,Anti-Asthmatic,1,2017,completed,in trial,-,,
1637,AZD8871,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_034,AZD8871,Anti-Asthmatic,1,2017,completed,in trial,-,,
1638,AZD8871,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_035,AZD8871,Anti-Asthmatic,1,2017,completed,in trial,-,,
1639,AZD8871,small molecule,Aminergic ,agonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_036,AZD8871,Anti-Asthmatic,1,2017,completed,in trial,-,,
1640,AZD8871,small molecule,Aminergic ,agonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_037,AZD8871,Anti-Asthmatic,1,2017,completed,in trial,-,,
1641,azelastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,456,"cdx-313, budesonide + azelastine nasal spray",Anti-Allergic,2,2009,completed,in trial,-,,2540229|8829888|9585822|11752352|19209282|17723160|10478514
1642,azp-531,peptide,Peptide,agonist,unacylated ghrelin,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,MMAapril2016_0315,"azp-531, unacylated ghrelin",Antidiabetic,1,2014,ongoing,in trial,-,,
1643,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,115,"alks 29, Baclofen/samidorphan",alcohol dependance,1,2008,discontinued,in trial,-,,10658574|15235087|8388192|10751439|11008066|19303900|10328880|10545129
1644,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0071,"pxt3003, baclofen + naltrexone + sorbitol",for type 1A Charcot-Marie-Tooth disease,3,2016,recruiting,in trial,-,,10658574|15235087|8388192|10751439|11008066|19303900|10328880|10545129
1645,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,115,"alks 29, Baclofen/samidorphan",alcohol dependance,1,2008,discontinued,in trial,-,,8388192|11752352|10386831|19303900|10444662|10482760|10494996|10545129|10094428
1646,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0072,"pxt3003, baclofen + naltrexone + sorbitol",for type 1A Charcot-Marie-Tooth disease,3,2016,recruiting,in trial,-,,8388192|11752352|10386831|19303900|10444662|10482760|10494996|10545129|10094428
1647,barusiban,protein,Peptide,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Sep2016_290,barusiban,Fertility,2,2012,completed,in trial,-,,
1648,basimglurant,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,ASH_Sep2016_341,basimglurant,fragile x syndrome,2,2015,completed,in trial,-,,
1649,batefenterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_188,batefenterol,chronic obstructive pulmonary disease (COPD),2,2016,completed,in trial,-,,
1650,batefenterol,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_56,batefenterol,chronic obstructive pulmonary disease (COPD),2,2015,completed,in trial,-,,
1651,batefenterol,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_82,batefenterol,chronic obstructive pulmonary disease (COPD),2,2016,completed,in trial,-,,
1652,bavisant,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_243,bavisant,attention deficit hyperactivity disorder,2,2011,withdrawn,in trial,-,No development reported,
1653,bci-838,small molecule,Amino acid ,antagonist,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmay2016_0306,bci-838,Anti-depressant,1,2012,completed,in trial,-,No development reported,
1654,bci-838,small molecule,Amino acid ,antagonist,,primary,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmay2016_0307,bci-838,Anti-depressant,1,2012,completed,in trial,-,No development reported,
1655,bedoradrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_189,bedoradrine,Anti-Asthmatic,2,2009,completed,in trial,-,No development reported,
1656,beraprost,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,337,beraprost,Antihypertensive,3,2011,withdrawn,in trial,-,"No longer marketed, but may still be available",11790158
1657,betahistine,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1464,"obe101,histalean,anti-obesity ",Anti-obesity,2,2008,discontinued,in trial,-,,18447604|11700150
1658,betahistine,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAaug2017_029,"betahistine dihydrochloride spray, AM-125",Dizzy/Fainting Spells,1,2017,ongoing,in trial,-,,18447604|11700150
1659,betahistine,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1464,"obe101,histalean,anti-obesity ",Anti-obesity,2,2008,discontinued,in trial,-,,18447604|11700150|20530654
1660,betahistine,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAaug2017_030,"betahistine dihydrochloride spray, AM-125",Dizzy/Fainting Spells,1,2017,ongoing,in trial,-,,18447604|11700150|20530654
1661,bevantolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD056,-,Antihypertensive,2,1989,discontinued,in trial,-,Decided 1989 not to market it in US and elsewhere,2568629|2858236|6148733|2888789|17628611
1662,bf-1,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,343,bf-1,Anti-migraine,1,2016,ongoing,in trial,-,,
1663,bg-9928,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,345,bg-9928,congestive heart failure,2,2008,terminated,in trial,-,,
1664,bgc20-1531 ,small molecule,Lipid ,antagonist,,primary,PTGER4,pe2r4_human,P35408,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,347,bgc20-1531,Anti-migraine,2,2009,discontinued,in trial,-,,
1665,BI 665088,antibody,Protein,antagonist,,primary,CX3CR1,cx3c1_human,P49238,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Jul2017_03,BI 665088,kidney disease,1,2017,ongoing,in trial,-,,
1666,bifeprunox,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,,16237379|17393144|17659474
1667,bifeprunox,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,,17393144|17659474
1668,bifeprunox,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,,
1669,bifeprunox,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,,
1670,bifeprunox,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,,
1671,bifeprunox,small molecule,Aminergic ,agonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,,
1672,biib014,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2164,vipadenantis,Antiparkinson,2,2006,discontinued,in trial,-,,
1673,bim23a760,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,358,bim23a760,Antineoplastic ; treatment for acromegaly,2,2009,discontinued,in trial,-,,
1674,bim23a760,small molecule,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,358,bim23a760,Antineoplastic ; treatment for acromegaly,2,2009,discontinued,in trial,-,,
1675,bim23a760,small molecule,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,358,bim23a760,Antineoplastic ; treatment for acromegaly,2,2009,discontinued,in trial,-,,
1676,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmar2016_0297,"helios insert, bimatoprost ocular insert",Antiglaucomic,2,2016,completed,in trial,-,,11740958|12222762|14733708|18452763|689791|19697832|17724194|11752352
1677,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmar2016_0296,"helios insert, bimatoprost ocular insert",Antiglaucomic,2,2016,completed,in trial,-,,14733708|16877408
1678,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmar2016_0298,"helios insert, bimatoprost ocular insert",Antiglaucomic,2,2016,completed,in trial,-,,14733708|19232013|16877408
1679,binodenoson,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,363,"binodenoson, mre 0470,corvue",Diagnostic,3,2009,completed,in trial,-,No development reported,17531571|16524538
1680,bl-1020,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2424,bl-1020,schizophrenia,3,2011,terminated,in trial,-,,
1681,bl-1020,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,2424,bl-1020,schizophrenia,3,2011,terminated,in trial,-,,
1682,bl-1020,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2424,bl-1020,schizophrenia,3,2011,terminated,in trial,-,,
1683,bl-8040,peptide,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,APR13_0001,bl-8040,Antineoplastic,2,2016,recruiting,in trial,-,"discontinued for sole intervention, now in combination trials",
1684,BNC-101,antibody,Orphan ,antagonist,,primary,LGR5,lgr5_human,O75473,Class A (Rhodopsin),GpCR;Rhodopsin,Class A orphans,not established,ASH_Jul2017_08,BNC101,Antineoplastic,1,2016,ongoing,in trial,-,,
1685,boxaban,small molecule,Lipid ,antagonist,"hepatoren,  vasculan,  ifetroban",primary,TBXA2R,ta2r_human,P21731,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAjun2016_0011,"boxaban, hepatoren, vasculan, ifetroban",Treatment of asystemic scleroderma; hepatorenal syndrome; asthma,2,2017,not open yet,in trial,-,,
1686,bremelanotide,peptide,Peptide,agonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,383,bremelanotide,sexual dysfunction,3,2015,ongoing,in trial,-,,
1687,bremelanotide,peptide,Peptide,agonist,,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,383,bremelanotide,sexual dysfunction,3,2015,ongoing,in trial,-,,
1688,bremelanotide,protein,Peptide,agonist,,primary,MC3R,mc3r_human,P41968,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,ASH_Sep2016_260,bremelanotide,sexual dysfunction,3,2015,ongoing,in trial,-,,
1689,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2274,"cd07805/47, sansrosa, col-118",erythema,2,2008,completed,in trial,-,,10799649|11481271|1373179|11752352
1690,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2274,"cd07805/47, sansrosa, col-118",erythema,2,2008,completed,in trial,-,,14610637|11606316|12670699|16757535
1691,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2274,"cd07805/47, sansrosa, col-118",erythema,2,2008,completed,in trial,-,,14610637|8097565
1692,BTX-1503,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_041,BTX 1204; BTX 1308; BTX 1503; BTX1204,Skin disorder therapies,1,2017,ongoing,in trial,-,,
1693,BTX-1503,small molecule,Lipid ,antagonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_042,BTX 1204; BTX 1308; BTX 1503; BTX1204,Skin disorder therapies,1,2017,ongoing,in trial,-,,
1694,bucindolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,396,"bucindolol hydrochloride,gencaro",heart failure,2,2013,recruiting,in trial,-,,
1695,bucindolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,396,"bucindolol hydrochloride,gencaro",heart failure,2,2013,recruiting,in trial,-,,
1696,budiodarone,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,404,"budiodarone, ati-2042",Anti-Arrhythmia,2,2005,completed,in trial,-,,
1697,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Anti-depressant; Analgesics; opioid addiction,1,2010,completed,in trial,-,,10729371|10942856|11275413|12435410|15100703|11752352
1698,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,422,cam2038,Anti-depressant; Analgesics; opioid addiction,3,2016,recruiting,in trial,-,,10729371|10942856|11275413|12435410|15100703|11752352
1699,buprenorphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2109,v1003,Anti-depressant; Analgesics; opioid addiction,2,2006,completed,in trial,-,,10729371|10942856|11275413|12435410|15100703|11752352
1700,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 5461, Buprenorphine/samidorphan",Anti-depressant; Analgesics; opioid addiction,3,2017,completed,in trial,-,,17244875|16953647
1701,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Anti-depressant; Analgesics; opioid addiction,1,2010,completed,in trial,-,,17244875|16953647
1702,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,422,cam2038,Anti-depressant; Analgesics; opioid addiction,3,2016,recruiting,in trial,-,,17244875|16953647
1703,buprenorphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2109,v1003,Anti-depressant; Analgesics; opioid addiction,2,2006,completed,in trial,-,,17244875|16953647
1704,buprenorphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 5461, Buprenorphine/samidorphan",Anti-depressant; Analgesics; opioid addiction,3,2017,completed,in trial,-,,19666890|16443205|16169027
1705,buprenorphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2109,v1003,Anti-depressant; Analgesics; opioid addiction,2,2006,completed,in trial,-,,19666890|16443205|16169027
1706,bupropion/trazodone,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0460,"lorexys, sip-104, bupropion/trazodone",Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,2,2014,completed,in trial,-,,
1707,bupropion/trazodone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0461,"lorexys, sip-104, bupropion/trazodone",Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,2,2014,completed,in trial,-,,
1708,bupropion/trazodone,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0462,"lorexys, sip-104, bupropion/trazodone",Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,2,2014,completed,in trial,-,,
1709,bvt.115959,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,411,bvt.115959,Analgesics,2,2007,discontinued,in trial,-,,
1710,bvt.28949,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,412,bvt.28949,Antiglaucomic,2,2010,unknown,in trial,-,Sweden,
1711,cal-1,cell therapy,Protein,not available,autologous t cell and blood stem cell therapy,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAapril2016_0320,"cal-1, autologous t cell and blood stem cell therapy",antiviral ; HIV,2,2012,ongoing,in trial,-,,
1712,calcitonin human,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,376,"bn-002,capsitonin",Anti-osteoporotic,2,2013,completed,in trial,-,,
1713,calcitonin human,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,2154,viaderm-calcitonin,Anti-osteoporotic,1,2011,completed,in trial,-,,
1714,calcitonin salmon recombinant,peptide,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,817,fortical,Anti-osteoporotic,3,2008,discontinued,in trial,-,,7610922
1715,camicinal,small molecule,Peptide,agonist,,primary,MLNR,mtlr_human,O43193,Class A (Rhodopsin),GPCR;Rhodopsin,Motilin receptors,not established,ASH_Sep2016_262,camicinal,gastroparesis,2,2014,completed,in trial,-,,
1716,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAapril2016_0328,"epidiolex, oral liquid cannabidiol, gwp42003",schizophrenia,2,2013,completed,in trial,-,,
1717,cannabidiol,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_004,"PTL101 capsules, purified CBD",epilepsy,2,2017,ongoing,in trial,-,,
1718,cannabidiol,small molecule,Lipid ,antagonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_005,"PTL101 capsules, purified CBD",epilepsy,2,2017,ongoing,in trial,-,,
1719,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAaug2017_006,"PTL101 capsules, purified CBD",epilepsy,2,2017,ongoing,in trial,-,,
1720,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAaug2017_038,CBD,Graft Versus Host Disease,2,2017,completed,in trial,-,,
1721,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAmar2016_0268,cannabidiol,epilepsy,3,2016,not open yet,in trial,-,,
1722,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAmar2016_0271,"epidiolex, oral liquid cannabidiol, gwp42003",epilepsy,3,2016,recruiting,in trial,-,,
1723,cannabidivarin,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAmay2016_0403,"gwp42006, Cannabidivarin",epilepsy,2,2015,recruiting,in trial,-,,
1724,carbetocin,small molecule,Peptide,agonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD078,-,Labor Inducing,3,2016,completed,in trial,-,Approved in Europe but not FDA,9760035|15740719|11752352
1725,carmoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_187,carmoterol,chronic obstructive pulmonary disease (COPD),2,2008,discontinued,in trial,-,,
1726,casopitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,436,"casopitant mesilate, 679769,rezonic, zunrisa",Antiemetics,3,2009,discontinued,in trial,-,discontinued due to safety data,
1727,ccl2-lpm,protein,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,445,ccl2-lpm,Anti-inflammatory,1,2009,terminated,in trial,-,Terminated due to resources and slow enrollment not safety,
1728,ccx025,small molecule,Protein,antagonist,,primary,CCR9,ccr9_human,P51686,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,446,ccx025,Anti-inflammatory,1,2009,unknown,in trial,-,,
1729,ccx140,small molecule,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,447,ccx140,Anti-inflammatory ; Antidiabetic,2,2011,completed,in trial,-,,
1730,ccx168,small molecule,Peptide,antagonist,,primary,C5AR1,c5ar1_human,P21730,Class A (Rhodopsin),GPCR;Rhodopsin,Complement peptide receptors,not established,448,ccx168,Anti-inflammatory,3,2016,recruiting,in trial,-,,
1731,ccx282,small molecule,Protein,antagonist,,primary,CCR9,ccr9_human,P51686,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,449,"ccx282, traficet-en",Anti-inflammatory ; Crohn's disease; ulceraite colitis,3,2012,terminated,in trial,-,Terminated due to lack of efficacy,
1732,ccx354,small molecule,Protein,antagonist,,primary,CCR1,ccr1_human,P32246,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,450,ccx354,Anti-inflammatory ; DMARD,2,2010,completed,in trial,-,,
1733,ccx507,small molecule,Protein,antagonist,,primary,CCR9,ccr9_human,P51686,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAmay2016_0216,ccx507,ulcerative colitis; inflammatory bowel disease,1,2014,completed,in trial,-,,
1734,ccx832,small molecule,Protein,antagonist,,primary,CMKLR1,cml1_human,Q99788,Class A (Rhodopsin),GPCR;Rhodopsin,Chemerin receptor,not established,451,ccx832,Anti-inflammatory ; for treatment for autoimmune disease,1,2011,discontinued,in trial,-,,
1735,ccx872,small molecule,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAapril2016_0147,ccx872,Antineoplastic ; pancreatic cancer,1,2015,ongoing,in trial,-,,
1736,cebranopadol,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_264,cebranopadol,diabetic neuropathy,3,2016,recruiting,in trial,-,,
1737,cebranopadol,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_267,cebranopadol,diabetic neuropathy,3,2016,recruiting,in trial,-,,
1738,cebranopadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_273,cebranopadol,"osteoarthritis, knee",3,2016,recruiting,in trial,-,,
1739,cebranopadol,small molecule,Peptide,agonist,,primary,OPRL1,oprx_human,P41146,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,not established,ASH_Sep2016_276,cebranopadol,Analgesics,3,2016,recruiting,in trial,-,,
1740,cenerimod,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMAaug2017_043,Cenerimod,Systemic Lupus Erythematosus,2,2017,ongoing,in trial,-,,
1741,cenicriviroc,small molecule,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_292,cenicriviroc,antiviral ; HIV,3,2017,recruiting,in trial,-,,
1742,cenicriviroc,small molecule,Protein,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,ASH_Sep2016_293,cenicriviroc,antiviral ; HIV,3,2017,recruiting,in trial,-,,
1743,cer627,small molecule: combination,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,MMA2015_0071,cer627,Dyslipidemia with low HDL,1,2010,discontinued,in trial,-,,
1744,cer627,small molecule: combination,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,MMA2015_0072,cer627,Dyslipidemia with low HDL,1,2010,discontinued,in trial,-,,
1745,cerc-501,small molecule,Peptide,antagonist,ly2456302,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0074,"cerc-501, ly2456302",Substance use disorders,2,2016,recruiting,in trial,-,,
1746,cerlapirdine,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_43,cerlapirdine,Alzheimer's disease,2,2009,discontinued,in trial,-,,
1747,cf101,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_320,"cf101, Piclidenoson",keratoconjunctivitis sicca,3,2015,not open yet,in trial,-,,
1748,cf-101,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,473,cf-101,Anti-inflammatory ; DMARD,3,2015,not open yet,in trial,-,,
1749,cf-102,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,474,cf-102,Antineoplastic,2,2014,recruiting,in trial,-,,
1750,cf602,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAapril2016_0230,cf602,sexual dysfunction,1,2017,not open yet,in trial,-,,
1751,cgrp,peptide,Peptide,agonist,,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,477,"cgrp, Akela Pharma",Anti-Asthmatic,2,2013,discontinued,in trial,-,EU,
1752,chorionic gonadotropin,protein,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,2529,"ml-04, LDI-100",Antineoplastic,3,2016,not open yet,in trial,-,,20836886
1753,cinalukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,NRDD106,-,Anti-Asthmatic,1,2005,discontinued,in trial,-,,11752352|9042047|19826192
1754,cis-uca eye drops,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0333,cis-uca eye drops,for ocular surface inflammation,2,2014,completed,in trial,-,,
1755,clazosentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,495,"clazosentan, axv-343434,pivlaz",vasospasm,2,2015,recruiting,in trial,-,,
1756,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,220,"arc-4558, 0.1% clonidine hycrochloride gel",diabetic neuropathy; ADHD; antimucositic,3,2016,discontinued,in trial,-,,28715875
1757,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,220,"arc-4558, 0.1% clonidine hycrochloride gel",diabetic neuropathy; ADHD; antimucositic,3,2016,discontinued,in trial,-,,28715875
1758,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,502,"clonidine lauriad, ba-028",diabetic neuropathy; ADHD; antimucositic,2,2011,completed,in trial,-,,28715875
1759,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,502,"clonidine lauriad, ba-028",diabetic neuropathy; ADHD; antimucositic,2,2011,completed,in trial,-,,28715875
1760,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,220,"arc-4558, 0.1% clonidine hycrochloride gel",diabetic neuropathy; ADHD; antimucositic,3,2016,discontinued,in trial,-,,11752127|12357167|15306201|14757140|12098614
1761,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,502,"clonidine lauriad, ba-028",diabetic neuropathy; ADHD; antimucositic,2,2011,completed,in trial,-,,11752127|12357167|15306201|14757140|12098614
1762,CNTX-0290,small molecule,Peptide,agonist,,primary,SSTR4,ssr4_human,P31391,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAaug2017_046,CNTX-0290,Analgesics,1,2017,completed,in trial,-,,
1763,CNTX-6970,small molecule,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAaug2017_044,CNTX-6970,Analgesics,1,2017,completed,in trial,-,,
1764,corifollitropin alfa,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,526,"corifollitropin alfa,elonva",Fertility,3,2015,recruiting,in trial,-,,
1765,corticotropin-releasing factor,peptide,Peptide,agonist,,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,528,"corticotropin-releasing factor,xerecept",peritumoral brain edema,3,2005,discontinued,in trial,-,,
1766,cpb-307,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMAmar2016_0127,cpb-307,autoimmune diseases,1,2014,completed,in trial,-,,
1767,cr665,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,539,"cr665, JNJ 38488502",Analgesics,2,2004,discontinued,in trial,-,,
1768,cr845,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,540,cr845,Analgesics,3,2015,recruiting,in trial,-,,
1769,cromolyn sodium,small molecule,Orphan ,agonist,,primary,GPR35,gpr35_human,Q9HC97,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,established,MMAmar2016_0133,pa101b,autoimmune diseases,2,2016,completed,in trial,-,,
1770,ctce-9908,protein,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,2376,ctce-9908,Antineoplastic,2,2007,discontinued,in trial,-,,
1771,ctp-499,small molecule,Nucleotide ,not available,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2268,ctp-499,diabetic nephropathy,2,2011,completed,in trial,-,,
1772,ctp-499,small molecule,Nucleotide ,not available,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2268,ctp-499,diabetic nephropathy,2,2011,completed,in trial,-,,
1773,cur-61414,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,2823,cur-61414,Antineoplastic,1,2010,completed,in trial,-,,
1774,cvt-3619,small molecule,Nucleotide ,partial agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,568,cvt-3619,Antihyperlipidemic,1,2010,completed,in trial,-,,
1775,cvt-6883,small molecule,Nucleotide ,antagonist,,primary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,569,cvt-6883,Anti-Asthmatic,1,2008,completed,in trial,-,,
1776,cyclobenzaprine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0082,tnx-102,"fibromyalgia, PTSD",3,2017,recruiting,in trial,-,,12498911|8884233
1777,dac:glp-1,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,590,"dac:glp-1, cjc-1131",Antidiabetic,2,2007,discontinued,in trial,-,,
1778,dac:grf,peptide,Peptide,agonist,,primary,GHRHR,ghrhr_human,Q02643,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,591,dac:grf,hormone replacement,2,2007,discontinued,in trial,-,,
1779,danirixin,small molecule,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_297,"danirixin, GSK1325756",chronic obstructive pulmonary disease (COPD),2,2017,recruiting,in trial,-,,
1780,darusentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,599,darusentan,Antihypertensive,3,2006,discontinued,in trial,-,,17890870|17049116
1781,davalintide,protein,Peptide,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,ASH_Sep2016_325,davalintide,Anti-obesity,2,2008,discontinued,in trial,-,,
1782,decoglurant,small molecule,Amino acid ,NAM,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,ASH_Sep2016_336,decoglurant,unipolar depression,2,2011,discontinued,in trial,-,,
1783,decoglurant,small molecule,Amino acid ,NAM,,primary,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,ASH_Sep2016_338,decoglurant,unipolar depression,2,2011,discontinued,in trial,-,,
1784,denufosol,small molecule,Nucleotide ,agonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,614,"denufosol tetrasodium, ins37217 respiratory",cystic fibrosis,3,2009,discontinued,in trial,-,,12407168|12407169|12458155|14507899|15704203|16475938|17446337
1785,Denufosol,small molecule,Nucleotide ,agonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,990,"Denufosol, ins37217",rhegmatogenous retinal detachment,2,2004,discontinued,in trial,-,,12407168|12407169|12458155|14507899|15704203|16475938|17446337
1786,Denufosol,small molecule,Nucleotide ,agonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,991,"Denufosol, ins37217 intranasal",cystic fibrosis; perennial allergic rhinitis,3,2009,discontinued,in trial,-,,12407168|12407169|12458155|14507899|15704203|16475938|17446337
1787,deuterium containing analog of sodium oxybate,small molecule,Amino acid ,agonist,gamma hydroxybutyric acid,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0771,jzp-386,sleep disorders; narcolepsy,1,2014,completed,in trial,-,,
1788,deuterium containing analog of sodium oxybate,small molecule,Amino acid ,agonist,gamma hydroxybutyric acid,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0773,jzp-386,sleep disorders; narcolepsy,1,2014,completed,in trial,-,,
1789,dexloxiglumide,small molecule,Peptide,antagonist,,primary,CCKAR,cckar_human,P32238,Class A (Rhodopsin),GPCR;Rhodopsin,Cholecystokinin receptors,established,626,"dexloxiglumide, cr 2017",motilitant,3,2005,discontinued,in trial,-,,17112294
1790,dg041,small molecule,Lipid ,antagonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,629,dg041,Platelet Aggregation Inhibitor,2,2006,discontinued,in trial,-,Iceland,
1791,dg3173,small molecule,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,632,dg3173,hormone replacement,2,2014,ongoing,in trial,-,,
1792,dg3173,small molecule,Peptide,agonist,,primary,SSTR4,ssr4_human,P31391,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,632,dg3173,hormone replacement,2,2014,ongoing,in trial,-,,
1793,dg3173,small molecule,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,632,dg3173,hormone replacement,2,2014,ongoing,in trial,-,,
1794,dipraglurant,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,ASH_Sep2016_339,dipraglurant,Antiparkinson,2,2011,completed,in trial,-,,
1795,diquafosol,small molecule,Nucleotide ,agonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,644,"diquafosol tetrasodium, ins365 ophthalmic,prolacria",opthalmological,3,2009,discontinued,in trial,-,,
1796,domperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD184,-,Antiemetics,2,2015,recruiting,in trial,-,,12010185|15894081|1683559|11752352|18970411
1797,DP1038,peptide,Peptide,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAaug2017_047,"DP1038, intranasal octreotide acetate",growth hormone deficiency,1,2017,completed,in trial,-,,
1798,DP1039,peptide,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAaug2017_048,"DP1038, intranasal octreotide acetate",growth hormone deficiency,1,2017,completed,in trial,-,,
1799,DP1040,peptide,Peptide,agonist,,primary,SSTR3,ssr3_human,P32745,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAaug2017_049,"DP1038, intranasal octreotide acetate",growth hormone deficiency,1,2017,completed,in trial,-,,
1800,DP1041,peptide,Peptide,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAaug2017_050,"DP1038, intranasal octreotide acetate",growth hormone deficiency,1,2017,completed,in trial,-,,
1801,drinabant,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,ASH_Sep2016_306,drinabant,schizophrenia,2,2007,discontinued,in trial,-,discontinued due to insufficient level of efficacy,
1802,drm04,small molecule,Aminergic ,antagonist,anticholinergic,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAfeb2016_0095,"drm04, anticholinergic",hyperhidrosis,3,2015,completed,in trial,-,,
1803,dsc127,peptide,Peptide,agonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,2280,dsc127,diabetic foot ulcers,3,2013,discontinued,in trial,-,,
1804,ecopipam,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,686,ecopipam,Speech and language disorders,3,2016,recruiting,in trial,-,,
1805,efpeglenatide,peptide,Peptide,agonist,hm11260c,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmar2016_0245,"efpeglenatide, hm11260c",Antidiabetic,2,2014,completed,in trial,-,,
1806,Elagolix,small molecule,Peptide,antagonist,nbi-56418,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1388,nbi-56418,"Endometriosis, Antineoplastic",3,2016,recruiting,in trial,-,,
1807,elagolix,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Sep2016_257,elagolix,endometriosis,3,2016,recruiting,in trial,-,,
1808,elinogrel,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,701,"elinogrel, prt060128, adp receptor antagonist",antiplatelet,2,2008,discontinued,in trial,-,,
1809,elsiglutide,peptide,Peptide,agonist,,primary,GLP2R,glp2r_human,O95838,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2464,zp1846,Antidiuretic,2,2012,completed,in trial,-,,
1810,eltoprazine,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0086,eltoprazine,dyskinesias,2,2015,ongoing,in trial,-,,
1811,eltoprazine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0087,eltoprazine,dyskinesias,2,2015,ongoing,in trial,-,,
1812,elubrixin,small molecule,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_300,elubrixin,ulcerative colitis,2,2007,discontinued,in trial,-,,
1813,ema401,small molecule,Peptide,antagonist,,primary,AGTR2,agtr2_human,P50052,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,not established,MMAmay2016_0377,ema401,peripheral neuropathic pain; post herpetic neuralgia,2,2017,not open yet,in trial,-,,
1814,emicerfont,small molecule,Peptide,antagonist,,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,ASH_Sep2016_330,emicerfont,irritable bowel syndrome,2,2007,discontinued,in trial,-,,
1815,ep-100,peptide,Peptide,not available,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,715,ep-100,Antineoplastic,2,2011,completed,in trial,-,Seems like still investigating as of 2014 article,
1816,ep-100,peptide,Peptide,not available,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,715,ep-100,Antineoplastic,2,2011,completed,in trial,-,Seems like still investigating as of 2014 article,
1817,epelsiban,small molecule,Peptide,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Sep2016_291,epelsiban,premature ejaculation,2,2016,withdrawn,in trial,-,"Had no activity since 2009, then shows 2016 a phase 2 trial, but withdrawn due to change in portfolio prioritization",
1818,eplivanserine,small molecule,Aminergic ,inverse agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,721,"eplivanserine, sr 46349,ciltyri",insomnia,3,2009,discontinued,in trial,-,Sanofi withdrew application for fda approval 2009,
1819,eplivanserine,small molecule,Aminergic ,inverse agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,721,"eplivanserine, sr 46349,ciltyri",insomnia,3,2009,discontinued,in trial,-,Sanofi withdrew application for fda approval 2009,
1820,erenumab,antibody,Peptide,antagonist,amg 334,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,MMAapril2016_0116,"amg 334, Erenumab",Anti-migraine,3,2017,completed,in trial,-,,
1821,esmirtazapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_237,esmirtazapine,insomnia,3,2008,discontinued,in trial,-,,26047892
1822,esmirtazapine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,732,"esmirtazapine, org-4420",insomnia; menopausal symptoms,3,2009,discontinued,in trial,-,discontinued by Organon,
1823,esmirtazapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,732,"esmirtazapine, org-4420",insomnia; menopausal symptoms,3,2009,discontinued,in trial,-,discontinued by Organon,
1824,esmirtazapine,small molecule,Aminergic ,antagonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_146,esmirtazapine,insomnia,3,2008,discontinued,in trial,-,,
1825,esmirtazapine,small molecule,Aminergic ,antagonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_165,esmirtazapine,insomnia,3,2008,discontinued,in trial,-,,
1826,esmirtazapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_38,esmirtazapine,insomnia,3,2008,discontinued,in trial,-,,
1827,etilevodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,,
1828,etilevodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,,
1829,etilevodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,,
1830,etilevodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,,
1831,etilevodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,,
1832,exenatide,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1046,itca 650,Antidiabetic,3,2017,not open yet,in trial,-,,16722815|17292977|17353295|16534527|17379930|20649595|15331551|15495988|15700891|16341288|16627399|11752352
1833,exendin (9-39) ,peptide,Peptide,antagonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAjun2016_0019,exendin (9-39) ,hypoglycemia,2,2016,recruiting,in trial,-,Appears pause in research from 2009-2016,
1834,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,MMAmar2016_0122,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,,
1835,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0123,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,,
1836,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM7,grm7_human,Q14831,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0124,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,,
1837,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0125,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,,
1838,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM4,grm4_human,Q14833,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0125,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,,
1839,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM6,grm6_human,O15303,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0125,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,,
1840,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM8,grm8_human,O00222,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0125,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,,
1841,felypressin,peptide,Peptide,agonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD226,-,Hemostatic s; Vasoconstricting,1,2010,completed,in trial,-,"Not approved in US, but used here and elsewhere",17139284|17016423|18655903|11752352
1842,fenfluramine,small molecule,Aminergic ,agonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0273,"zx008, brabafen, low-dose fenfluramine",epilepsy; Dravet's syndrome,3,2016,recruiting,in trial,-,,10617681|11104741|12761331|14659797|16960982|17202450
1843,fenfluramine,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0274,"zx008, brabafen, low-dose fenfluramine",epilepsy; Dravet's syndrome,3,2016,recruiting,in trial,-,,10617681|12708517|15869562|16249524|16973729
1844,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,69,aerolef,Analgesics,2,2010,completed,in trial,-,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
1845,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,259,at3022,Analgesics,1,2011,discontinued,in trial,-,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
1846,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,782,"fentanyl lauriad, ba-041",Analgesics,2,2014,discontinued,in trial,-,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
1847,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,783,fentanyl mdts,Analgesics,1,2009,discontinued,in trial,-,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
1848,fentanyl,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,786,fentanyl taifun,Analgesics,3,2011,discontinued,in trial,-,,15589524|16114980|16332149|16376082|16797997|11752352|19403616
1849,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,69,aerolef,Analgesics,2,2010,completed,in trial,-,,15665994|15828941|15868528|16372825|16861092|19403616
1850,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,259,at3022,Analgesics,1,2011,discontinued,in trial,-,,15665994|15828941|15868528|16372825|16861092|19403616
1851,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,782,"fentanyl lauriad, ba-041",Analgesics,2,2014,discontinued,in trial,-,,15665994|15828941|15868528|16372825|16861092|19403616
1852,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,783,fentanyl mdts,Analgesics,1,2009,discontinued,in trial,-,,15665994|15828941|15868528|16372825|16861092|19403616
1853,fentanyl,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,786,fentanyl taifun,Analgesics,3,2011,discontinued,in trial,-,,15665994|15828941|15868528|16372825|16861092|19403616
1854,fevipiprant,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_308,fevipiprant,Anti-Asthmatic,3,2017,recruiting,in trial,-,,
1855,fipamezole,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,795,"fipamezole , jp-1730",Antiparkinson,2,2010,discontinued,in trial,-,,
1856,fipamezole,small molecule,Aminergic ,antagonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,796,"fipamezole, jp-1730",Antiparkinson,2,2010,discontinued,in trial,-,,
1857,fipamezole,small molecule,Aminergic ,antagonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,796,"fipamezole, jp-1730",Antiparkinson,2,2010,discontinued,in trial,-,,
1858,fk352b,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,799,fk352b,Antihypertensive,2,2005,discontinued,in trial,-,,
1859,flupenthixol,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD240,-,schizophrenia,3,2015,recruiting,in trial,-,"Never approved by fda, clinical trials in Europe in 2005",
1860,flupenthixol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD240,-,schizophrenia,3,2015,recruiting,in trial,-,"Never approved by fda, clinical trials in 1989",
1861,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1682,"pt005, formoterol fumarate hydrofluoroalkane metered dose inhaler",chronic obstructive pulmonary disease (COPD),3,2015,discontinued,in trial,-,,12090787|14662724|16432501|2544117|7675115|11752352|9506248|14720051|18686730|1718682|17594727
1862,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1861,"skyepharma,flutiform",Bronchodilator,3,2010,completed,in trial,-,Approved in Europe but not FDA,12090787|14662724|16432501|2544117|7675115|11752352|9506248|14720051|18686730|1718682|17594727
1863,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2275,apd209,Appetite stimulant,2,2013,completed,in trial,-,,12090787|14662724|16432501|2544117|7675115|11752352|9506248|14720051|18686730|1718682|17594727
1864,fsh-gex,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,825,fsh-gex,Fertility,2,2013,completed,in trial,-,,
1865,fx125l,small molecule,Peptide,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,831,fx125l,Anti-Asthmatic,1,2009,completed,in trial,-,Great Britain,
1866,gc021109,small molecule,Nucleotide ,agonist,,primary,P2RY6,p2ry6_human,Q15077,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,MMAfeb2016_0055,gc021109,Alzheimer's disease,1,2015,completed,in trial,-,,
1867,gepirone,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,848,gepirone,Anti-depressant,3,1999,completed,in trial,-,"Was rejected 3 times for fda approval, reversed decision in march 2016 - headed for approval and martketing",
1868,glasdegib,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,ASH_Sep2016_343,glasdegib,Antineoplastic,2,2016,completed,in trial,-,,
1869,glp,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,699,eligen pyy-3-36 + glp-1,Appetite suppressant,2,2009,completed,in trial,-,,
1870,glp1 agonist ,unknown,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2155,viaderm-glp1 agonist,Antidiabetic,1,2010,completed,in trial,-,,
1871,glpg0974,small molecule,Lipid ,antagonist,,primary,FFAR2,ffar2_human,O15552,Class A (Rhodopsin),GPCR;Rhodopsin,Free fatty acid receptors,not established,MMAmay2016_0156,glpg0974,Anti-inflammatory ; neutrophil driven inflammation; ulcerative colitis,2,2013,completed,in trial,-,,
1872,glpg1205,small molecule,Orphan ,antagonist,,primary,GPR84,gpr84_human,Q9NQS5,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,MMAapril2016_0323,glpg1205,for ulcerative colitis; IBS,2,2015,completed,in trial,-,,
1873,GMA102,antibody,Peptide,antagonist,,primary,GLP1R,glp1r_human,P43220,Class A (Rhodopsin),GpCR;Rhodopsin,Glucagon receptor family,established,ASH_Jul2017_09,GMA102,Antidiabetic,1,2017,ongoing,in trial,-,,
1874,gsk-1004723,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,878,gsk-1004723,Anti-Allergic,2,2009,discontinued,in trial,-,,
1875,gsk-1004723,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,878,gsk-1004723,Anti-Allergic,2,2009,discontinued,in trial,-,,
1876,gsk163090,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_5,gsk163090,unipolar depression,2,2009,discontinued,in trial,-,,
1877,gsk163090,small molecule,Aminergic ,antagonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_8,gsk163090,unipolar depression,2,2009,discontinued,in trial,-,,
1878,gsk163090,small molecule,Aminergic ,antagonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_9,gsk163090,unipolar depression,2,2009,discontinued,in trial,-,,
1879,gsk-961081,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,881,gsk-961081,Bronchodilator,2,2015,completed,in trial,-,,
1880,gsk-961081,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,881,gsk-961081,Bronchodilator,2,2015,completed,in trial,-,,
1881,gtp-010,protein,Peptide,antagonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,885,gtp-010,irritable bowel syndrome,2,2008,discontinued,in trial,-,,
1882,gtp-200,peptide,Peptide,agonist,,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,886,gtp-200,Appetite stimulant,2,2006,discontinued,in trial,-,,
1883,gtx-758,small molecule,Protein,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,888,gtx-758,Antineoplastic,2,2012,recruiting,in trial,-,Other studies were terminated from FDA hold,
1884,histamine,small molecule,Aminergic ,agonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,463,ceplene,cytorprotective  during cancer treatment,3,2015,recruiting,in trial,-,Has orphan designation to be used as adjunct with IL-2 for acute myeloid leukemia,17334413|17359382|11752352
1885,homspera,protein,Peptide,agonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,1907,"substance p,homspera, radilex, viprovex",idiopathic pulmonary fibrosis,1,2011,ongoing,in trial,-,,
1886,h-pth 1-34,peptide,Peptide,partial agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2153,viaderm hpth 1-34,Anti-osteoporotic,2,2009,discontinued,in trial,-,,
1887,h-pth 1-34,peptide,Peptide,partial agonist,,primary,PTH2R,pth2r_human,P49190,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2153,viaderm hpth 1-34,Anti-osteoporotic,2,2009,discontinued,in trial,-,,
1888,HTL18318,small molecule,Aminergic ,agonist,,primary,OPRM,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Mar2017_2,HTL18318,dementia ; schizophrenia,1,2016,completed,in trial,-,,
1889,hydrocodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,,11752352|10640321|16291875|2849950|14600248|20665209|18606504
1890,hydrocodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,,16291875|14600248|11752352
1891,hydromorphone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0260,"ltx-04,  hydromorphone hcl",Analgesics,1,2015,completed,in trial,-,,11869661|12479250|11305075|18789923
1892,hydromorphone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0262,"ltx-04,  hydromorphone hcl",Analgesics,1,2015,completed,in trial,-,,17139284|17016423|16433932
1893,hydromorphone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0261,"ltx-04,  hydromorphone hcl",Analgesics,1,2015,completed,in trial,-,,9301669|2849950|7511163|17658959|2478994|11752352
1894,ibipinabant,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,ASH_Sep2016_305,ibipinabant,Antidiabetic,3,2007,discontinued,in trial,-,,
1895,idalopirdine,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_42,idalopirdine,Alzheimer's disease,3,2014,recruiting,in trial,-,,
1896,iferanserin,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0414,"iferanserin ointment, ven 309",Antihemorrhoidal,3,2011,discontinued,in trial,-,,
1897,incb3284,small molecule,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,966,incb3284,Anti-inflammatory ; DMARD,2,2005,discontinued,in trial,-,,
1898,ino-8875,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,985,ino-8875,Antiglaucomic,3,2015,completed,in trial,-,,
1899,ins-50589,unknown,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,992,ins-50589,antithrombotic,2,2006,discontinued,in trial,-,,
1900,int-767,small molecule,Steroid ,agonist,,primary,GPBAR1,gpbar_human,Q8TDU6,Class A (Rhodopsin),GPCR;Rhodopsin,Bile acid receptors,not established,MMAapril2016_0196,int-767,Treatment of liver fibrosis,1,2015,ongoing,in trial,-,Appears to be heading to phase 2 trials as of 2015,
1901,intepirdine,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_44,intepirdine,Alzheimer's disease,2,2016,recruiting,in trial,-,,
1902,inv102,small molecule,Aminergic ,inverse agonist,nadolol,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0225,"inv102, nadolol",for inflammatory lung disease,2,2013,ongoing,in trial,-,,11752352|7981009|17622774|8574280|1349493|10433496
1903,ipafricept,antibody,Protein,antagonist,FZD8-IgG;OMP-54F28,primary,FZD8,fzd8_human,Q9H461,Class A (Rhodopsin),GPCR;Rhodopsin,Frizzled,not established,ASH_Jul2017_04,FZD8IgG,Antineoplastic,1,2017,ongoing,in trial,-,,
1904,iph5401,antibody,Peptide,antagonist,,primary,C5AR1,c5ar1_human,P21730,Class A (Rhodopsin),GPCR;Rhodopsin,Complement peptide receptors,not established,ASH_Jul2017_02,IPH5401,Antineoplastic,1,2017,recruiting,in trial,-,,
1905,ipi-926,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,2824,"ipi-926, Patidegib",Antineoplastic,2,2016,recruiting,in trial,-,Continual inhibition as mode of action,
1906,irdabisant,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_246,irdabisant,cognitive impairment,1,2013,completed,in trial,-,,
1907,isis 325568,antisense oligo,Peptide,antagonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1030,isis 325568,Antidiabetic,1,2007,discontinued,in trial,-,,
1908,istradefylline,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1043,"istradefylline, kw-6002",Antiparkinson,3,2005,completed,in trial,-,Not approved by fda -denied in 2008,
1909,iti-007,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1048,"iti-007, iti-722",schizophrenia,3,2016,recruiting,in trial,-,,
1910,iti-007,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1048,"iti-007, iti-722",schizophrenia,3,2016,recruiting,in trial,-,,
1911,itopride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1049,"itopride,itax",motilitant,3,2012,completed,in trial,-,Not approved yet by FDA,17300287|16495395
1912,jnj-37822681,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1054,jnj-37822681,schizophrenia,2,2013,completed,in trial,-,,
1913,jvs-100,dna plasmid,Protein,agonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1056,jvs-100,cardioprotectant,2,2015,recruiting,in trial,-,,
1914,kn38-7271,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1076,"kn38-7271, BAY 7271, BAY-387271",neuroprotectant,2,2005,discontinued,in trial,-,No development reported,
1915,kn38-7271,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1076,"kn38-7271, BAY 7271, BAY-387271",neuroprotectant,2,2005,discontinued,in trial,-,No development reported,
1916,kos-2187,small molecule,Peptide,agonist,,primary,MLNR,mtlr_human,O43193,Class A (Rhodopsin),GPCR;Rhodopsin,Motilin receptors,not established,1078,kos-2187,gastrointestinal motility disorders,1,2006,discontinued,in trial,-,,
1917,kp201,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1079,kp201 (prodrug of hydrocodone),Analgesics,2,2015,completed,in trial,-,Difficult to get good clinical trial info for,
1918,kp201,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1079,kp201 (prodrug of hydrocodone),Analgesics,2,2015,completed,in trial,-,Difficult to get good clinical trial info for,
1919,kp201,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1079,kp201 (prodrug of hydrocodone),Analgesics,2,2015,completed,in trial,-,Difficult to get good clinical trial info for,
1920,kuc-7483,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1082,"kuc-7483, Ritobegron",overactive bladder,3,2009,completed,in trial,-,"Article from 2012 suggests may be worth more research, but also possibly discontinued",
1921,ladarixin,small molecule,Protein,antagonist,,primary,CXCR1,cxcr1_human,P25024,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_296,ladarixin,bullous pemphigoid,2,2016,recruiting,in trial,-,,
1922,ladarixin,small molecule,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_298,ladarixin,bullous pemphigoid,2,2016,recruiting,in trial,-,,
1923,laropiprant,small molecule,Lipid ,antagonist,,primary,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1300,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",for counteracting niacin-induced flushing,3,2007,discontinued,in trial,-,Side effects,
1924,laropiprant,small molecule,Lipid ,antagonist,,primary,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1301,"mk-0542b, extended release niacin + laropiprant +simvastatin",for counteracting niacin-induced flushing,3,2007,discontinued,in trial,-,Side effects,
1925,las-100977,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1092,las-100977,Bronchodilator,2,2011,completed,in trial,-,,
1926,lasmiditan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1093,"lasmiditan, col-144, ly-573144",Anti-migraine,3,2015,ongoing,in trial,-,,
1927,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1436,"nova21027,catioprost",Antiglaucomic,2,2015,completed,in trial,-,,16249494|14646172|15037111|9733584|12204699|11752352
1928,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAfeb2016_0059,"roclatan, rhopressa + latanoprost",Antiglaucomic,3,2017,completed,in trial,-,,16249494|14646172|15037111|9733584|12204699|11752352
1929,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0719,"eye-d, controlled-release latanoprost insert",Antiglaucomic,1,2014,completed,in trial,-,,16249494|14646172|15037111|9733584|12204699|11752352
1930,lecozotan,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_2,lecozotan,Alzheimer's disease,3,2006,discontinued,in trial,-,,
1931,lemborexant,small molecule,Peptide,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,ASH_Sep2016_278,lemborexant,insomnia,2,2016,recruiting,in trial,-,,
1932,lemborexant,small molecule,Peptide,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,ASH_Sep2016_280,lemborexant,insomnia,2,2016,recruiting,in trial,-,,
1933,lesogaberan,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,1108,"lesogaberan, azd-3355",gastrointestinal reflux disease,2,2016,ongoing,in trial,-,Had been discontinued since 2009 - new trial in 2016,
1934,lesogaberan,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,1108,"lesogaberan, azd-3355",gastrointestinal reflux disease,2,2016,ongoing,in trial,-,Had been discontinued since 2009 - new trial in 2016,
1935,levodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,,17553470|15710490|15824260|15728856|18549347|11978145|9633680
1936,levodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0101,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,,17553470|15710490|15824260|15728856|18549347|11978145|9633680
1937,levodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,,18549347|11978145|9633680
1938,levodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,,18549347|11978145|9633680
1939,levodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,,18549347|11978145|9633680
1940,levodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,,18549347|11978145|9633680
1941,levodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0102,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,,18549347|11978145|9633680
1942,levodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0103,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,,18549347|11978145|9633680
1943,levodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0104,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,,18549347|11978145|9633680
1944,levodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0105,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,,18549347|11978145|9633680
1945,lgd-6972,small molecule,Peptide,antagonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0453,lgd-6972,Antidiabetic,2,2016,recruiting,in trial,-,,
1946,lixivaptan,small molecule,Peptide,antagonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1157,lixivaptan,hyponatremia,3,2010,completed,in trial,-,"Some information from 2012 but does not appear to labeled discontinued, just postponed",
1947,ljpc-501,peptide,Peptide,agonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMA2015_0090,athos-3,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),3,2015,completed,in trial,-,,
1948,ljpc-501,peptide,Peptide,agonist,,primary,AGTR2,agtr2_human,P50052,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,not established,MMA2015_0091,athos-3,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),3,2015,completed,in trial,-,,
1949,lu 02-750,unknown,Aminergic ,unknown,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,,
1950,lu 02-750,unknown,Aminergic ,unknown,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,,
1951,lu 02-750,unknown,Aminergic ,unknown,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,,
1952,lu 02-750,unknown,Aminergic ,unknown,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,,
1953,lu 02-750,unknown,Aminergic ,unknown,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,,
1954,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,completed,in trial,-,,
1955,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,completed,in trial,-,,
1956,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,completed,in trial,-,,
1957,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,completed,in trial,-,,
1958,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,completed,in trial,-,,
1959,lu-ae58054,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1177,"lu-ae58054 , ly-483518, sgs518",schizophrenia,3,2014,ongoing,in trial,-,,
1960,luteinizing hormone-releasing hormone,peptide,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2097,"tztx-001,teverelix la",Antineoplastic,2,2005,completed,in trial,-,"Seems to be planning Phase 3, but can't find recent dated information",
1961,luteinizing hormone-releasing hormone,peptide,Peptide,antagonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2097,"tztx-001,teverelix la",Antineoplastic,2,2005,completed,in trial,-,"Seems to be planning Phase 3, but can't find recent dated information",
1962,ly2140023,small molecule,Amino acid ,agonist,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,1190,"ly2140023, Pomaglumetad methionil, LY 404039, LY 2140023",schizophrenia,3,2011,discontinued,in trial,-,Ely Lily discontinued due to lack of efficacy,
1963,ly2140023,small molecule,Amino acid ,agonist,,primary,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,1190,"ly2140023, Pomaglumetad methionil, LY 404039, LY 2140023",schizophrenia,3,2011,discontinued,in trial,-,Ely Lily discontinued due to lack of efficacy,
1964,ly2590443,small molecule,Aminergic ,antagonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_46,ly2590443,Anti-migraine,2,2008,discontinued,in trial,-,,
1965,ly2881835,small molecule,Lipid ,agonist,,primary,FFAR1,ffar1_human,O14842,Class A (Rhodopsin),GPCR;Rhodopsin,Free fatty acid receptors,not established,ASH_Jul2017_01,LY2881835,Antidiabetic,1,2011,completed,in trial,-,,
1966,m0002,small molecule,Peptide,antagonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1204,m0002,ascites,2,2010,discontinued,in trial,-,,
1967,macimorelin,peptide,Peptide,agonist,aezs-130,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,MMAmay2016_0080,"macimorelin,  aezs-130","growth hormone deficiency, cancer cachexia",3,2015,completed,in trial,-,Applied for fda approval in 2013 and rejected in 2014,
1968,mar701,peptide,Peptide,agonist,,primary,GIPR,gipr_human,P48546,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,not established,1217,mar701,Antidiabetic,1,2011,discontinued,in trial,-,,
1969,mar701,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1217,mar701,Antidiabetic,1,2011,discontinued,in trial,-,,
1970,mavoglurant,small molecule,Amino acid ,antagonist,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,ASH_Sep2016_340,mavoglurant,obsessive-compulsive disorder,2,2016,recruiting,in trial,-,,
1971,mbx-2982,small molecule,Lipid ,agonist,,primary,GPR119,gp119_human,Q8TDV5,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,1225,mbx-2982,Antidiabetic,2,2009,discontinued,in trial,-,,
1972,mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY1,p2ry1_human,P47900,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1",
1973,mc-1,small molecule,Orphan ,antagonist,,primary,P2RY10,p2y10_human,O00398,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1",
1974,mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY11,p2y11_human,Q96G91,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1",
1975,mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY13,p2y13_human,Q9BPV8,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1",
1976,mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY14,p2y14_human,Q15391,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1",
1977,mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY4,p2ry4_human,P51582,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1",
1978,mc-1,small molecule,Orphan ,antagonist,,primary,P2RY8,p2ry8_human,Q86VZ1,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1",
1979,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY1,p2ry1_human,P47900,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,,
1980,mc-4232 + mc-1,small molecule,Orphan ,antagonist,,primary,P2RY10,p2y10_human,O00398,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,,
1981,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY11,p2y11_human,Q96G91,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,,
1982,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,,
1983,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY13,p2y13_human,Q9BPV8,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,,
1984,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY14,p2y14_human,Q15391,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,,
1985,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,,
1986,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY4,p2ry4_human,P51582,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,,
1987,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,primary,P2RY6,p2ry6_human,Q15077,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,,
1988,mc-4232 + mc-1,small molecule,Orphan ,antagonist,,primary,P2RY8,p2ry8_human,Q86VZ1,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,,
1989,mcd-386,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1228,mcd-386,Alzheimer's disease,1,2005,discontinued,in trial,-,,
1990,metoclopramide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,758,evk-001,diabetic gastroparesis,3,2016,completed,in trial,-,,11752352|8730709|8230103|7745844|8981558|9876882|15835479
1991,metoclopramide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1355,mt 100,Anti-migraine,3,2005,completed,in trial,-,"received not approved letter from FDA in 2005, but mt-400 was approved",11752352|8730709|8230103|7745844|8981558|9876882|15835479
1992,metoclopramide,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,758,evk-001,diabetic gastroparesis,3,2016,completed,in trial,-,,17139284|17016423|16466463|15835479
1993,metoclopramide,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1355,mt 100,Anti-migraine,3,2005,completed,in trial,-,"received not approved letter from FDA in 2005, but mt-400 was approved",17139284|17016423|16466463|15835479
1994,mg01ci,small molecule,Aminergic ,antagonist,extended-release metadoxine,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0480,"mg01ci, extended-release metadoxine,",neurologic disorders; ADHD,3,2015,terminated,in trial,-,FDA clinical hold,
1995,milveterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1290,"milveterol. td-3327, gsk-159797",Bronchodilator,2,2005,discontinued,in trial,-,,
1996,min-001,small molecule,Aminergic ,agonist,cyr-101,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0202,"min-001,  cyr-101",schizophrenia,2,2009,completed,in trial,-,Can't find information if discontinued or not,
1997,min-117,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0204,min-117,Anti-depressant,2,2016,completed,in trial,-,,
1998,min-117,small molecule,Aminergic ,not available,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAapril2016_0206,min-117,Anti-depressant,2,2016,completed,in trial,-,,
1999,min-117,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0206,min-117,Anti-depressant,2,2016,completed,in trial,-,,
2000,min-117,small molecule,Aminergic ,not available,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAapril2016_0207,min-117,Anti-depressant,2,2016,completed,in trial,-,,
2001,min-202,small molecule,Peptide,antagonist,jnj-42847922,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,MMA2016_0029,"min-202, jnj-42847922",Anti-depressant and sleep disorder therapy,2,2015,completed,in trial,-,,
2002,mitemcinal,small molecule,Peptide,agonist,,primary,MLNR,mtlr_human,O43193,Class A (Rhodopsin),GPCR;Rhodopsin,Motilin receptors,not established,1296,"mitemcinal, gm-611",gastroparesis,2,2002,discontinued,in trial,-,,
2003,mk-0893,small molecule,Peptide,antagonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,ASH_Sep2016_333,mk-0893,Antidiabetic,2,2013,discontinued,in trial,-,,
2004,mkc-253,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1308,mkc-253,Antidiabetic,1,2008,discontinued,in trial,-,,
2005,mle4901,small molecule,Peptide,antagonist,azd4901,primary,TACR3,nk3r_human,P29371,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,not established,MMAapril2016_0263,"mle4901,  azd4901",for Polycystic Ovarian Syndrome,2,2016,ongoing,in trial,-,,
2006,mn-221,unknown,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1317,mn-221,Anti-Asthmatic,2,2008,completed,in trial,-,no information on next phase plans,
2007,mn-246,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1318,mn-246,overactive bladder,1,2010,discontinued,in trial,-,,
2008,mn-305,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1319,mn-305,Anti-depressant; hypnotic,2,2007,discontinued,in trial,-,,
2009,mod-6031,peptide,Peptide,agonist,long-acting oxyntomodulin,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0898,"mod-6031, long-acting oxyntomodulin",Antidiabetic ; Anti-obesity,1,2016,recruiting,in trial,-,,
2010,mod-6031,peptide,Peptide,agonist,long-acting oxyntomodulin,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0899,"mod-6031, long-acting oxyntomodulin",Antidiabetic ; Anti-obesity,1,2016,recruiting,in trial,-,,
2011,modimelanotide,protein,Peptide,agonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,ASH_Sep2016_259,modimelanotide,acute kidney injury,2,2013,discontinued,in trial,-,,
2012,modimelanotide,protein,Peptide,agonist,,primary,MC3R,mc3r_human,P41968,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,ASH_Sep2016_261,modimelanotide,acute kidney injury,2,2013,discontinued,in trial,-,,
2013,mogamulizumab,antibody,Protein,antagonist,,primary,CCR4,ccr4_human,P51679,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAjun2016_0001,mogamulizumab,Antineoplastic,3,2012,ongoing,in trial,-,,
2014,mogamulizumab,antibody,Protein,antagonist,,primary,CCR4,ccr4_human,P51679,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAjun2016_0001,mogamulizumab,Antineoplastic,3,2012,ongoing,in trial,-,,
2015,molindone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2425,"spn810 ,zalvari",ADHD,3,2016,recruiting,in trial,-,,17016423|9577836|9353417|9342550|11752352
2016,montelukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,1163,"loratadine + montelukast sodium,claritin + singulair",Anti-Asthmatic,3,2012,completed,in trial,-,FDA rejected combination form,15013935|15456537|16815057|16815146|17199874|11752352
2017,MOR107,peptide,Peptide,agonist,,primary,AGTR2,agtr2_human,P50052,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,not established,MMAaug2017_015,"LP2, MOR107",Diabetic Kidney Disease,1,2017,ongoing,in trial,-,,
2018,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1013,"intranasal morphine,rylomine",Analgesics,2,2008,completed,in trial,-,,16530171|16534251|16539674|16650582|16678156|11752352|12015197
2019,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1207,"m6g, cee 04-410",Analgesics,3,2008,completed,in trial,-,,16530171|16534251|16539674|16650582|16678156|11752352|12015197
2020,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1279,"mh-200, tak-453 sr, morphine hcl,anpec",Analgesics,3,2002,completed,in trial,-,,16530171|16534251|16539674|16650582|16678156|11752352|12015197
2021,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1335,"morphine/dextromethorphan,morphidex",Analgesics,3,2006,discontinued,in trial,-,,16530171|16534251|16539674|16650582|16678156|11752352|12015197
2022,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,2,2002,discontinued,in trial,-,,16530171|16534251|16539674|16650582|16678156|11752352|12015197
2023,morphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,,16530171|16534251|16539674|16650582|16678156|11752352|12015197
2024,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1013,"intranasal morphine,rylomine",Analgesics,2,2008,completed,in trial,-,,16530171|16580639|16580848|16682505|11752352
2025,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1207,"m6g, cee 04-410",Analgesics,3,2008,completed,in trial,-,,16530171|16580639|16580848|16682505|11752352
2026,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1279,"mh-200, tak-453 sr, morphine hcl,anpec",Analgesics,3,2002,completed,in trial,-,,16530171|16580639|16580848|16682505|11752352
2027,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1335,"morphine/dextromethorphan,morphidex",Analgesics,3,2006,discontinued,in trial,-,,16530171|16580639|16580848|16682505|11752352
2028,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,2,2002,discontinued,in trial,-,,16530171|16580639|16580848|16682505|11752352
2029,morphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,,16530171|16580639|16580848|16682505|11752352
2030,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1013,"intranasal morphine,rylomine",Analgesics,2,2008,completed,in trial,-,,17139284|17016423|9808678|7959748|16753266
2031,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1207,"m6g, cee 04-410",Analgesics,3,2008,completed,in trial,-,,17139284|17016423|9808678|7959748|16753266
2032,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1279,"mh-200, tak-453 sr, morphine hcl,anpec",Analgesics,3,2002,completed,in trial,-,,17139284|17016423|9808678|7959748|16753266
2033,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1335,"morphine/dextromethorphan,morphidex",Analgesics,3,2006,discontinued,in trial,-,,17139284|17016423|9808678|7959748|16753266
2034,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,2,2002,discontinued,in trial,-,,17139284|17016423|9808678|7959748|16753266
2035,morphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,,17139284|17016423|9808678|7959748|16753266
2036,mosapride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1337,"mosapride citrate, tak-370,gasmotin",Gastrointestinal reflux disease (GERD),3,2016,recruiting,in trial,-,"Not approved by the FDA, but in other countries for GERD. Trials for many other indications: diabetes, IBS",
2037,msx-122,small molecule,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1354,msx-122,Antineoplastic,1,2007,discontinued,in trial,-,,
2038,mt-1303,small molecule,Lipid ,antagonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMAmar2016_0211,mt-1303,autoimmune diseases; Multiple Sclerosis; Crohn's disease,2,2015,ongoing,in trial,-,,
2039,nabilone,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1812,sativex,Analgesics; neuropathic pain; restlegs legs syndrome,3,2014,recruiting,in trial,-,,11786493|17450170|17139494|15221424|11698062
2040,nabilone,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1812,sativex,Analgesics; neuropathic pain; restlegs legs syndrome,3,2014,recruiting,in trial,-,,17139494|11698062|8981483|10575283|8864542|11752352
2041,nalbuphine,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,2,2006,discontinued,in trial,-,,10844102|8388112|9084061|9399970|18425947|16517095|19403853|15602503|18810678|17407276
2042,nalbuphine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,2,2006,discontinued,in trial,-,,17139284|17016423|8388112|15655510|16517095|19403853|15602503|10534607|17407276
2043,nalbuphine,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,2,2006,discontinued,in trial,-,,8093631|2826773|11752352
2044,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,,11752352|15788780|17661275|17487229|9673788|9040115
2045,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,,11752352|15788780|17661275|17487229|9673788|9040115
2046,naltrexone,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching,11752352|15788780|17661275|17487229|9673788|9040115
2047,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,,11752352|18354714|9040115|17661275|19484223
2048,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,,11752352|18354714|9040115|17661275|19484223
2049,naltrexone,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching,11752352|18354714|9040115|17661275|19484223
2050,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,,11752352|19068776|18354714|17918759|17661275|17487229|9673788
2051,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,,11752352|19068776|18354714|17918759|17661275|17487229|9673788
2052,naltrexone,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching,11752352|19068776|18354714|17918759|17661275|17487229|9673788
2053,namacizumab,antibody,Lipid,NAM,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GpCR;Rhodopsin,Cannabinoid receptors,established,ASH_Jul2017_10,Namacizumab,Fibrosis,1,2017,ongoing,in trial,-,,
2054,naronapride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_41,naronapride,constipation,2,2009,completed,in trial,-,,
2055,nbi-42902,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,869,"gnrh receptor antagonist, nbi-42902",postmenopausal symptoms; Antineoplastic,2,2005,discontinued,in trial,-,,
2056,nbi-42902,small molecule,Peptide,antagonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,869,"gnrh receptor antagonist, nbi-42902",postmenopausal symptoms; Antineoplastic,2,2005,discontinued,in trial,-,,
2057,ncx 1510,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1390,"ncx 1510, ox-nla",Anti-Allergic,2,2009,completed,in trial,-,,
2058,ncx116,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,378,"bol-303259-x, ncx 116, pf-03187207, Latanoprostene bunod",Antiglaucomic,3,2013,ongoing,in trial,-,,
2059,nelotanserin,small molecule,Aminergic ,inverse agonist,apd-125,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0233,"nelotanserin, apd-125",dementia; Parkinson's disease,2,2016,recruiting,in trial,-,,
2060,nemifitide,peptide,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,983,"inn-00835, nemifitide",Anti-depressant,3,2010,discontinued,in trial,-,Dates approximate - difficult to get info,
2061,ngd-4715,small molecule,Peptide,antagonist,,primary,MCHR1,mchr1_human,Q99705,Class A (Rhodopsin),GPCR;Rhodopsin,Melanin-concentrating hormone,not established,1408,ngd-4715,Appetite suppressant,2,2008,discontinued,in trial,-,,
2062,ngx267,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1410,ngx267,dry mouth,2,2008,discontinued,in trial,-,,
2063,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,467,cer627,Antidyslipidaemic,1,2010,discontinued,in trial,-,,12522134|12646212|15580557|16018973|16099840
2064,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1300,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",Antidyslipidaemic,3,2011,discontinued,in trial,-,,12522134|12646212|15580557|16018973|16099840
2065,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1301,"mk-0542b, extended release niacin + laropiprant +simvastatin",Antidyslipidaemic,3,2011,discontinued,in trial,-,,12522134|12646212|15580557|16018973|16099840
2066,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",substance abuse deterrant,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010,12522134|12646212|15580557|16018973|16099840
2067,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,467,cer627,Antidyslipidaemic,1,2010,discontinued,in trial,-,,12563315|15929991|16018973|16099840|16322797|12522134
2068,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1300,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",Antidyslipidaemic,3,2011,discontinued,in trial,-,,12563315|15929991|16018973|16099840|16322797|12522134
2069,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1301,"mk-0542b, extended release niacin + laropiprant +simvastatin",Antidyslipidaemic,3,2011,discontinued,in trial,-,,12563315|15929991|16018973|16099840|16322797|12522134
2070,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",substance abuse deterrant,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010,12563315|15929991|16018973|16099840|16322797|12522134
2071,niacin receptor agonist,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1412,niacin receptor agonist,Anti-atherosclerotic,2,2009,discontinued,in trial,-,,
2072,niacin receptor agonist,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1412,niacin receptor agonist,Anti-atherosclerotic,2,2009,discontinued,in trial,-,,
2073,nktr-181,small molecule polymer conjugate,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1420,nktr-181,Analgesics,3,2015,ongoing,in trial,-,,
2074,nn9924,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1429,nn9924,Antidiabetic,3,2016,ongoing,in trial,-,,
2075,np2 enkephalin,viral gene delivery,Peptide,agonist,,primary,DOR,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2421,np2 enkephalin,Analgesics,2,2011,discontinued,in trial,-,,
2076,npsp795,small molecule,Ion ,antagonist,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,MMAmar2016_0202,npsp795,hypocalcaemia,2,2014,completed,in trial,-,,
2077,nrp290,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1444,nrp290,Analgesics,1,2006,discontinued,in trial,-,,
2078,nrp290,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1444,nrp290,Analgesics,1,2006,discontinued,in trial,-,,
2079,nrp290,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1444,nrp290,Analgesics,1,2006,discontinued,in trial,-,,
2080,nu206,protein,Orphan ,not available,,primary,LGR4,lgr4_human,Q9BXB1,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,2528,"nu206, r-spondin1",gastrointestinal disease,1,2006,discontinued,in trial,-,,
2081,nu206,protein,Orphan ,not available,,primary,LGR5,lgr5_human,O75473,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,2528,"nu206, r-spondin1",gastrointestinal disease,1,2006,discontinued,in trial,-,,
2082,nxn-188,small molecule,Aminergic ,antagonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1460,nxn-188,Anti-migraine,2,2009,discontinued,in trial,-,,
2083,nxn-188,small molecule,Aminergic ,antagonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1460,nxn-188,Anti-migraine,2,2009,discontinued,in trial,-,,
2084,obe001,small molecule,Peptide,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,MMAapril2016_0035,obe001,labor and delivery,3,2017,recruiting,in trial,-,,
2085,OBE2109,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,MMAaug2017_010,"OBE2109, KLH-2109",Endometriosis; Uterine fibroids,2,2017,ongoing,in trial,-,,
2086,obinepitide,small molecule,Peptide,agonist,,primary,NPY2R,npy2r_human,P49146,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,2027,"tm30338,obinepitide",Anti-obesity,2,2010,completed,in trial,-,Sweden,
2087,obinepitide,small molecule,Peptide,agonist,,primary,PPYR1,npy4r_human,P50391,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,2027,"tm30338,obinepitide",Anti-obesity,2,2010,completed,in trial,-,Sweden,
2088,oc000459 ,small molecule,Lipid ,antagonist,,primary,PD2R2,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,1466,oc000459,Anti-Allergic,2,2016,recruiting,in trial,-,,
2089,oc459,small molecule,Lipid ,antagonist,,primary,PD2R2,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,MMAmay2016_0684,oc459,for allergic rhinitis,2,2016,recruiting,in trial,-,,
2090,odelepran,small molecule,Peptide,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_263,odelepran,alcohol dependence,2,2008,discontinued,in trial,-,,
2091,odelepran,small molecule,Peptide,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_268,odelepran,alcohol dependence,2,2008,discontinued,in trial,-,,
2092,odelepran,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_275,odelepran,alcohol dependence,2,2008,discontinued,in trial,-,,
2093,opa-6566,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAmay2016_0512,opa-6566,Antiglaucomic,2,2011,completed,in trial,-,,
2094,opc-14523,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1662,"prs-013, opc-14523",Anti-depressant,2,2009,completed,in trial,-,No development reported,
2095,opc-28326,small molecule,Aminergic ,antagonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1501,opc-28326,vasodilator,2,2006,discontinued,in trial,-,,
2096,opc-28326,small molecule,Aminergic ,antagonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1501,opc-28326,vasodilator,2,2007,discontinued,in trial,-,,
2097,opc-51803,small molecule,Peptide,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1503,"opc-51803, sou-003",incontinence,2,2006,discontinued,in trial,-,,
2098,ordopidine,small molecule,Aminergic ,not available,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2422,acr325,Antiparkinson,1,2009,completed,in trial,-,mode of action termed a 'dopamine stabilizer',
2099,ormd-0901,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1519,"ormd-0901, oral glp-1 analog",Antidiabetic,1,2016,completed,in trial,-,,
2100,orvepitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,ASH_Sep2016_287,orvepitant,unipolar depression,2,2016,not open yet,in trial,-,Trials had been terminated in 2009 due to assessment of isolated events of seizure during program,
2101,ostabolin-c,peptide,Peptide,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1530,"ostabolin-c,  zt-031",Anti-osteoporotic,2,2008,discontinued,in trial,-,Change within company direction,
2102,ostabolin-c,peptide,Peptide,agonist,,primary,PTH2R,pth2r_human,P49190,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1530,"ostabolin-c,  zt-031",Anti-osteoporotic,2,2008,discontinued,in trial,-,Change within company direction,
2103,ot-730,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1533,ot-730,Antiglaucomic,2,2009,discontinued,in trial,-,,
2104,ot-730,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1533,ot-730,Antiglaucomic,2,2009,discontinued,in trial,-,,
2105,OTSA-101-DTPA-90Y,antibody,Protein,antagonist,Yttrium,primary,FZD10,fzd10_human,Q9ULW2,Class A (Rhodopsin),GpCR;Rhodopsin,Frizzled,not established,ASH_Jul2017_05,OTSA101DTPA90Y,Antineoplastic,1,2017,ongoing,in trial,-,,
2106,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2351,dr-3001,incontinence,3,2013,discontinued,in trial,-,,15963006|16188951|19446545|20590605|17222678
2107,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2351,dr-3001,incontinence,3,2013,discontinued,in trial,-,,17139284|17016423|19275276|19446545|20590605|17222678|16406943|11752352
2108,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2351,dr-3001,incontinence,3,2013,discontinued,in trial,-,,17139284|17016423|20590605|17222678|16406943
2109,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,696,"eli-154, oxycodone (once daily)",Analgesics,2,2012,discontinued,in trial,-,,17525040|11752352
2110,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,,17525040|11752352
2111,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",Analgesics,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010,17525040|11752352
2112,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1547,"oxycodone, pti-821,remoxy",Analgesics,3,2016,completed,in trial,-,waiting for FDA approval,17525040|11752352
2113,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching,17525040|11752352
2114,oxycodone,small molecule,Peptide,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0079,"rexista, oxycodone xr",Analgesics,3,2016,completed,in trial,-,waiting for new FDA approval,17525040|11752352
2115,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,696,"eli-154, oxycodone (once daily)",Analgesics,2,2012,discontinued,in trial,-,,17525040|18039433|17467904
2116,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,,17525040|18039433|17467904
2117,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",Analgesics,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010,17525040|18039433|17467904
2118,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1547,"oxycodone, pti-821,remoxy",Analgesics,3,2016,completed,in trial,-,waiting for FDA approval,17525040|18039433|17467904
2119,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching,17525040|18039433|17467904
2120,oxycodone,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0080,"rexista, oxycodone xr",Analgesics,3,2016,completed,in trial,-,waiting for new FDA approval,17525040|18039433|17467904
2121,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,696,"eli-154, oxycodone (once daily)",Analgesics,2,2012,discontinued,in trial,-,,17525040|18039433|19474215
2122,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,,17525040|18039433|19474215
2123,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",Analgesics,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010,17525040|18039433|19474215
2124,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1547,"oxycodone, pti-821,remoxy",Analgesics,3,2016,completed,in trial,-,waiting for FDA approval,17525040|18039433|19474215
2125,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching,17525040|18039433|19474215
2126,oxycodone,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0078,"rexista, oxycodone xr",Analgesics,3,2016,completed,in trial,-,waiting for new FDA approval,17525040|18039433|19474215
2127,ozanimod,small molecule,Lipid ,agonist,rpc1063,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,1790,rpc1063,Multiple Sclerosis,3,2017,completed,in trial,-,,
2128,ozarelix,peptide,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1891,"spi-153, d-63153,ozarelix",Antineoplastic,2,2010,discontinued,in trial,-,,
2129,ozarelix,peptide,Peptide,antagonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1891,"spi-153, d-63153,ozarelix",Antineoplastic,2,2010,discontinued,in trial,-,,
2130,p2045,peptide,Peptide,agonist,188re-p2045,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAmay2016_0746,"p2045, 188re-p2045",Antineoplastic,1,2014,withdrawn,in trial,-,Withdrawn due to PI left study institution; had 10 year break in research,
2131,pa-401,protein,Protein,antagonist,,primary,CXCR1,cxcr1_human,P25024,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1553,"pa-401, pa04-001",Anti-inflammatory ; immunosuppressant,1,2012,discontinued,in trial,-,,
2132,pa-401,protein,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1553,"pa-401, pa04-001",Anti-inflammatory ; immunosuppressant,1,2012,discontinued,in trial,-,,
2133,pardoprunox,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,,
2134,pardoprunox,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,,
2135,pardoprunox,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,,
2136,pb1023,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1569,"pb1023, glp-1-elp-120,glymera",Antidiabetic,2,2012,completed,in trial,-,,
2137,pbf-509,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAapril2016_0077,pbf-509,Antineoplastic,2,2015,recruiting,in trial,-,,
2138,pbf-680,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAmar2016_0115,pbf-680,Anti-Asthmatic,2,2015,recruiting,in trial,-,,
2139,pbf-999,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAapril2016_0022,pbf-999,Huntington's disease,1,2016,terminated,in trial,-,Terminated due to change in therapeutic indication,
2140,pd-6735,small molecule,Melatonin ,agonist,tik-301,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1575,"pd-6735, ly-156735, tik-301",Hypnotics and Sedatives,2,2004,completed,in trial,-,May still be researched,
2141,pd-6735,small molecule,Melatonin ,agonist,tik-301,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1575,"pd-6735, ly-156735, tik-301",Hypnotics and Sedatives,2,2004,completed,in trial,-,May still be researched,
2142,pdc31,peptide,Lipid ,antagonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0526,pdc31,pre-term labor; dysmenorrhea,1,2010,completed,in trial,-,,
2143,peptide yy,peptide,Peptide,agonist,,primary,NPY2R,npy2r_human,P49146,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,699,eligen pyy-3-36 + glp-1,Appetite suppressant,1,2009,completed,in trial,-,endogenous ligand,
2144,pexacerfont,small molecule,Peptide,antagonist,,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,ASH_Sep2016_331,pexacerfont,anxiety,3,2008,discontinued,in trial,-,,
2145,pf-00610355,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1591,pf-00610355,Bronchodilator,2,2009,discontinued,in trial,-,,
2146,pf-03654746,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_245,pf-03654746,allergic rhinitis,2,2011,discontinued,in trial,-,,
2147,pf-03654764,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_244,pf-03654764,allergic rhinitis,2,2009,discontinued,in trial,-,,
2148,pf-05212377,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_45,pf-05212377,Alzheimer's disease,2,2012,terminated,in trial,-,Terminated not due to safety concerns - may still be viable drug to investigate,
2149,piclozotan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_3,piclozotan,stroke,2,2008,discontinued,in trial,-,,
2150,pitolisant,small molecule,Aminergic ,inverse agonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_242,pitolisant,Antiparkinson,3,2016,not open yet,in trial,-,,
2151,plozalizumab,antibody,Protein,antagonist,MLN-1202,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1310,mln-1202,Anti-inflammatory ; DMARD; Diabetic neophropathy,2,2009,discontinued,in trial,-,,
2152,plozalizumab,antibody,Protein,antagonist,MLN-1202,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1310,mln-1202,Antineoplastic,2,2015,completed,in trial,-,added entry - new indication,
2153,ponesimod,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,1630,ponesimod,Anti-inflammatory ; multiple sclerosis,3,2016,recruiting,in trial,-,,
2154,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmar2016_0005,p2b001,Antiparkinson,3,2016,ongoing,in trial,-,,11752352|18691132
2155,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmar2016_0004,p2b001,Antiparkinson,3,2016,ongoing,in trial,-,,11752352|18691132|10641988
2156,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmar2016_0006,p2b001,Antiparkinson,3,2016,ongoing,in trial,-,,11752352|18691132|10641988
2157,preladenant,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1645,"preladenant, sch-420814",Antiparkinson,3,2011,discontinued,in trial,-,,
2158,pridopidine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1647,"pridopidine, acr-16,huntexil",Huntington's disease,3,2008,completed,in trial,-,Needs another Phase 3 trial before FDA considers approval,
2159,pro 140,antibody,Protein,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1649,pro 140,antiviral ; HIV,3,2016,recruiting,in trial,-,,
2160,procaterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD459,-,Bronchodilator,3,2015,recruiting,in trial,-,,12428391|15069780|1682484|1684063|1968366|11752352
2161,prochlorperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,301,"az-001, staccato prochlorperazine",Anti-migraine,2,2016,recruiting,in trial,-,,11752352|16677982|2527092|17044574|18534808|18955042|17169748
2162,promethazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAapril2016_0105,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,completed,in trial,-,,11752352|12657913|8098142|2576052|3011460|9442829|2866055
2163,prs-211375,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,429,cannabinor,Analgesics,2,2007,discontinued,in trial,-,,
2164,prx-00023,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1666,"prx-00023, Naluzotan",Anti-depressant,3,2011,discontinued,in trial,-,,
2165,prx-07034,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1667,prx-07034,Anti-obesity ; nootropic,1,2007,completed,in trial,-,Sold to undisclosed company in 2009,
2166,prx-08066,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1668,prx-08066,Antihypertensive,2,2008,completed,in trial,-,,
2167,prx-3140,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1671,prx-3140,Alzheimer's disease,2,2013,completed,in trial,-,,
2168,ps433540,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1673,ps433540,"Focal segmental glomerulosclerosis, Antihypertensive",2,2012,recruiting,in trial,-,,
2169,ps433540,small molecule,Peptide,antagonist,,primary,AGTR2,agtr2_human,P50052,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,not established,1673,ps433540,"Focal segmental glomerulosclerosis, Antihypertensive",2,2012,recruiting,in trial,-,,
2170,ps433540,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1673,ps433540,"Focal segmental glomerulosclerosis, Antihypertensive",2,2012,recruiting,in trial,-,,
2171,psd-506,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1676,psd-506,overactive bladder,2,2009,discontinued,in trial,-,,
2172,psd-506,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1676,psd-506,overactive bladder,2,2009,discontinued,in trial,-,,
2173,psn602,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1678,psn602,Anti-obesity,1,2009,discontinued,in trial,-,,
2174,psn821,small molecule,Lipid ,agonist,,primary,GPR119,gp119_human,Q8TDV5,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,1679,psn821,Antidiabetic,2,2011,discontinued,in trial,-,,
2175,PTH analog,small molecule,Peptide,agonist,768974,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,10,"768974, parathyroid hormone analog",Anti-osteoporotic,2,2011,discontinued,in trial,-,,
2176,pti-202,unknown,Peptide,not available,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1684,pti-202,Analgesics,1,2006,completed,in trial,-,Not good information - may have changed names within Pain Therapeutics,
2177,pti-202,unknown,Peptide,not available,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1684,pti-202,Analgesics,1,2006,completed,in trial,-,Not good information - may have changed names within Pain Therapeutics,
2178,pti-202,unknown,Peptide,not available,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1684,pti-202,Analgesics,1,2006,completed,in trial,-,Not good information - may have changed names within Pain Therapeutics,
2179,PTR-36,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,MMAaug2017_009,ADC3680B; PTR-36,Anti-Asthmatic,2,2017,ongoing,in trial,-,,
2180,pw2101,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1690,pw2101,Antihypertensive,1,2005,discontinued,in trial,-,,
2181,pxt002331,small molecule,Amino acid ,PAM,,primary,GRM4,grm4_human,Q14833,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmay2016_0906,pxt002331,Antiparkinson,1,2015,completed,in trial,-,,
2182,q-122,small molecule,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAmar2016_0157,q-122,Anti-inflammatory ; hot flashes,1,2014,completed,in trial,-,,
2183,ralinepag,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,ASH_Sep2016_314,"ralinepag, APD-811",Antihypertensive,2,2014,recruiting,in trial,-,,
2184,re-021,small molecule,Peptide,antagonist,sparsentan,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMAapril2016_0044,"re-021, sparsentan",kidney disease; nephropathy,2,2012,completed,in trial,-,,
2185,re-021,small molecule,Peptide,antagonist,sparsentan,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,MMAapril2016_0045,"re-021, sparsentan",kidney disease; nephropathy,2,2012,completed,in trial,-,,
2186,relugolix,small molecule,Peptide,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Sep2016_258,relugolix,endometriosis,3,2017,recruiting,in trial,-,,
2187,remd-477,antibody,Peptide,antagonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAapril2016_0214,remd-477,Antidiabetic,2,2017,recruiting,in trial,-,,
2188,renzapride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1734,renzapride,irritable bowel syndrome,3,2008,discontinued,in trial,-,Terminated due to insufficient over placebo in study,1364818
2189,renzapride,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1734,renzapride,irritable bowel syndrome,3,2008,discontinued,in trial,-,Terminated due to insufficient over placebo in study,
2190,reparixin,small molecule,Protein,antagonist,,primary,CXCR1,cxcr1_human,P25024,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAmay2016_0551,reparixin,Antidiabetic; type I diabetes,3,2013,ongoing,in trial,-,,
2191,reparixin,small molecule,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAmay2016_0552,reparixin,Antidiabetic; type I diabetes,3,2013,ongoing,in trial,-,,
2192,retosiban,small molecule,Peptide,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Sep2016_289,retosiban,premature birth,3,2015,recruiting,in trial,-,,
2193,rev131,small molecule,Aminergic ,antagonist,,primary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1745,rev131,Anti-Allergic,2,2006,discontinued,in trial,-,,
2194,rg1068,peptide,Peptide,agonist,,primary,SCTR,sctr_human,P47872,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1749,"rg1068, synthetic secretin,secreflo","autism, schizophrenia",3,2004,discontinued,in trial,-,,
2195,rimegepant,small molecule,Peptide,antagonist,,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,ASH_Sep2016_329,rimegepant,Anti-migraine,2,2011,discontinued,in trial,-,,
2196,rm-493,peptide,Peptide,agonist,setmelanotide,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,MMAmay2016_0229,"rm-493, setmelanotide",Anti-obesity,3,2017,recruiting,in trial,-,,
2197,ro4917523,small molecule,Amino acid ,antagonist,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,MMAmay2016_0177,ro4917523,"Major depressive disorder, Fragile X syndrome",2,2012,discontinued,in trial,-,discontinued due to negative results,
2198,rolofylline,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1780,"rolofylline, mk-7418, kw-3902",congestive heart failure,3,2007,discontinued,in trial,-,,
2199,ronacaleret,small molecule,Ion ,antagonist,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,1782,"ronacaleret, 751689",Anti-osteoporotic,2,2007,discontinued,in trial,-,discontinued due to lack of evidence of efficacy,21593114
2200,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1057,jzp-7,restless legs syndrome,1,2008,discontinued,in trial,-,,11752352|1683559|10446316|18691132|10641988|17573046
2201,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1057,jzp-7,restless legs syndrome,1,2008,discontinued,in trial,-,,11752352|18691132|10641988
2202,rusalatide,peptide,Peptide,agonist,,primary,F2R,par1_human,P25116,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2048,"tp-508,chrysalin",diabetic foot ulcers,3,2005,discontinued,in trial,-,,
2203,rusalatide,peptide,Peptide,agonist,,primary,F2RL2,par3_human,O00254,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2048,"tp-508,chrysalin",diabetic foot ulcers,3,2005,discontinued,in trial,-,,
2204,rusalatide,peptide,Peptide,agonist,,primary,F2RL3,par4_human,Q96RI0,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2048,"tp-508,chrysalin",diabetic foot ulcers,3,2005,discontinued,in trial,-,,
2205,rvt-101,small molecule,Aminergic ,antagonist,"sb-742457,  gsk 742457",primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0106,"rvt-101, sb-742457, gsk 742457",Alzheimer's disease,3,2015,ongoing,in trial,-,,
2206,rx-10045,small molecule,Protein,agonist,,primary,CMKLR1,cml1_human,Q99788,Class A (Rhodopsin),GPCR;Rhodopsin,Chemerin receptor,not established,2317,rx-10045,dry eye,2,2014,completed,in trial,-,,
2207,rx-10045,small molecule,Lipid ,partial agonist,,primary,LTB4R,lt4r1_human,Q15722,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,not established,2317,rx-10045,dry eye,2,2014,completed,in trial,-,,
2208,ryi-018,antibody,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0280,ryi-018,liver disease; nonalcoholic steatohepatitis,1,2017,not open yet,in trial,-,,
2209,samidoprhan,small molecule,Peptide,antagonist,,primary,MOR,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,APR13_0013,alks 3831,addiction,3,2016,recruiting,in trial,-,,
2210,saprisartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD489,-,Antihypertensive,2,1997,discontinued,in trial,-,,10579749|11752352
2211,saredutant,small molecule,Peptide,antagonist,,primary,TACR2,nk2r_human,P21452,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,not established,1810,"saredutant, sr 48968",Anti-depressant,3,2006,discontinued,in trial,-,Sanofi-aventis discontinued due to reprioritization of RD portfolio,
2212,sb-649868,small molecule,Peptide,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,ASH_Sep2016_277,sb-649868,insomnia,2,2007,completed,in trial,-,Suspected discontinued,
2213,sb-649868,small molecule,Peptide,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,ASH_Sep2016_279,sb-649868,insomnia,2,2007,completed,in trial,-,Suspected discontinued,
2214,sch-527123,small molecule,Protein,antagonist,,primary,CXCR1,cxcr1_human,P25024,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1822,"sch-527123, ps-291822, ps-938285, navarixin",chronic obstructive pulmonary disease (COPD),2,2009,discontinued,in trial,-,,
2215,sch-527123,small molecule,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1822,"sch-527123, ps-291822, ps-938285, navarixin",chronic obstructive pulmonary disease (COPD),2,2009,discontinued,in trial,-,,
2216,selepressin,protein,Peptide,agonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Sep2016_288,selepressin,septic shock,3,2015,recruiting,in trial,-,,
2217,semaglutide,peptide,Peptide,agonist,nn9535,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0563,"semaglutide, nn9535 ",Antidiabetic,3,2017,recruiting,in trial,-,,
2218,sens-111,small molecule,Aminergic ,antagonist,,primary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAapril2016_0282,sens-111,for vertigo and tinnitus,3,2017,recruiting,in trial,-,,
2219,SEP-363856,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,MMAaug2017_003,SEP-363856,Antiparkinson; Schizophrenia; Psychosis,2,2016,completed,in trial,-,,
2220,SEP-363856,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAaug2017_004,SEP-363857,Antiparkinson; Schizophrenia; Psychosis,2,2016,completed,in trial,-,,
2221,ser100,small molecule,Peptide,agonist,,primary,OPRL1,oprx_human,P41146,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,not established,MMAmay2016_0735,ser100,Antihypertensive,2,2013,completed,in trial,-,,
2222,serelaxin,peptide,Peptide,agonist,,primary,RXFP1,rxfp1_human,Q9HBX9,Class A (Rhodopsin),GPCR;Rhodopsin,Relaxin receptors,not established,MMA_2017_003,"serelaxin, relaxin, RLX-030A, SUN-Y8002",Heart failure therapies,3,2014,completed,in trial,-,fda refused approval,
2223,serelaxin,peptide,Peptide,agonist,,primary,RXFP2,rxfp2_human,Q8WXD0,Class A (Rhodopsin),GPCR;Rhodopsin,Relaxin receptors,not established,MMA_2017_005,"serelaxin, relaxin, RLX-030A, SUN-Y8002",Heart failure therapies,3,2014,completed,in trial,-,fda refused approval,
2224,setipiprant,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_309,setipiprant,seasonal allergic rhinitis,3,2016,recruiting,in trial,-,,
2225,siponimod,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,ASH_Sep2016_304,siponimod,chronic progressive multiple sclerosis,3,2014,ongoing,in trial,-,,
2226,SL 650472,small molecule,Aminergic ,antagonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2074,"trelanserin, sl 65.0472",intermittent claudication,2,2006,discontinued,in trial,-,,
2227,SL 650472,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2074,"trelanserin, sl 65.0472",intermittent claudication,2,2006,discontinued,in trial,-,,
2228,sofpironium bromide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0805,bbi-4000,Anticholinergics; for thetopical treatment of primary axillary hyperhidrosis,2,2017,recruiting,in trial,-,,
2229,solabegron,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1874,"solabegron, gw 427353",Antidiabetic; irritable bowel syndrome; incontinence,1,2016,recruiting,in trial,-,"Had Phase 2 trials for IBS and overactive bladder in 2007, but now after 10 year break clinical trials starting again",18372395
2230,sou-001,small molecule,Aminergic ,not available,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1881,"sou-001, drp-001",incontinence,2,2006,discontinued,in trial,-,,
2231,sou-001,small molecule,Aminergic ,not available,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1881,"sou-001, drp-001",incontinence,2,2006,discontinued,in trial,-,,
2232,sou-001,small molecule,Aminergic ,not available,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1881,"sou-001, drp-001",incontinence,2,2006,discontinued,in trial,-,,
2233,spi-1620,peptide,Peptide,agonist,,primary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1892,spi-1620,adjuvant to chemotherapy,2,2013,discontinued,in trial,-,,
2234,strontium ranelate,small molecule,Ion ,agonist,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,1905,"strontium ranelate, s12911",Anti-osteoporotic,3,2015,completed,in trial,-,European trials and marketed,
2235,stx107,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,1906,stx107,Fragile X syndrome,2,2011,completed,in trial,-,,
2236,sufentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,243,"arx-03, sufentanil + triazolam nanotab",Analgesics; adjuvant to anesthesia,2,2011,suspended,in trial,-,,11299311|1688220|2847746|3014923|6131653|11752352
2237,sufentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1909,"sufentanil transdermal patch,transdur-sufentanil",Analgesics,2,2015,discontinued,in trial,-,,11299311|1688220|2847746|3014923|6131653|11752352
2238,sufentanil,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1910,"sufentanil,chronogesic",Analgesics,2,2015,discontinued,in trial,-,,11299311|1688220|2847746|3014923|6131653|11752352
2239,sulpiride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD504,-,Antidepressive ; Second-Generation; Antipsychotic,3,2016,recruiting,in trial,-,Not FDA approved but used in other countries,12010185|7518029|11752352
2240,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0106,"cl-h1t, promethazine + sumatriptan",Anti-migraine,3,2013,completed,in trial,-,,11513839
2241,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0109,"cl-h1t, promethazine + sumatriptan",Anti-migraine,3,2013,completed,in trial,-,,10073743|10367177|11015308|15178373|11752352|10225363|18723285|12110114
2242,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0108,"cl-h1t, promethazine + sumatriptan",Anti-migraine,3,2013,completed,in trial,-,,10101238|10225363|10454495|10458598|10513577|11752352|11874390|12010765|10772044|18723285|12110114
2243,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0107,"cl-h1t, promethazine + sumatriptan",Anti-migraine,3,2013,completed,in trial,-,,11313163|11641558|11874390|12010765|15554784|11752352|10225363|10454495|10772044|18723285|12110114
2244,surinabant,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1917,"surinabant, sr 147778","smoking-cessation, obesity",2,2007,discontinued,in trial,-,,
2245,suvn-502,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1920,suvn-502,Alzheimer's disease,2,2015,recruiting,in trial,-,,
2246,suvn-d4010,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0094,suvn-d4010,Alzheimer's disease,1,2017,recruiting,in trial,-,,
2247,suvn-g3031,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmar2016_0093,suvn-g3031,Alzheimer's disease,1,2016,recruiting,in trial,-,,
2248,svt-40776,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1921,"svt-40776, tarafenacin",incontinence,2,2011,completed,in trial,-,,
2249,syl040012,sirna,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1922,"syl040012, Bamosiran",Antiglaucomic,2,2014,completed,in trial,-,,
2250,syn120,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0309,"syn120, Landipirdine",cognitive disorders,2,2014,completed,in trial,-,,
2251,syn120,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0310,"syn120, Landipirdine",cognitive disorders,2,2014,completed,in trial,-,,
2252,t111,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAmay2016_0579,"t111, Nalbuphine extended release",pruritus,3,2014,ongoing,in trial,-,,
2253,t-62,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1930,t-62,Analgesics,2,2008,discontinued,in trial,-,"discontinued because patients experienced asymptomatic, transient elevations in liver transaminases",
2254,tak-441,small molecule,Protein,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,ASH_Sep2016_344,tak-441,basal cell carcinoma,1,2010,discontinued,in trial,-,,
2255,tak-875,small molecule,Lipid ,agonist,fasiglifam,primary,FFAR1,ffar1_human,O14842,Class A (Rhodopsin),GPCR;Rhodopsin,Free fatty acid receptors,not established,MMAmay2016_0580,"tak-875, fasiglifam",Antidiabetic,3,2013,discontinued,in trial,-,discontinued due to concerns about liver safety,
2256,taladegib,small molecule,Protein,antagonist,ly2940680,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,MMAmar2016_0177,"taladegib, ly2940680",Antineoplastic,2,2015,recruiting,in trial,-,,
2257,talnetant,small molecule,Peptide,antagonist,,primary,TACR3,nk3r_human,P29371,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,not established,1943,"talnetant, sb 223412",schizophrenia,2,2006,discontinued,in trial,-,,
2258,taranabant,small molecule,Lipid ,inverse agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1952,"taranabant, mk-0364",Anti-obesity ; smoking-cessation,3,2007,discontinued,in trial,-,discontinued because overall profile does not support development for obesity,
2259,tasosartan,small molecule,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD509,-,Antihypertensive,3,2000,discontinued,in trial,-,Disontinued due to safety profile,12113820|11683476|11046101|11752352
2260,taspoglutide,protein,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1958,"taspoglutide, itm-077, r1583, bim-51077",Antidiabetic,3,2011,discontinued,in trial,-,discontinued due to adverse gastrointestinal reactions,
2261,tbr-652,small molecule,Protein,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1962,"tbr-652, tak-652, Cenicriviroc",antiviral ; HIV; Nonalcoholic Steatohepatitis,3,2017,recruiting,in trial,-,,
2262,td-1211,small molecule,Peptide,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1971,"td-1211, Axelopran",opioid-induced gastrointestinal side-effects,2,2012,completed,in trial,-,,
2263,td-2749,unknown,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1972,td-2749,motilitant,1,2005,discontinued,in trial,-,,
2264,td-4208,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0081,"td-4208, Revefenacin",chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,,
2265,tecadenoson,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1973,tecadenoson,Anti-Arrhythmia,3,2009,discontinued,in trial,-,,16230891|15956124|13678937
2266,tedatioxetine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1173,lu aa24530,Anti-depressant,2,2009,discontinued,in trial,-,discontinued for strategic reasons,
2267,tedatioxetine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1173,lu aa24530,Anti-depressant,2,2009,discontinued,in trial,-,discontinued for strategic reasons,
2268,telcagepant,small molecule,Peptide,antagonist,,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,ASH_Sep2016_326,telcagepant,Anti-migraine,3,2008,discontinued,in trial,-,,
2269,temanogrel,small molecule,Aminergic ,inverse agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_24,temanogrel,acute coronary syndrome,1,2015,unknown,in trial,-,,
2270,terguride,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1981,terguride,"Diffuse cutaneous systemic sclerosis, Antihypertensive",3,2016,ongoing,in trial,-,Difficult to get info; 10 year break before investigating again in Europe,
2271,terguride,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1981,terguride,"Diffuse cutaneous systemic sclerosis, Antihypertensive",3,2016,ongoing,in trial,-,Difficult to get info; 10 year break before investigating again in Europe,
2272,tetrahydrocannabivarin (thcv),small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0329,"gwp42004, Tetrahydrocannabivarin-9",Antidiabetic,2,2014,completed,in trial,-,,
2273,tezosentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Sep2016_251,tezosentan,heart failure,3,2006,discontinued,in trial,-,,
2274,tezosentan,small molecule,Peptide,antagonist,,primary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Sep2016_252,tezosentan,heart failure,3,2006,discontinued,in trial,-,,
2275,tg-0054,small molecule,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,2002,"tg-0054, Burixafor",adjuvant to stem cell transplantation,2,2014,completed,in trial,-,,
2276,th0318,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2008,th0318,Antidiabetic,1,2004,discontinued,in trial,-,,
2277,THC:CBD,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_007,"PTL 201, Cannabidiol/tetrahydrocannabinol",Multiple Sclerosis,2,2016,ongoing,in trial,-,,
2278,THC:CBD,small molecule,Lipid ,antagonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_008,"PTL 201, Cannabidiol/tetrahydrocannabinol",Multiple Sclerosis,2,2016,ongoing,in trial,-,,
2279,tm30339,small molecule,Peptide,agonist,,primary,PPYR1,npy4r_human,P50391,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,2028,tm30339,Anti-obesity,2,2008,discontinued,in trial,-,,
2280,tm38837,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,2029,tm38837,Anti-obesity,1,2013,completed,in trial,-,,
2281,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,completed,in trial,-,,11752352|14769832|19168050|11193006
2282,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,completed,in trial,-,,16188951|14769832|19168050|11193006
2283,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,completed,in trial,-,,17139284|17016423|14769832
2284,tonabersat,small molecule,Aminergic ,antagonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2038,tonabersat,Anti-migraine,2,2007,discontinued,in trial,-,,
2285,toreforant,small molecule,Aminergic ,antagonist,,primary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_247,toreforant,Anti-Asthmatic,2,2014,completed,in trial,-,,
2286,tozadenant,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1926,syn-115,Antiparkinson,3,2017,not open yet,in trial,-,,
2287,tpi-asm8,antisense oligo,Protein,antagonist,,primary,CCR3,ccr3_human,P51677,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,2049,tpi-asm8,Anti-Asthmatic,2,2010,discontinued,in trial,-,,
2288,trabodenoson,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMA_CLDATES_0363,trabodenoson and latanoprost,Antiglaucomic,2,2016,completed,in trial,-,,
2289,tradipitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,ASH_Sep2016_286,tradipitant,alcohol dependence,2,2016,recruiting,in trial,-,,
2290,tramadol,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,,12570923
2291,tramadol,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0679,e-58425,Analgesics,3,2017,recruiting,in trial,-,,12570923
2292,tramadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,,10961373|10991912|1309873|15509185|16793069|11752352|17380034|8955860
2293,tramadol,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0678,e-58425,Analgesics,3,2017,recruiting,in trial,-,,10961373|10991912|1309873|15509185|16793069|11752352|17380034|8955860
2294,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,,15105221|16679816
2295,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0676,e-58425,Analgesics,3,2017,recruiting,in trial,-,,15105221|16679816
2296,trospium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2350,alks 27,chronic obstructive pulmonary disease (COPD),2,2007,discontinued,in trial,-,,17139284|17016423
2297,trv120027,protein,Peptide,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,2279,trv120027,Antihypertensive,2,2013,recruiting,in trial,-,,
2298,trv130,small molecule,Peptide,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0607,"trv130, Oliceridine",Analgesics; post-operative pain,3,2016,recruiting,in trial,-,,
2299,trv734,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0140,trv734,Analgesics,1,2015,completed,in trial,-,,
2300,ts-032,unknown,Amino acid ,agonist,pf-4802540,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,2090,"ts-032, pf-4802540",schizophrenia,1,2008,discontinued,in trial,-,,
2301,ts-032,unknown,Amino acid ,agonist,pf-4802540,primary,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,2090,"ts-032, pf-4802540",schizophrenia,1,2008,discontinued,in trial,-,,
2302,tt-223,injectible islet neogenesis therapy,Peptide,agonist,,primary,CCKBR,gasr_human,P32239,Class A (Rhodopsin),GPCR;Rhodopsin,Cholecystokinin receptors,established,2092,tt-223,Antidiabetic; injectable islet neogenesis therapy for diabetes,2,2008,discontinued,in trial,-,,
2303,tt-223,injectible islet neogenesis therapy,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2092,tt-223,Antidiabetic; injectable islet neogenesis therapy for diabetes,2,2008,discontinued,in trial,-,,
2304,tt-401,peptide,Peptide,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0612,"tt-401, Pegapamodutide, LY2944876",Antidiabetic,2,2014,completed,in trial,-,,
2305,tt-401,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0613,"tt-401, Pegapamodutide, LY2944876",Antidiabetic,2,2014,completed,in trial,-,,
2306,ttp054,small molecule,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0113,ttp054,Antidiabetic,2,2012,discontinued,in trial,-,,
2307,ttp273,small molecule,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmar2016_0255,ttp273,Antidiabetic,2,2016,completed,in trial,-,,
2308,txa127,peptide,Orphan ,agonist,angiotensin(1-7),primary,MAS1,mas_human,P04201,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,MMAmay2016_0617,"txa127, angiotensin (1-7)",for stem cell engraftment and thrombocytopenia,2,2012,discontinued,in trial,-,,
2309,txa127,peptide,Orphan ,agonist,angiotensin(1-7),primary,MAS1,mas_human,P04201,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,MMAmay2016_0617,"txa127, angiotensin (1-7)","Non-HodgkinHodgkin Disease, Multiple Myeloma",2,2016,ongoing,in trial,-,,
2310,tzp-102,small molecule,Peptide,agonist,,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,2096,tzp-102,gastroparesis,2,2012,terminated,in trial,-,Clinical trial terminated due to Insufficient efficacy in planned interim futility analysis; no development reported on drug itself,
2311,ubrogepant,small molecule,Peptide,antagonist,,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,ASH_Sep2016_327,ubrogepant,Anti-migraine,3,2016,recruiting,in trial,-,,
2312,ulimorelin,small molecule,Peptide,agonist,,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,2095,"tzp-101, Ulimorelin",gastroparesis,2,2016,recruiting,in trial,-,,17436082
2313,ulocuplumab,antibody,Protein,antagonist,bms 936564,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,369,"bms 936564, mdx-1338",Antineoplastic,3,2017,ongoing,in trial,-,"discontinued for sole intervention, now in combination trials",
2314,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmar2016_0193,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",chronic obstructive pulmonary disease (COPD),3,2016,ongoing,in trial,-,,23435542
2315,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmar2016_0194,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",chronic obstructive pulmonary disease (COPD),3,2016,ongoing,in trial,-,,23435542
2316,urocortin 2,peptide,Peptide,agonist,,primary,CRHR2,crfr2_human,Q13324,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,2105,"urocortin 2, 358-086-15",congestive heart failure,2,2012,discontinued,in trial,-,,
2317,v24343,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,2112,v24343,Anti-obesity,1,2008,discontinued,in trial,-,,
2318,v81444,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAmay2016_0766,"v81444, CPI 444",Antiparkinson,2,2014,completed,in trial,-,,
2319,va106483,small molecule,Peptide,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2115,"va106483, Fedovapagon",BPH-related urinary symptoms,3,2015,recruiting,in trial,-,,
2320,va111913,small molecule,Peptide,antagonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2116,va111913,dysmenorrhea,2,2010,completed,in trial,-,,
2321,vabicaserin,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_39,vabicaserin,schizophrenia,2,2008,discontinued,in trial,-,,
2322,vantictumab,antibody,Protein,antagonist,omp-18r5,primary,FZD7,fzd7_human,O75084,Class F (Frizzled),GPCR;Frizzled,Frizzled,not established,2457,omp-18r5,Antineoplastic,1,2013,ongoing,in trial,-,,
2323,vapitadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,2123,"vapitadine dihydrochloride,hivenyl","Anti-Allergic, pruritus",2,2006,completed,in trial,-,No development reported,
2324,vasoactive intestinal peptide,peptide,Peptide,antagonist,,primary,VIPR1,vipr1_human,P32241,Class B1 (Secretin),GPCR;Secretin,VIP and PACAP receptors,not established,288,"aviptadil,invicorp",sexual dysfunction,3,2016,completed,in trial,-,Difficult to get info; trials in Europe,
2325,vasoactive intestinal peptide,peptide,Peptide,antagonist,,primary,VIPR2,vipr2_human,P41587,Class B1 (Secretin),GPCR;Rhodopsin,VIP and PACAP receptors,not established,288,"aviptadil,invicorp",sexual dysfunction,3,2016,completed,in trial,-,Difficult to get info; trials in Europe,
2326,vasomera,peptide,Peptide,antagonist,pb1046,primary,VIPR2,vipr2_human,P41587,Class B1 (Secretin),GPCR;Rhodopsin,VIP and PACAP receptors,not established,MMAmay2016_0630,"vasomera, pb1046",Antihypertensive,2,2016,recruiting,in trial,-,,
2327,velneperit,small molecule,Peptide,antagonist,,primary,NPY5R,npy5r_human,Q15761,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,2144,"velneperit, s-2367",Anti-obesity,2,2010,discontinued,in trial,-,,
2328,velusetrag,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2145,"velusetrag, td-5108",motilitant,2,2014,ongoing,in trial,-,,
2329,vercirnon,small molecule,Protein,antagonist,,primary,CCR9,ccr9_human,P51686,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_294,vercirnon,crohn's disease,3,2011,discontinued,in trial,-,,
2330,verucerfont,small molecule,Peptide,antagonist,nbi-77860,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,MMA2016_0047,"verucerfont, nbi-77860, 561679",Congenital Adrenal Hyperplasia,2,2013,completed,in trial,-,,
2331,vestipitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,2148,"vestipitant, gw 597599",tinnitus; hypnotic,2,2012,discontinued,in trial,-,,
2332,vibegron,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAaug2017_002,"MK-4618, RVT-901",Urinary incontinence,2,2017,completed,in trial,,,
2333,vicriviroc,small molecule,Protein,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,2157,vicriviroc,antiviral ; HIV,3,2007,discontinued,in trial,-,,
2334,vidupiprant,small molecule,Lipid ,antagonist,,primary,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_307,"vidupiprant, AMG853",Anti-Asthmatic,2,2009,discontinued,in trial,-,,
2335,vidupiprant,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_310,"vidupiprant, AMG853",Anti-Asthmatic,2,2009,discontinued,in trial,-,,
2336,vilanterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmar2016_0195,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",chronic obstructive pulmonary disease (COPD),3,2016,ongoing,in trial,-,,23131596
2337,vofopitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,2170,"vofopitant, gr-205171",post-traumatic stress disorder; hypnotic,2,2008,discontinued,in trial,-,,
2338,volinanserin,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2172,volinanserin,Hypnotics and Sedatives,3,2008,discontinued,in trial,-,discontinued due to absence of demonstration of efficacy of volinanserin in primary insomnia with predominant sleep maintenance problems,
2339,vpd-737,small molecule,Peptide,antagonist,serlopitant,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,MMAmay2016_0635,"vpd-737, serlopitant",pruritus,2,2016,recruiting,in trial,-,,
2340,vr-147,small molecule,Aminergic ,not available,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2179,vr-147,Anti-migraine,1,2008,discontinued,in trial,-,,
2341,vr-147,small molecule,Aminergic ,not available,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2179,vr-147,Anti-migraine,1,2008,discontinued,in trial,-,,
2342,vrs-859,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2182,"vrs-859, Exenatide-XTEN",Antidiabetic,1,2017,ongoing,in trial,-,,
2343,vsn16r,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAmay2016_0803,vsn16r,Antispasmodics;  for spatisity related to multiple sclerosis,2,2015,recruiting,in trial,-,,
2344,x4p-001,small molecule,Protein,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAapril2016_0220,x4p-001,Antineoplastic ; renal cell carcinoma,3,2016,recruiting,in trial,-,,
2345,xaliproden,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2200,"xaliproden, sr 57746a",neuroprotectant,3,2006,discontinued,in trial,-,,
2346,xanomeline + trospium chloride,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_016,"LY 246708, Trospium chloride/xanomeline tartrate",Schizophrenia; Alzheimer's disease,2,2017,ongoing,in trial,-,,
2347,xp21279,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,completed,in trial,-,,
2348,xp21279,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,completed,in trial,-,,
2349,xp21279,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,completed,in trial,-,,
2350,xp21279,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,completed,in trial,-,,
2351,xp21279,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,completed,in trial,-,,
2352,ykp10811,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0641,ykp10811,for chronic or functional constipation,2,2014,completed,in trial,-,,
2353,ykp-1358,unknown,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2226,"ykp-1358, Relenopride",schizophrenia,2,2008,completed,in trial,-,Inferred dates,
2354,ykp-1358,unknown,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2226,"ykp-1358, Relenopride",schizophrenia,2,2008,completed,in trial,-,Inferred dates,
2355,ym-178,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2229,"ym-178, Mirabegron",overactive bladder,3,2016,recruiting,in trial,-,,
2356,ym-598,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2230,ym-598,Antineoplastic,2,2002,discontinued,in trial,-,,
2357,yttrium-90 edotreotide,peptide,Peptide,antagonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2232,"yttrium-90 edotreotide,onalta",Antineoplastic,2,2010,not open yet,in trial,-,Issue with drug not being available,
2358,yttrium-90 edotreotide,peptide,Peptide,antagonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2232,"yttrium-90 edotreotide,onalta",Antineoplastic,2,2010,not open yet,in trial,-,Issue with drug not being available,
2359,yttrium-90 edotreotide,peptide,Peptide,antagonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2232,"yttrium-90 edotreotide,onalta",Antineoplastic,2,2010,not open yet,in trial,-,Issue with drug not being available,
2360,zibotentan,small molecule,Peptide,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2241,"zibotentan, zd-4054, azd-4054",Antineoplastic,3,2008,discontinued,in trial,-,discontinued because early efficacy review by the Independent Data Monitoring Committee indicated it was unlikely to meet its primary efficacy endpoints,
2361,zicronapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1176,lu-31130,schizophrenia,3,2011,completed,in trial,-,No development reported,
2362,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0110,zp-triptan,Anti-migraine,3,2016,completed,in trial,-,,11513839
2363,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0111,zp-triptan,Anti-migraine,3,2016,completed,in trial,-,,10463324|10563228|11752352|10844127|11513839|11594437|15096229|20407761|9859690|9399012
2364,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0112,zp-triptan,Anti-migraine,3,2016,completed,in trial,-,,10844127|11513839|11594437|15096229|11752352|10463324|10563228|20407761|9859690|9399012
2365,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0113,zp-triptan,Anti-migraine,3,2016,completed,in trial,-,,11752352|15096229|15320857|12434581|11834243|9718276
2366,zp1848,peptide,Peptide,agonist,,primary,GLP2R,glp2r_human,O95838,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2251,zp1848,Crohn's disease,2,2016,recruiting,in trial,-,,
2367,zpl-389,small molecule,Aminergic ,antagonist,zpl-3893787,primary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmar2016_0120,"zpl-389, zpl-3893787",Anti-inflammatory ; atopic dermatitis,2,2015,completed,in trial,-,,
2368,zyd1,peptide,Peptide,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2256,zyd1,Antidiabetic,1,2012,completed,in trial,-,,
2369,agn-214868,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,terminated,in trial,-,Lack of efficacy,
2370,agn-214868,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,terminated,in trial,-,Lack of efficacy,
2371,agn-214868,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,terminated,in trial,-,Lack of efficacy,
2372,agn-214868,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,terminated,in trial,-,Lack of efficacy,
2373,agn-214868,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,terminated,in trial,-,Lack of efficacy,
2374,agn-214868,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,terminated,in trial,-,Lack of efficacy,
2375,alks 33,small molecule,Peptide,antagonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,115,"alks 29, Baclofen+samidorphan",alcohol dependance; Anti-depressant,1,2008,discontinued,in trial,-,,
2376,alks 33,small molecule,Peptide,antagonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,116,"alks 33, samidorphan",alcohol dependance; Anti-depressant,2,2009,completed,in trial,-,,
2377,alks 33,small molecule,Peptide,antagonist,alks5461,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 33, alks 5461, Buprenorphine+samidorphan",alcohol dependance; Anti-depressant,3,2014,completed,in trial,-,,
2378,alks 33,small molecule,Peptide,antagonist,samidorphan,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0184,"alks 3831,  olanzapine + alks 33,samidorphan",Anti-obesity,3,2016,recruiting,in trial,-,,
2379,alks 37,small molecule,Peptide,antagonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,117,alks 37,motilitant,2,2011,discontinued,in trial,-,,
2380,avr118,peptide nucleic acid,Nucleotide ,not available,,secondary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2269,"avr123, AVR118","Antineoplastic agent, wound healing accelerant",2,2011,discontinued,in trial,-,,
2381,avr118,peptide nucleic acid,Nucleotide ,not available,,secondary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2269,"avr123, AVR118","Antineoplastic agent, wound healing accelerant",2,2011,discontinued,in trial,-,,
2382,avr118,peptide nucleic acid,Nucleotide ,not available,,secondary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2269,"avr123, AVR118","Antineoplastic agent, wound healing accelerant",2,2011,discontinued,in trial,-,,
2383,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0328,"epidiolex, oral liquid cannabidiol, gwp42003",schizophrenia,2,2013,completed,in trial,-,,
2384,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0328,"epidiolex, oral liquid cannabidiol, gwp42003",schizophrenia,2,2013,completed,in trial,-,,
2385,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_039,CBD,Graft Versus Host Disease,2,2017,completed,in trial,-,,
2386,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_040,CBD,Graft Versus Host Disease,2,2017,completed,in trial,-,,
2387,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmar2016_0268,cannabidiol,epilepsy,3,2016,not open yet,in trial,-,,
2388,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmar2016_0269,cannabidiol,epilepsy,3,2016,not open yet,in trial,-,,
2389,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmar2016_0270,"epidiolex, oral liquid cannabidiol, gwp42003",epilepsy,3,2016,recruiting,in trial,-,,
2390,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmar2016_0271,"epidiolex, oral liquid cannabidiol, gwp42003",epilepsy,3,2016,recruiting,in trial,-,,
2391,cannabidivarin,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmay2016_0402,"gwp42006, Cannabidivarin",epilepsy,2,2015,recruiting,in trial,-,,
2392,cannabidivarin,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmay2016_0403,"gwp42006, Cannabidivarin",epilepsy,2,2015,recruiting,in trial,-,,
2393,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,Diuretic,
2394,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,,
2395,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,,
2396,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,,
2397,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,,
2398,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,,
2399,corticotropin-releasing factor,peptide,Peptide,agonist,,secondary,CRHR2,crfr2_human,Q13324,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,528,"corticotropin-releasing factor,xerecept",peritumoral brain edema,3,2005,discontinued,in trial,-,,
2400,darusentan,small molecule,Peptide,antagonist,,secondary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Sep2016_253,darusentan,Antihypertensive,3,2006,discontinued,in trial,-,,
2401,davalintide,protein,Peptide,agonist,,secondary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,ASH_Sep2016_328,davalintide,Anti-obesity,2,2008,discontinued,in trial,-,,
2402,dexpramipexole,small molecule,Aminergic ,agonist,,secondary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,627,"dexpramipexole, kns-760704",amyotrophic lateral sclerosis (ALS),3,2012,terminated,in trial,-,Did not meet its primary efficacy endpoint,
2403,dexpramipexole,small molecule,Aminergic ,agonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,627,"dexpramipexole, kns-760704",amyotrophic lateral sclerosis (ALS),3,2012,terminated,in trial,-,Did not meet its primary efficacy endpoint,
2404,dexpramipexole,small molecule,Aminergic ,agonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,627,"dexpramipexole, kns-760704",amyotrophic lateral sclerosis (ALS),3,2012,terminated,in trial,-,Did not meet its primary efficacy endpoint,
2405,dg3173,small molecule,Peptide,agonist,,secondary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,632,dg3173,hormone replacement,2,2014,ongoing,in trial,-,,
2406,fasoracetam monohydrate,small molecule,Amino acid ,not available,,secondary,GRM1,grm1_human,Q13255,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0121,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,completed,in trial,-,,
2407,guanabenz,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_147,guanabenz,Multiple Sclerosis,1,2015,recruiting,in trial,-,,1666366
2408,mc-1,small molecule,Lipid ,antagonist,,secondary,LPAR4,lpar4_human,Q99677,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1",
2409,mc-1,small molecule,Lipid ,antagonist,,secondary,LPAR6,lpar6_human,P43657,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1",
2410,mc-4232 + mc-1,small molecule,Lipid ,antagonist,,secondary,LPAR4,lpar4_human,Q99677,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,,
2411,mc-4232 + mc-1,small molecule,Lipid ,antagonist,,secondary,LPAR6,lpar6_human,P43657,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,,
2412,pardoprunox,small molecule,Aminergic ,agonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,,
2413,pardoprunox,small molecule,Aminergic ,agonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,,
2414,pardoprunox,small molecule,Aminergic ,agonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,,
2415,pardoprunox,small molecule,Aminergic ,agonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,,
2416,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0100,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,completed,in trial,-,,12476402
2417,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0101,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,completed,in trial,-,,12476402
2418,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0102,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,completed,in trial,-,,12476402
2419,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0103,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,completed,in trial,-,,12476402
2420,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0104,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,completed,in trial,-,,12476402
2421,renzapride,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1734,renzapride,irritable bowel syndrome,3,2008,discontinued,in trial,-,Terminated due to insufficient over placebo in study,
2422,renzapride,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1734,renzapride,irritable bowel syndrome,3,2008,discontinued,in trial,-,Terminated due to insufficient over placebo in study,
2423,spi-1620,peptide,Peptide,agonist,,secondary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1892,spi-1620,adjuvant to chemotherapy,2,2013,discontinued,in trial,-,Appears to not meet efficacy end point,
2424,sufentanil,small molecule,Peptide,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,243,"arx-03, sufentanil + triazolam nanotab",Analgesics; adjuvant to anesthesia,2,2011,suspended,in trial,-,,1330549|8612823
2425,sufentanil,small molecule,Peptide,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1909,"sufentanil transdermal patch,transdur-sufentanil",Analgesics,2,2015,discontinued,in trial,-,,1330549|8612823
2426,sufentanil,small molecule,Peptide,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1910,"sufentanil,chronogesic",Analgesics,2,2015,discontinued,in trial,-,,1330549|8612823
2427,sufentanil,small molecule,Peptide,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,243,"arx-03, sufentanil + triazolam nanotab",Analgesics; adjuvant to anesthesia,2,2011,suspended,in trial,-,,8612823|2467589
2428,sufentanil,small molecule,Peptide,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1909,"sufentanil transdermal patch,transdur-sufentanil",Analgesics,2,2015,discontinued,in trial,-,,8612823|2467589
2429,sufentanil,small molecule,Peptide,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1910,"sufentanil,chronogesic",Analgesics,2,2015,discontinued,in trial,-,,8612823|2467589
2430,tolterodine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,completed,in trial,-,,16406943
2431,tolterodine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,completed,in trial,-,,16406943
2432,va111913,small molecule,Peptide,antagonist,,secondary,AVPR1B,v1br_human,P47901,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2116,va111913,dysmenorrhea,2,2010,completed,in trial,-,,
2433,va111913,small molecule,Peptide,antagonist,,secondary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2116,va111913,dysmenorrhea,2,2010,completed,in trial,-,,
2434,vabicaserin,small molecule,Aminergic ,agonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_22,vabicaserin,schizophrenia,2,2008,discontinued,in trial,-,,
2435,vabicaserin,small molecule,Aminergic ,agonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_27,vabicaserin,schizophrenia,2,2008,discontinued,in trial,-,,
2436,xanomeline + trospium chloride,small molecule,Aminergic ,agonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_017,"LY 246708, Trospium chloride/xanomeline tartrate",Schizophrenia; Alzheimer's disease,2,2017,ongoing,in trial,-,,
2437,xanomeline + trospium chloride,small molecule,Aminergic ,agonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_018,"LY 246708, Trospium chloride/xanomeline tartrate",Schizophrenia; Alzheimer's disease,2,2017,ongoing,in trial,-,,
2438,xanomeline + trospium chloride,small molecule,Aminergic ,agonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_019,"LY 246708, Trospium chloride/xanomeline tartrate",Schizophrenia; Alzheimer's disease,2,2017,ongoing,in trial,-,,
2439,xanomeline + trospium chloride,small molecule,Aminergic ,agonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAaug2017_020,"LY 246708, Trospium chloride/xanomeline tartrate",Schizophrenia; Alzheimer's disease,2,2017,ongoing,in trial,-,,
2440,adx71441,small molecule,Amino acid ,PAM,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0243,adx71441,neurologic disorders,0,2017,not open yet,preclinical,-,,
2441,adx71441,small molecule,Amino acid ,PAM,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0244,adx71441,neurologic disorders,0,2017,not open yet,preclinical,-,,
2442,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAapril2016_0296,"zyn002, Topical cannabidiol gel",Anticonvulsants; Antiepileptics,0,2017,not open yet,preclinical,-,,
2443,CNTX-6016,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_045,CNTX-6016,Analgesics,0,2017,not open yet,preclinical,-,,
2444,cosyntropin,peptide,Peptide,agonist,,primary,MC2R,acthr_human,Q01718,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,established,MMAmar2016_0275,"re-034, cosyntropin, tetracosactid",epilepsy,0,2016,ongoing,preclinical,-,,15710205|2156274|20562554|11752352
2445,nps-2143,small molecule,Ion ,antagonist,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,1441,nps-2143,Anti-osteoporotic,0,2015,completed,preclinical,-,,
2446,sb-269652,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMA_2017_002,sb-269652,antipsychotic,0,2000,unknown,preclinical,-,,
2447,srx-1177,peptide,Peptide,not available,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,MMAapril2016_0099,srx-1177,Antineoplastic,0,2015,not open yet,preclinical,-,,
2448,tetrahydrocannabinol prodrug,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_001,"THC prodrug transdermal patch,ZYN001",neuropathic pain; fibromyalgia,0,2016,not open yet,preclinical,-,,17828291
2449,tetrahydrocannabinol prodrug,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAaug2017_001,"THC prodrug transdermal patch,ZYN001",neuropathic pain; fibromyalgia,0,2016,not open yet,preclinical,-,,20943404
2450,tetrahydrocannabinol prodrug,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAaug2017_001,"THC prodrug transdermal patch,ZYN001",neuropathic pain; fibromyalgia,0,2016,not open yet,preclinical,-,,
2451,yohimbine,small molecule,Aminergic ,antagonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD564,-,Mydriatics; Anti-impotence,0,2000,discontinued,preclinical,-,Inferred dates,12438517|11226402|16176444|12591093|12110610|10611634
2452,yohimbine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD564,-,Mydriatics; Anti-impotence,0,2000,discontinued,preclinical,-,Inferred dates,17558432|17664022|10506165|12591093|16325800|10611634
2453,yohimbine,small molecule,Aminergic ,antagonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD564,-,Mydriatics; Anti-impotence,0,2000,discontinued,preclinical,-,Inferred dates,8872361|12110610|10822066|12170055|17123717|10611634
2454,cannabidiol,small molecule,Lipid ,agonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0296,"zyn002, Topical cannabidiol gel",Anticonvulsants; Antiepileptics,0,2017,not open yet,preclinical,-,,
2455,cannabidiol,small molecule,Lipid ,agonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0297,"zyn002, Topical cannabidiol gel",Anticonvulsants; Antiepileptics,0,2017,not open yet,preclinical,-,,
2456,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,,17139284|17016423
2457,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,,17139284|17016423
2458,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,,17139284|17016423
2459,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,,17139284|17016423
2460,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,,17139284|17016423
2461,benzquinamide,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,,17139284|17016423|2905706|6130555
2462,sertindole,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market,11888555|19506838
2463,sertindole,small molecule,Aminergic ,inverse agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market,16925508|11594443
2464,sertindole,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market,16925508|11752352|19506838|18293356|20856607
2465,sertindole,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market,16925508|7530204|11594443
2466,sertindole,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market,16925508
2467,sertindole,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market,16925508
2468,sertindole,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market,16925508|11594443
